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ABSTRACT 
This is an investigation into alcohol dehydrogenases (ADHs) from Geobacillus 
thermoglucosidasius.  Eighteen ADHs have been studied, with seven taken for closer 
inspection.  Characterisation was carried out to determine the industrial significance of 
these enzymes, starting with the substrate scope of the ADHs.  The key results obtained are 
as follows: 
ADH A is the alcohol dehydrogenase domain of the bifunctional ADHE enzyme (Extance, 
2012; Extance et al., 2013).  It has been determined that the substrate scope, whilst 
restricted to linear aliphatic aldehydes, extends at least to dodecanal.  Also, with a 
specificity constant of 167 mM-1 min-1 it appears that ADH A could prefer butanal to 
shorter-chain aldehydes such as ethanal and propanal with specificity constants of 38 mM-1 
min-1 and 35  mM-1 min-1, respectively.  Thus ADH A may have a preference for longer 
aldehydes than previously believed due to its native role in the production of ethanol from 
acetyl-coA.   
ADH B was previously investigated for its potential role in the production of butanol.  Here 
it was confirmed as an NADH-dependent ADH, with a substrate scope limited to five carbon 
length substrates and smaller, with residual activity with C6 substrates. ADH B 
demonstrated activity with ethyl 4-chloroacetoacetate, an intermediate in the production 
of statins.  Further, an estimated half-life whilst stored at 4°C of 770 days; retention of 86% 
activity with 10vol% ethyl acetate and 92% activity with 10vol% acetonitrile; and a specific 
activity of 27 U mg-1 with 3M 2-butanone are all indications that ADH B is a potentially 
useful enzyme for industry. 
The last enzyme to be previously investigated was ADH C, which in this work was confirmed 
to be an acetoin reductase with a very small substrate scope exclusively based around the 
acetoin motif, and therefore no further work was conducted. 
ADH D and ADH F both have broad substrate scopes including the industrially-relevant 
substrates, 5-norbornene-2-carboxaldehyde, 1-phenyl-1,2-propanedione, ethyl 4-
chloroacetoacetate and ethyl-2-oxo-4-phenylbutyrate.  ADH D is an NADPH-dependent 
enzyme whereas ADH F can utilise both NADH and NADPH.  Both enzymes are annotated as 
aldo-keto reductases, which is further indicated by multiple sequence alignment with the 
most similar available protein sequences and crystal structures.  Thus, these two enzymes 
are the first aldo-keto reductases to be examined from moderate thermophiles, and are 
tentatively assigned in the AKR family as AKR6D1 and AKR5G4 respectively.   
ADH D has a very low KM (≤0.1 µM) with NADPH, giving a specificity constant of 2,800,000 
mM-1 min-1, substantially higher than any other noted.  ADH D showed >80% activity from 
pH 5.0 - 8.0. The enzyme was resistant to solvents DMSO (at 5 vol%) and ethyl acetate, 
acetonitrile and cyclopentyl methyl ether (at 20vol%). 
ADH F had the broadest substrate scope of any ADH tested, with 1-phenyl-1,2-
propanedione the most preferred substrate with a KM of 0.010 mM and a specificity 
constant of 54,000 mM-1 min-1.  It greatly preferred sodium phosphate at pH 7.0, as almost 
any deviation resulted in a substantial loss of activity.  Activity of ≥70% was recorded in 
5vol% DMSO, ethyl acetate, acetonitrile, cyclopentyl methyl ether and 50vol% hexane . 
x 
Both ADH D and F have optimal activities at 70 °C and both may have application in the 
biotechnology industry for the production of pharmaceutical intermediates and other high 
value chemicals. 
ADH E acts solely as an aldehyde reductase, with Vmax using NADH of 74, 331, 320 and 281 
U mg-1 for methanal, ethanal, propanal and butanal, respectively.  Activity with NADPH was 
limited (< 1% compared with NADH).  Activity was also noted with higher aldehydes such as 
octanal and furfural.  
ADH G is an NADPH-dependent ADH utilizing aldehydes only.  It has an optimal 
temperature of 60°C with a half-life of under two hours at that temperature. 
In conclusion, this thesis reports a feasibility study into the potential industrial use of 
specific enzymes for a variety of purposes ranging from the production of pharmaceutical 
intermediates to bioremediation.  ADHs D and F are most likely to have use in the 
biotechnology industry, and ADHs B and E may be suitable for cofactor regeneration.   ADH 
E may additionally be useful in the bioremediation industry.  In addition, the anticipated 
biological significance of these enzymes is described. 
   
xi 
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With the current drive towards a sustainable chemical industry, it has become more frequent 
to consider biological solutions to problems previously considered the sole domain of 
chemistry (Clouthier and Pelletier, 2012).  The derivation of chemicals from biorenewable 
sources, biocatalysis for the further processing, and bioremediation of waste streams are 
distinct elements that are all being pursued to a greater or lesser degree depending on their 
technological requirements.  The fusion of these individual elements into existing processes is 
one approach; the de novo creation of entirely new processes is another (Vennestrøm et al., 
2011). 
By the application of new ways of thinking with traditional approaches, utilising old 
technologies with new materials and substrates, new routes to current chemical products can 
be discovered and innovative additional products can be found.  The current cultural shift 
towards sustainability is a phase that is ending, giving way to the realisation that sustainability 
is not merely a sociological phenomenon, but by approaching technical problems in a holistic 
manner, it is possible to discover new solutions.  There is a compelling business case, a 
compelling technical case and a compelling ecological case for a sustainable chemical industry.  
The only way a truly sustainable chemical industry can be created is by the use of biology, by 
replacing the carbon source in the industry with biologically derived materials rather than oil.  
This is not a simple or easy process; however, the concept of a biorefinery is important and a 
necessary one (Clark, 2007; Kamm and Kamm, 2007). 
This will only become possible through the application of apparently disparate disciplines and 
fields; it is crucial to look forward and anticipate the required union of the biological and 
chemical sciences with their counterparts in the engineering disciplines.  There is a plenitude 
of fields that could be useful (Murphy, 2011); however, one route is to focus on the 
enzymology and industrial biotechnology areas as critical mediators between the products 
needed and the source materials on offer (Hatti-Kaul et al., 2007; Wohlgemuth, 2009; Wenda 
et al., 2011; Philp et al., 2013). 
Specifically alcohol dehydrogenases (ADHs) are enzymes that have been growing increasingly 
popular industrially, with examples being used across the chemical industry and in other fields 
(Musa and Phillips, 2011).  This is because they are heavily studied and also because the 
products that they form are in high demand. 
Additionally it is becoming evident that thermophilic organisms have something to offer the 
chemical industry.  Previously considered useful only in techniques such as Polymerase Chain 
Reactions (PCR), thermophiles are gradually making progress as a major source of useful 
enzymes and as key species for further investigation (Niehaus et al., 1999). 
Thus the literature will be reviewed with focus on the role of alcohol dehydrogenases from 
thermophilic organisms such as Geobacillus thermoglucosidasius, but with emphasis on the 
wider context within the fields of chemical synthesis and sustainability and the chemical 
industry.  Examples will be drawn from a range of relevant industries, including the 
pharmaceutical, cosmetic, fine chemical, bioplastic, biofuel and water industries as 




1.1. ROLE OF BIOLOGY IN CHEMICAL SYNTHESIS 
This section will consider the ways in which biology and associated disciplines have already 
become part of chemical synthesis, and the reasons behind this.  A full analysis of sustainable 
development is outside the scope of this review and therefore analysis will be constrained to a 
comparative analysis of potential effects of biology, biotechnology and associated disciplines 
to the sustainability of the chemical industry. 
1.1.1. SUSTAINABLE CHEMISTRY 
Sustainable chemistry, or green chemistry, is the development of new chemical processes that 
are inherently safer, produce less waste, and are environmentally benign.  Starting in the early 
1990s, this field has become increasingly well supported through academic interest, industrial 
support and political will (Anastas and Kirchhoff, 2002; Wohlgemuth, 2009; Dunn, 2011).  
There is still debate on which metrics to use for measuring the “greenness” of a process 
(Jiménez-González et al., 2012); however, various methods such as atom economy and E factor 
are among those considered valid.  In the case of atom economy, a process is considered 
better if a greater proportion of the atoms used as reactants end up in the final product rather 
than as waste.  Importantly, this measure ignores solvents and additional reagents not directly 
involved with the reaction, whereas the E factor deliberately includes all waste streams and is 
defined as indicated in Equation 1  (Sheldon, 2012).  Deliberation continues as to whether 




𝑅𝑎𝑤 𝑀𝑎𝑡𝑒𝑟𝑖𝑎𝑙𝑠 − 𝐷𝑒𝑠𝑖𝑟𝑒𝑑 𝑃𝑟𝑜𝑑𝑢𝑐𝑡
𝑇𝑜𝑡𝑎𝑙 𝑃𝑟𝑜𝑑𝑢𝑐𝑡
 
Equation 1 - E factor equation, typically calculated on a mass basis, giving a value of kg waste per kg 
product.  Typical values range from 1-5 kg waste per kg product for bulk chemicals through to 20-
100kg waste kg
-1
 product or higher in the pharmaceutical industry (Sheldon, 2012). 
 
There are various reasons behind the move towards green chemistry.  Toxicity of waste 
streams is one particular driver, with the chemical industry producing voluminous quantities of 
waste that is difficult to dispose of.  Even relatively benign materials such as sodium chloride 
can become major problems when considering industrial processes, as tons of such materials 
can still be problematic.  Conversely, waste streams containing heavy metals can become an 
issue with very small quantities. 
Another pressure on the chemical industry is climate change, and therefore the carbon 
footprint of the industry and the effects of emissions upon the atmosphere are coming under 
increasing scrutiny with public perception of climate change becoming more prevalent.  Tied 
into this is the decreased reliance upon fossil fuels, either for energy or as raw materials, and 
this, de facto, encourages the industry to consider biological methods of obtaining raw 
materials. 
A third area of consideration is cost and efficiency.  As sustainability inherently considers cost 
and economic reasons to be integral to the concept, then it has become increasingly difficult 
for industry to marginalise sustainable chemistry as something alien and incomprehensible.  
Even if a company solely considers processes based upon financial considerations, green 
chemistry provides solutions which are intrinsically better in this regard. 
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Finally, as with all areas of industry, regulation is king.  All the previously mentioned themes 
are emphasised with the development of regulations that either stimulate industry to change, 
or harshly encourage process development.  In particular, the REACH regulations (Registration, 
Evaluation, Authorisation and restriction of CHemicals)  instigated by the European Union and 
their US counterparts the Toxic Substances Control Act are particularly all-encompassing and 
compel the chemical industry to a higher standard than previously undertaken in terms of 
monitoring production and storage of toxic chemicals (Clark, 2007; Philp et al., 2013).  
 
1.1.2. PRINCIPLES OF GREEN CHEMISTRY 
The principles of green chemistry have been promulgated as follows (Anastas and Eghbali, 
2010): 
1. Prevention.  It is better to prevent waste than to treat or clean up waste after it is 
formed. 
2. Atom Economy.  Synthetic methods should be designed to maximise the incorporation 
of all materials used in the process into the final product. 
3. Less Hazardous Chemical Synthesis.  Whenever practicible, synthetic methodologies 
should be designed to use and generate substances that pose little or no toxicity to 
human health and the environment. 
4. Designing Safer Chemicals.  Chemical products should be designed to preserve 
efficacy of the function while reducing toxicity. 
5. Safer Solvents and Auxiliaries.  The use of auxiliary substances (e.g. solvents, 
separation agents, etc.) should be made unnecessary whenever possible, and when 
used, innocuous. 
6. Design for Energy Efficiency.  Energy requirements of chemical processes should be 
recognised for their environmental and economic impacts and should be minimised.  If 
possible, synthetic methods should be conducted at ambient temperature and 
pressure. 
7. Use of Renewable Feedstocks.  A raw material or feedstock should be renewable 
rather than depleting whenever technically and economically practicable. 
8. Reduce Derivatives.  Unnecessary derivatisation (use of blocking groups, 
protection/deprotection, temporary modification of physical/chemical processes) 
should be minimised or avoided if possible, because such steps require additional 
reagents and can generate waste. 
9. Catalysis.  Catalytic reagents (as selective as possible) are superior to stoichiometric 
reagents. 
10. Design for Degradation.  Chemical products should be designed so that at the end of 
their function they break down into innocuous degradation products and do not 
persist in the environment. 
11. Real-Time Analysis for Pollution Prevention.  Analytical methodologies need to be 
further developed to allow for real-time, in-process monitoring and control prior to 
formation of hazardous substances. 
12. Inherently Safer Chemistry for Accident Prevention.  Substances and the form of a 
substance used in a chemical process should be chosen to minimise the potential for 
chemical accidents, including releases, explosions and fires. 
These principles can be arranged in groups loosely based around themes of safety, 
environmental protection and efficiency.  In essence, the aim of any new chemical process 
should be to reduce waste, reduce toxicity and reduce safety concerns if it is designed with 
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reference to these principles.  In keeping with other movements such as Quality by Design in 
the pharmaceutical industry (Blacker and Williams, 2011; Laird, 2011), these principles also 
encourage forward thinking and planning new processes carefully by considering alternatives 
wherever possible. 
Another important aspect is put forward by Principle 10, the concept that not only should a 
chemical product be designed in conjunction with an efficient process, but that at the end of 
their usefulness they are designed to be easily degradable or perhaps otherwise used.  The 
idea that a product beyond its useful lifespan can be utilised in a new capacity or constructed 
in such a manner as to allow easier recyclability or reusability is a relatively old idea only 
recently coming to the fore (Ellen MacArthur Foundation, 2015; Kiser, 2016; Stahel, 2016).   
There are several fields of study that incorporate these ideas.  Life-cycle assessments are a tool 
used to evaluate the sustainability of a given process, and these historically used only to 
incorporate the effects of production, called cradle-to-gate.  More frequently they now 
consider cradle-to-grave, analysing the effects of transportation, sale, use and disposal of the 
product in question.  They may even go cradle-to-cradle, which follows the waste materials of 
the product until the point they are utilised in new products (Hatti-Kaul et al., 2007).  Industrial 
ecology is the study of the flow of materials and energy in industrial processes (Garner and 
Keoleian, 1995).  Using ecosystems as a model, different feedstocks and routes can be 
compared for their efficiency and safety.  These flows link different processes together, 
perhaps from disparate industries, in order to effectively absorb each component of a process 
so that there is no waste (Jacquet et al., 2015).  This is termed the circular economy, whereby 
the products from a process are not simply discarded at the end of their useful lifetime, as in 
the linear economy.  Central to this transformative approach is the concept of designing 
processes to be reversible and products to be easily degraded or reused, as implied by 
Principle 10 above (Stahel, 2016).  One of the goals is to ensure that all flows from industrial 
processes are ultimately able to be discharged into environmental processes with no 
noticeable effect. 
Obviously not every process is going to be able to maximise conformity to each of the 
principles of green chemistry or be integrated into a circular economy.  There has also been 
debate as to whether a circular economy can ever realistically be obtained, with 
thermodynamic and social restraints present (Bilitewski, 2012; De Man and Friege, 2016).  That 
said, when used as inspiration, it is possible that improvements will be seen on a sector or 
reaction basis. 
 
1.1.3. SANDESTIN DECLARATION AND GREEN ENGINEERING 
In July 2001 at the Sandestin Resort in Florida, the first conference on “Green Engineering – 
Defining the Principles” was held, leading to the attendees establishing what became known as 
the Sandestin Declaration.  This was a set of principles of Green Engineering, replicating and 
extending the Principles of Green Chemistry to the engineering fields (Abraham and Nguyen, 
2003).  These draft principles were refined and finalised to read thus (Anastas and 
Zimmerman, 2003): 
1. Designers need to strive to ensure that all material and energy inputs and outputs are 
as inherently non-hazardous as possible. 
2. It is better to prevent waste than to treat or clean up waste after it is formed. 
3. Separation and purification operations should be designed to minimise energy 
consumption and materials use. 
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4. Products, processes and systems should be designed to maximise mass, energy, space 
and time efficiency. 
5. Products, processes and systems should be “output pulled” rather than “input pushed” 
through the use of energy and materials. 
6. Embedded entropy and complexity must be viewed as an investment when making 
design choices on recycle, reuse or beneficial disposition. 
7. Targeted durability, not immortality, should be a design goal. 
8. Design for unnecessary capacity or capability (e.g. “one size fits all”) solutions should 
be considered a design flaw. 
9. Material diversity in multicomponent products should be minimised to promote 
disassembly and value retention. 
10. Design of products, processes and systems must include integration and 
interconnectivity with available energy and materials flows. 
11. Products, processes and systems should be designed for performance in a commercial 
“afterlife”. 
12. Material and energy inputs should be renewable rather than depleting. 
 
Whilst the principles of both Green Chemistry and Green Engineering are broad, occasionally 
indistinct, and can be misinterpreted, their general emphasis is to consider not only the 
individual process under investigation, but also how that process will be used.  Particularly in 
engineering, scale up is an important consideration and often overlooked at laboratory scale.  
Important too is a holistic viewpoint, with a life-cycle analysis of the system to prevent an 
improved process inadvertently causing bigger issues elsewhere in the system.  This is 
particularly highlighted in Principle 6 of Green Engineering – embedded complexity refers both 
to the complexity of a given product but also the system in place to create the product.  
Embedded entropy in this case is similar, implying that a product with high complexity is likely 
to require substances with greater mass, more types of materials and higher entropy.  This 
relates to the concept of a circular economy insofar as this principle means that these inherent 
characteristics of a product need to be taken into account when considering disposal or reuse.  
It also concerns the interactions of different disciplines during the lifetime of a product, which 
needs to incorporate a holistic approach involving both upstream and downstream 
perspectives.   Scale-up is one aspect of this.  An approach that may be very efficient at 
laboratory scale may suddenly be ineffective at pilot plant or larger scale.  Principles 9 and 11 
also refer to the end-of-life considerations of products, including the circular economy 
concept. 
A simple example of this would be a chemical process with greater conversion, but would 
result in more expensive, energy intensive separation in order to effect a greater yield.  This 
would be a situation where a “better” process may in fact cause a “worse” overall result and 
therefore needs to be considered carefully before implementation.   
Though the majority of the principles often refer to overall analyses and can appear to be 
obvious, by way of example, consider principle 5 of Green Engineering.  Typically in chemical 
reactions there is a surplus of at least one reactant, in order to drive the reaction to 
completion.  Of benefit to analysis at bench scale, this is simply untenable at industrial scale, 
for cost, efficiency and sustainability reasons.  Therefore, the implication from the principle is 
to create an in situ product recovery (ISPR) system whereby one of the products is removed to 
invoke Le Châtelier’s Principle from the product side rather than the reactant side. 
There are differences between Green Chemistry and Green Engineering, which reflects the 
different emphases between the fields.  Whereas the principles of Green Chemistry are 
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written to ensure that a given process is as technically perfect as possible, with as few steps, 
with as much safety, and as ecologically sound as possible, the principles of Green Engineering 
are more focussed on the same issues at the system scale.  In both cases though it is likely that 
any given process or system will require more investment in terms of financing and time in 
advance of implementation instead of piecemeal after implementation when problems arise.  
The adage “a stitch in time saves nine” is the general premise behind these principles. 
 
1.1.4. GENERAL APPLICABILITY OF BIOLOGY TO PRINCIPLES 
It is of benefit to utilise biotechnology in chemical synthesis and broadly in the chemical 
industry as by using a biological approach to complex chemical issues the principles of both 
Green Chemistry and Green Engineering can be adhered to.  In particular, bioconversions and 
biotransformations are inherently safer than their chemical counterparts in terms of chemical 
safety by a reduced use of heavy metals, organic solvents and moderation of reaction 
conditions.  Biological safety will depend upon the nature of the transformation undertaken, 
whether viable whole cells are used, the species involved and the specifics of each process.  
The biological approach can be considered advantageous in many ways, but is not a panacea 
(Clouthier and Pelletier, 2012).  In terms of renewability, as enzymes derive from alternative 
carbon sources to oil, this decouples the carbon input from fossil fuels.  Waste streams are less 
likely to contain heavy metals and particularly toxic chemicals with severely damaging 
environmental and human health effects, yet they are much more likely to be extremely dilute 
aqueous streams which pose issues of volume and of processing. 
Energy efficiency is outstandingly complex to determine as it is likely that a biological process 
will be carried out at a lower temperature than an equivalent chemical process, which would 
seem to indicate greater energy efficiency in the biological process.  Conversely, biological 
processes may take longer, require substantial amounts of cooling to maintain 37 oC if a 
mesophilic organism is used, may necessitate energetically costly methods of separation to 
remove water from the product, and may have a greater number of by-products requiring 
further processing.  Therefore, it may not be immediately possible to designate a biological 
system or process to be superior to an existing chemical process. 
One major advantage of utilising a biological approach is that existing waste streams may be 
utilised as feedstocks for new processes.  Furthermore, waste streams from any biological 
process may have use elsewhere as a feed for another process.  Particular examples of the 
usefulness of this would be in the production of food, for instance corn, or in the biofuel 
industry where glycerol is an unwanted by-product (Zhou et al., 2008).  This leads to the 
concepts of a biorefinery (Clark et al., 2006; Kamm and Kamm, 2007), industrial ecology and 
the potential for a circular economy.  Substantial amounts of biomass are produced worldwide 
each year (Vennestrøm et al., 2011), with the majority of it being burnt or otherwise discarded.  
Lignocellulosic material is one of the most heavily considered materials as a biorenewable 
resource, and the full utilisation of it would represent a seismic shift in industrial carbon flow, 
with huge numbers of chemicals potentially being produced from lignocellulose, including 
vanillin, furans, sugars, ethanol and other alcohols as well as various organic acids.  These may 
be used for a variety of purposes: biofuels, bioplastics and intermediates for an assortment of 
chemical processes (Hatti-Kaul et al., 2007; Serrano-Ruiz et al., 2011; Azadi et al., 2012). 
As previously mentioned, the utilisation of renewable feedstocks does not obligate subsequent 
processing also to be biological as the two approaches are independent of each other.  Thus 
work is ongoing to integrate renewable feedstocks into existing chemical processes whilst 
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equally research is conducted into developing biological routes to products, irrespective of the 
origin of the starting materials (Ran et al., 2008; May, 2009; Ma et al., 2010).  This leads to a 
situation whereby renewable feedstocks may be used in a grossly wasteful chemical process or 
where a fossil fuelled process is catalysed biologically in an equally wasteful manner.   By 
creating enhanced processes, of either chemical or biological nature, then gradually the 
chemical industry will become more sustainable, even if an apparent patchwork of unit 
operations are combined to create entirely new platforms for processing. 
Two of the most well recognised sustainable processes are the production of artemisinin, an 
anti-malarial drug, and sitagliptin, a treatment for type 2 diabetes.  In the first case, artemisinin 
is traditionally obtained botanically, from Artemisia annua, a plant used in Chinese medicine.  
Due to the difficulties in extracting the product and purifying it, it was expensive, especially so 
for an anti-malarial drug where cost may be a particular concern.  Production volume was also 
a major limiting factor, as the herb itself requires an extensive amount of manpower to grow 
and harvest, which combined with relatively low yields, explains the prices of up to $1600/kg 
(Hale et al., 2007).   The new process was to determine the metabolic pathway for the 
production of artemisinic acid, a direct precursor to the active molecule, and insert this 
pathway into yeast or Escherichia coli, which can be readily grown and harvested using existing 
technologies.  By incorporating genes from a wide range of species, a full pathway of 11 genes 
was inserted into E. coli in order to determine the optimal production method.  The methods 
used in this example required substantial effort; however, they have provided a framework 
that can be used for a great range of similar chemicals derived from isoprenoid pathways 
(Keasling, 2008; Anthony et al., 2009; Tsuruta et al., 2009). 
The final production method utilised yeast as the chassis organism to increase production 
efficiency and has been developed into an industrial scale process producing artemisinic acid, 
which can then be chemically catalysed to produce artemisinin.  This part-biological and part-
chemical synthetic route is termed a semi-synthetic production process, and is successful at 
the multi-ton scale (Paddon et al., 2013; Paddon and Keasling, 2014).  Whilst scientifically 
speaking a landmark case of synthetic biology, in terms of sustainability this process has been 
marred with flaws in economic design and social acceptance in recent years.  Combined, these 
issues have led Sanofi, the commercial producer, to suspend production entirely.  Economically 
speaking, the semi-synthetic production is not profitable at the current market price for 
artemisinin.  Although the price for botanically acquired artemisinin reached $1600/kg on 
occasion, it fluctuated wildly due to the lead time for growing and harvesting the herb.  More 
recently the price had stabilised, and has been as low as $250/kg, substantially below the 
breakeven point of $350-$400 established upon market entry.  It has also not helped that 
charity funding, which was critical to the research phase, has inevitably been withdrawn once 
a commercial process was developed (Peplow, 2013, 2016). 
Socially speaking, the botanical production of artemisinin involves an entire farming 
community and decentralised production and refinement.  This is the main reason for the 
fluctuating prices, as farmers choose whether to plant A. annua or another crop.  If the prices 
increase due to shortages, then many farmers plant the herb, causing mass overproduction 
shortly after.  This is one of the reasons why a semi-synthetic route was considered, to stabilise 
production volumes and prices.  There has been concern that the introduction of a 
commercial-scale, semi-synthetic process would have collapsed the botanical market, driving 
up prices for artemisinin and ruining the livelihood of the farmers who rely upon the crop.  
Instead, the above economic concerns have reduced the semi-synthetic method almost to a 
footnote (Peplow, 2013, 2016).  Overall the sustainability credentials of this process are 
severely undermined due to both social and economic failures.  Although the original goals of 
the project were admirable – to increase production of artemisinin to allow for mass 
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production of combined anti-malarial treatments and ultimately to save lives - semi-synthetic 
production of artemisinin may prove to be a cautionary tale on how not to commercialise 
synthetic biology triumphs. 
The second example, sitagliptin manufacture, went through three or technically four iterations 
in total before the process was accepted.  The full scheme is provided in Figure 1; however, in 
brief, the first generation process was an entirely chemocatalytic process plagued with 
substantial waste issues.  An alternative chemocatalytic process was considered, the second 
generation process, which contained a three-step one-pot reaction to dehydrositagliptin (12 in 
Figure 1), alternative starting materials to improve the atom economy, utilisation of effective 
catalyst recycling, and overall a much greater control than previous.  Purification was also 
enhanced by employing crystallisation and filtration rather than chromatographic or 
distillation techniques.  This process was scaled up successfully to production scale, having 
increased the overall yield from 52% to 65% and reduced the waste from 250kg to 50kg per kg 
of product. 
Further work removed a reaction step, leading to an improved second-generation process, (c) 
in Figure 1, but this was still considered suboptimal due to the transition metal mediated step 
still in place.  This was finally replaced with a heavily engineered transaminase to 
accommodate the substrate required, involving 27 mutations of the native enzyme.  This final 
process led to a further increase in the yield (13%), productivity (53%) and reduction in the 
waste produced (19%).  Typically, stereocontrol is a major reason for switching to an enzymatic 
route; however, this is not the overriding purpose in this particular case, as the final chemical 
process provided >99.9% ee.  The issue was that, in achieving the necessary enantiomeric 
purity, a crystallisation step was needed and the use of transition metals required specialised 
equipment and demanded assiduous removal of the metal.  By using the transaminase 
>99.95% ee was achieved, and this removed the necessity for a crystallisation step.  Thus, 
whilst an increase in enantiomeric excess was achieved, it was a secondary effect driven by 




Figure 1 - Schemes of three generations of process research and development towards the 
manufacture of sitagliptin phosphate.  Bn = benzyl,  binap = 2,2'-bis(diphenylphosphino)-1,1'-
binapthyl, cod = 1,5-cyclooctadiene, DIAD = diisopropyl azodicarboxylate, DMAP = 4 -
dimethylaminopyridine, NMM = N-methylmorpholine, segphos= (4,4’-bi-1,3-benzodioxole)-5,5’-
diylbis(diphenylphosphine).  Directly reproduced from Desai (2011). 
 
1.2. WHOLE CELL VERSUS ISOLATED ENZYME 
One of the common debates when considering an enzymatic reaction is whether to use whole 
cells or isolated enzymes to carry out the reaction, and this debate has evolved in recent years.  
Isolated enzymes are typically preferred to reduce side reactions, to ensure that the process 
undertaken is well understood, or to increase the space time yield (STY) of a process.  They 
may also be used to improve downstream processing, which will be cleaner, or to operate in 
conditions that may be inimical to whole cells (Goldberg et al., 2007a).  Something that is more 
rarely considered is the possibility of utilising multiple isolated enzymes for the purposes of 
creating a one pot multistep reaction.  More traditionally a rule of thumb is used whereby if 
you need more than two or three enzymes for a specific reaction then it is considered best to 
attempt a whole cell approach.  This usually refers to a single reaction that is sought, 
comprising multiple enzymatic steps, not an entire biosynthesis. 
The new approach has been termed biocatalytic cascade reactions (BCR) (Guterl and Sieber, 
2013) or synthetic pathway biotransformations (SyPaB) (Zhang et al., 2010), depending on the 
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emphasis of the work.  In the case of biocatalytic cascade reactions the aim is to enable 
production of a required chemical product as a one pot reaction, using enzymes sequentially 
to biologically synthesise a product from cheaper and readily available substrates.  In the case 
of synthetic pathway biotransformations, the aim is to replicate extant pathways in a cell-free 
environment or engineer superior pathways based upon natural equivalents, typically using a 
larger number of enzymes in both cases.   Another viewpoint is that SyPaB concentrates on 
biosynthesis, whereas BCR is effectively biotransformation.  Thus, whilst there may be 
considerable overlap between the two methods, the motivation is substantially divergent. 
What is particularly interesting about these methods is that they are not entirely new.  In 
chemistry the principle of domino reactions has been known for a long time (Tietze, 1996; 
Tietze and Modi, 2000), which are defined as “a process involving two or more bond-forming 
transformations (usually C-C bonds) which take place under the same reaction conditions 
without adding additional reagents and catalysts, and in which the subsequent reactions result 
as a consequence of the functionality formed in the previous step.” Indeed, enzymatic domino 
reactions such as the formation of vitamin B12 are referenced (Tietze, 1996). 
In addition to domino reactions, another key concept in organic synthetic chemistry is click 
chemistry.  Inspired by nature, reactions deemed to be good enough to be designated click 
reactions are those which are essentially irreversible due to thermodynamic constraints, 
produce exceptional yields that require minimal purification or isolation, and frequently use 
water as the operating solvent.  Whilst the reaction type or catalyst itself are not relevant, click 
chemistry is generally based around carbon chemistry, specifically the formation of larger 
molecules of interest from readily available small molecules in a modular method.  Taking the 
biological production of proteins and DNA as stimulus, it is not hard to see how this has 
become an accepted synthetic philosophy that has grown alongside the popularity of green 
chemistry.  Click chemistry was formally described by Kolb et al., (2001), with an update 
provided by Moses & Moorhouse, (2007). 
From the examples above, it can be noted that one-pot reactions are considered the ideal 
solution in both chemistry and biology, for much the same reasons.  Convenience and a 
predictable outcome are very important, but more than that a semi-batch process could be 
used.  A semi-batch, or fed-batch, process is one in which substrates can be added sequentially 
over time and the entire product emptied at the end.  Neither a batch nor continuous process, 
it is often used to maximise productivity from a single vessel (Azadi et al., 2012; Wettstein et 
al., 2012).  It is also of interest on safety grounds.  As the gradual addition of substrates adds a 
degree of control to the reaction,  in the case of strongly exothermic reactions with high rates 
of reaction, gradual addition of a reactant can reduce the risk of a runaway reaction (Dale, 
2011).   This could also be helpful to maintain, for example, a stable pH in a biological process. 
By definition a semi-batch process is not a domino reaction; however, neither SyPaB nor BCR 
are predicated on a purely batch environment.  That said, BCR would seem to lend itself better 
towards a full batch process, with a view to replicating an entire biosynthetic pathway that is 
fully balanced in terms of cofactors and associated reagents (Guterl and Sieber, 2013). 
In contrast to these cell free methods, the whole cell approach remains popular (Goldberg et 
al., 2007b) despite difficulties in maintaining cell viability and balancing this with a high 




1.3. BIOCONVERSION-CHEMISTRY-ENGINEERING INTERFACE 
It is important to acknowledge the different disciplines that could aid the progression towards 
a sustainable chemical industry and in particular the tools and techniques that could be 
deployed for an effective and sustainable synthesis platform.  One term for this area of 
research is the Bioconversion-Chemistry-Engineering (BiCE) Interface as it is the intersection of 
all these areas which is critical to the area moving forward (Smith et al., 2010; University 
College London, 2014). 
1.3.1. METABOLIC ENGINEERING, SYNTHETIC BIOLOGY AND CHEMICAL 
GENOMICS 
Metabolic engineering and synthetic biology are both relatively young disciplines and already 
having a profound impact upon industrial biotechnology and the chemical industry.  The 
former discipline is concerned with the determination of extant pathways in an organism, how 
they are organised and regulated, and how they may be improved by the addition, deletion or 
manipulation of specific genes in a pathway.  The latter is focused on the de novo creation of 
pathways, frequently through the development of specific elements, in order to construct 
desired pathways and even organisms.   
The two fields are frequently confused, and whilst there is overlap, they are distinct domains.  
An excellent differentiation between the two fields and their history is given by 
Stephanopoulos (2012).  Alternative designations are provided by Jarboe et al. (2010) for 
metabolic engineering: “the directed improvement of production, formation or cellular 
properties through the modification of specific biochemical reactions or the introduction of new 
ones with the use of recombinant technology”, and synthetic biology, “the design and 
construction of new biological components, such as enzymes, genetic circuits, and cells, or the 
redesign of existing biological systems.” 
Metabolic engineering is already providing benefits in the biofuel arena (Lü et al., 2011), with 
the field directly leading to fourth generation biofuels, whereby algae are engineered to 
produce biofuels more efficiently.  By determining exactly how algae produce fuels of interest, 
their genomes have been sequenced and metabolism determined in order to improve 
production of the biofuel of interest. 
Further work in this area is the development of pharmaceuticals (Lu et al., 2009), other 
advanced biofuels (Atsumi and Liao, 2008; Zhang et al., 2011), bulk chemicals (Shin et al., 
2013), enzymology and industrial biotechnology (Pirie et al., 2013),  
Similarly, synthetic biology has been used in the production of biofuels (Connor and Atsumi, 
2010; Jarboe et al., 2010; Kung et al., 2012), synthetic chemistry (Keasling, 2008; Carothers et 
al., 2009; Felnagle et al., 2012), production of natural products for drug discovery (Neumann 
and Neumann-Staubitz, 2010; Mitchell, 2011), regenerative medicine and other therapies 
(Burbelo et al., 2010; Ruder et al., 2011), production of reduced genome hosts (Gao et al., 
2010) and elsewhere in the chemical industry (Du et al., 2011). Approaches include pathway 
engineering (Prather and Martin, 2008), integrated gene circuits (Nandagopal and Elowitz, 
2011), DNA synthesis and organism level manipulations (Liang et al., 2011), creation of 
independent gene clusters that can be inserted as one unit (Fischbach and Voigt, 2010; 
Medema et al., 2010) and working with mixed populations of bacteria for a common purpose 
(Brenner et al., 2008). 
Common to most discussions of synthetic biology is the concept of being able to approach a 
problem at multiple levels.  Firstly at the DNA level, editing specific genes, gene regulation or 
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even creating entire clusters of genes regulated as necessary to provide optimal production of 
a given product or to restrict cofactor usage.  Another option is at the protein level, by 
manipulation of enzyme active sites through site-directed mutagenesis, whether to improve 
affinity for a given substrate or cofactor, to improve a rate of reaction, or conversely to 
weaken performance of an undesired enzyme to remove surpluses of product.  Alternatively, 
at organism level or above, it is possible to influence the entire genome by directed or 
adaptive evolution, or obligating an organism to respond to external stimulus, whether an 
additive or substrate in media or quorum sensing in one species or as part of a co-culture. 
Taken to a logical extreme, synthetic biology is about the reduction of desired activities to as 
few elements as possible, and using these elements as required to recreate them in a more 
favourable environment.  This is in contrast to metabolic engineering which is the epitome of 
holism, seeking to understand the entirety of a species and how it operates and how to 
manipulate it for the best advantage.  Pushing this concept of metabolic engineering further, it 
is possible to conceive of testing an organism’s response to given stimuli, not to merely 
encourage adaptive evolution, but to determine which genes are affected by the stimuli.  This 
is precisely what has been done to identify new methods of action for antibiotic resistance 
(Roemer et al., 2011), but can be applied much more widely.   
In the case of antibiotic resistance, a wide range of yeast strains were co-cultured with a 
potential antifungal agent and the relative proportions of different strains that grew were 
considered.  Strains that grew better when overexpressing a particular gene, and worse when 
that gene was deleted, allow the method of action to be determined of that particular agent.  
In essence, the genes required for resistance are discovered.  Therefore, if one gene were 
deleted from each strain, and in all strains tested every single non-essential gene was deleted, 
it could be determined from the relative proportions of survivors which genes had an influence 
upon the survival of the organism in the presence of a given inhibitory molecule. 
This approach can be utilised to determine which genes encode for any other particular task, 
by altering the stimulus to instigate the response required.  Essential genes and genes reacting 
to specific inhibitions can be discerned, and thus in principle any bioactive chemical can be 
used as a stimulus to uncover genes of interest.  This could include chemicals such as alcohols, 
aldehydes and ketones, which can be toxic to cells at relatively low concentrations.  This 
method is particularly important because it is typical for a given bioactive chemical to act on 
multiple gene products, making it difficult to determine all the potential interactions.  This is 
the power of this particular method; it is possible to identify all the responses from a range of 
compounds without foreknowledge of each gene’s activity or even if the chemicals being 
tested are even bioactive.  This approach is termed chemical genomics and is another 
important field that needs to be considered. 
Other areas of significance include the “omics” technologies, specifically genomics, proteomics 
and metabolomics, which cut across the areas previously mentioned (Dellomonaco et al., 
2010; Yang et al., 2011). 
 
1.3.2. CONVERGENCE AND THE BIOREFINERY 
Convergence is a new research model based around the principle of multiple disciplines 
effectively merging together with the aim of defining research teams by the problem that they 
investigate rather than the discipline they work in.  This takes traditional interdisciplinarity and 
multidisciplinarity a stage further, and indeed can incorporate disciplines and fields already 
considered interdisciplinary, for example synthetic biology. 
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Of particular note is the expectation that technologies, techniques and methods from quite 
disparate areas, from across the sciences and engineering fields, can be brought together in 
order to solve specific problems.  It is proposed that this is already occurring in the area of 
healthcare, specifically biomedicine, where advances in fields such as optics, information 
technology and nanotechnology are affecting a traditionally life sciences led discipline.  It is 
distinctively the application of ideas and techniques from one traditional discipline being 
applied to other disciplines, taking new approaches borrowed from entirely different areas of 
research and applying them as needed, modified to fit their new discipline.  Given the first two 
revolutions in this area, molecular biology and genomics, this is termed the third revolution of 
the biomedical field (Sharp et al., 2011). 
With the huge number of different disciplines and fields previously mentioned which may have 
relevance with regards to a sustainable chemical industry, it is plausible that convergence is 
necessary in this area, or perhaps in the more general area of sustainability, in order to 
accomplish the goal of converting the chemical industry into a clean and sustainable business 
(Philp et al., 2013).   
To a certain extent the framing of disciplines and research methods can be a result of funding 
streams, thereby becoming as much of a policy decision as a purely technical choice.  Thus it 
would be imperative that funding regimes, government and non-governmental groups could 
be persuaded of the necessity of such a change.  Fortunately, this area is gaining traction, with 
a report by the Organisation for Economic Co-Operation and Development (OECD) linking 
industrial biotechnology and climate change as part of convergence.  They recognise the 
importance of convergence as a vehicle for economic and scientific development: “Due to the 
current clean technology boom and the reaction of the market and consumers, the 
development of “green technologies” that improve energy efficiency, are less polluting and less 
consuming, is being stimulated.  An example is the so-called bio-inspired catalysis, at the 
boundary between biology and green chemistry.” (OECD Directorate of Science Technology and 
Industry, 2011) 
Whilst this is an energising paradigm shift, it is clear that it is by no means brand new or a fast 
process, with convergence between biology and chemistry noted at least a decade ago (Kaul et 
al., 2004).  That said, more disciplines than merely biological and informational sciences are 
now involved in the sustainable transformation of the chemical industry, with engineering, 
social sciences and humanities disciplines all being recruited, within sustainable development 
and climate mitigation as a whole (Kuiken, 2013). 
To illustrate a potential route for convergence, one needs to look no further than the 
biorefinery.  In traditional petrochemical purification it is necessary to fractionate crude oil to 
provide a wide range of different products such as petrol or bitumen.  In this manner, as much 
of the crude oil is utilised as possible, providing as many products as possible.  A similar 
approach can be taken with biomass as the feedstock, and using a small number of key 
intermediates as entry points for further processing into the full range of chemicals demanded 
by the chemical industry (Clark et al., 2006; Clark, 2007). 
The Department of Energy (DoE) in the United States has generated a “Top Ten” biobased 
products that it believes are the most needed, and is stimulating science and engineering to 
find an acceptable sustainable method of producing these chemicals (Werpy et al., 2004).  It is 
a point of interest that, common to petrochemicals, biofuels are a central part of the 
biorefinery concept (Bozell and Petersen, 2010).  It is also crucial that whilst the raw materials 
noted are biorenewable in origin, the subsequent processing is not limited to biocatalysis, and 
well established chemocatalysis is also referenced heavily.  The aim is to have key chemicals 
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that can provide the core of a new sustainable industry, not to convert everything to 
biocatalysis at all costs (Geboers et al., 2011; Serrano-Ruiz et al., 2011). 
Whilst the DoE is the most comprehensive and well known of those who have specified 
requirements for a biorefinery, they are by no means alone (Patel et al., 2006; Kamm and 
Kamm, 2007).  Whilst the DoE concentrated on a technologically independent list of candidate 
products, others have concentrated on specific technologies and the potential products that 
may be acquired from using specific feedstocks, e.g. lignocellulosic biomass (Dautzenberg et 
al., 2011; Wettstein et al., 2012) and glycerol (Johnson and Taconi, 2007), or even by species 
proposed to be central to biorefineries – Bacillus subtilis (Zhang and Zhang, 2010). 
Even with the use of biorefineries there is still likely to be some waste.  One of the final 
benefits of using biorenewable feedstocks and enzymatic transformations is that any by-
products are highly likely to be useful in some manner to another organism.  The challenge is 
to locate an economically viable solution for each by-product and this may require purification 
or separation of some sort.  Whilst it is obviously preferable to prevent waste formation, as 
per the Principles of Green Chemistry, this is not always possible.  Therefore the next best 
thing is to utilise all “waste” streams, recycling them into new systems.  This will lead towards 
the development of a circular economy, whereby all waste streams from one unit operation 
become feedstocks for another unit operation.  From a business perspective, this may require 
branching out into new fields unfamiliar and unrelated to the original project, which may 
necessitate careful thinking and consulting externally (Anastas and Eghbali, 2010). 
The ultimate deployment of biorefinery technology and moving towards a holistic view of the 
chemical industry as envisaged by a circular economy will demand input from across the 
sciences, engineering, and beyond.  Thus convergence is all but inevitable if this area of 
research is to proceed to an effective conclusion. 
 
1.3.3. ADVANTAGES OF THERMOPHILES 
Thermophiles, typically defined as organisms with optimal growing temperatures of 50 oC-
80 oC, and hyperthermophiles, defined as organisms with an optimal growing temperature in 
excess of 80 oC, have a number of potential advantages over traditionally utilised mesophilic 
organisms.  The most obvious advantage is that running a process at a higher temperature is 
liable to increase the rate of reaction, although this is mitigated somewhat by thermophilic 
enzymes being approximately as efficient as their mesophilic counterparts at their respective 
optimal temperatures.  Higher temperatures are believed to improve operating conditions in 
situations such as the degradation of lignocellulosic biomass because of the frequent reliance 
on high temperature pretreatments of the biomass and because high temperatures also assist 
with the breakdown of the biomass (Frock and Kelly, 2012; Lin et al., 2014).  
Broadly speaking, there are a very large number of enzymes already being considered from 
thermophilic organisms for industrial or research use (Willies et al., 2010; Chang and Yao, 
2011; Bergquist et al., 2014; Elleuche et al., 2014, 2015; Littlechild, 2015; Siddiqui, 2015).  This 
includes all three domains of life – Bacteria, Archaea, and even Eukarya, and ranges from the 
often used Thermus aquaticus DNA polymerase for molecular biology (Niehaus et al., 1999; 
Frock and Kelly, 2012) to polysaccharide degrading enzymes (Elleuche et al., 2015).   
Archaea is the most thermophilic of the domains, with Pyrococcus furiosus among the most 
thermophilic species with an optimal growing temperature of 100 °C (Zeldes et al., 2015); the 
highest temperature at which life is known to survive is nearing 125 °C, which Methanopyrus 
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kandleri can withstand at a pressure of 200 bar (Elleuche et al., 2014).  Individual enzymes may 
exceed even this, with enzyme activity being noted up to 130 °C  (Siddiqui, 2015; Sammond et 
al., 2016).  Bacteria is next in the thermophilicity table, with some organisms having optimal 
growth temperatures of up to 80 °C, including species such as Thermotoga maritima and 
Thermus thermophilus (Zeldes et al., 2015).  Eukarya is the least thermophilic of the three, yet 
the most resilient of the fungi can reach up to 61 °C (Oliveira et al., 2015). 
Many reactions are more advantageously conducted at high temperature, reducing viscosity, 
making reactions that were thermodynamically unfavourable possible and improving the range 
of options available.  Examples include the production of fructose from corn syrup using 
glucose isomerase, hydrogen production and methane production (Zeldes et al., 2015).  
Additionally, solubility of many substrates increase with temperature (Alves et al., 2007; 
Sammond et al., 2016), which is another key benefit.  This is not a constant benefit though, as 
there are examples where increasing temperature does not always increase the solubility 
(Stephenson et al., 1984; Stephenson and Stuart, 1986; Stephenson, 1993; Mączyski et al., 
2008).  Further, high temperature may degrade substrates and products, which must be 
considered. 
One of the principal advantages thermophiles have is that thermophilic enzymes are more 
frequently resistant to chemical additives, such as chaotropic agents and solvents, and to non-
neutral pH (Haki, 2003; de Carvalho, 2011).  This is believed to be because the same strategies 
used by thermophilic organisms to ensure their enzymes continue to function at higher 
temperatures also provide chemical resistance.   It has long been known that there are 
advantages to performing enzyme reactions in organic solvents, even in (near) anhydrous 
conditions (Dordick, 1989), and as organic solvent resistance is now more often assayed for, 
there are a range of enzymes known to be resistant in the presence of a wide variety of 
different solvents from water miscible alcohols to immiscible solvents like toluene and hexane 
to halogenated solvents such as chloroform (Doukyu and Ogino, 2010).  In addition to 
increased substrate and product solubility in solvents, advantages include higher rates of 
reaction, novel enzymatic activities, the ability to recover enzymes via simple filtration in 
anhydrous solvent conditions, more favourable thermodynamics (preferring synthesis over 
hydrolysis), enhanced thermostability in (near) anhydrous solvent and suppression of water-
dependent side reactions (Ogino and Ishikawa, 2001; Doukyu and Ogino, 2010). 
Although it is not yet possible to provide a generalised approach to thermophilicity (Sammond 
et al., 2016), there are many known features of genomes (Takami et al., 2004b; Frock and 
Kelly, 2012) and enzymes (Littlechild et al., 2013) which are associated with higher resistance 
to high temperature.   With reference to enzymes, these features can be split into which 
structural level they affect.  At the level of primary structure, thermolabile residues can be 
replaced with more stable ones; asparagines, glutamines and cysteines, where not catalytically 
relevant, may be replaced by alanines, prolines, aromatic or charged residues.  In terms of 
secondary structure, flexible loops or linker regions may be shortened or stabilised by 
interactions with metal ions; α-helices may also be stabilised by capping the helices, i.e. 
stabilising the dipole that forms from the directional nature of the helix by having negatively-
charged residues adjacent to the positively-charged N-terminus of the helix or positively-
charged residues adjacent to the negatively charged C-terminus.   In the tertiary structure, the 
structure may be more tightly packed to reduce available space between secondary and 
supersecondary structures, and increasing stabilisation may be achieved via more ion pairs, 
hydrogen bonds and disulphide bonds; more hydrophobic residues may also be more 
appropriately buried in the core of the enzyme, reducing the interactions with bulk solvent and 
increasing hydrophobic interactions.  Lastly, quaternary structure improvements may increase 
the number of subunits and increase the number of interactions between subunits to further 
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increase thermostability.  It should also be noted that, although this variety of possibilities 
implies a large difference between mesophilic and thermophilic proteins, in terms of 3D 
structure there is often little difference and protein sequences may be similar or dissimilar 
depending on the individual protein in question  (Cowan, 1997; Vieille et al., 2001; Sterpone 
and Melchionna, 2012; Littlechild et al., 2013; Salamanova et al., 2013). 
Another substantial advantage of utilising thermophiles is that when processing at higher 
temperatures, it is less likely that contamination will occur.  Common mesophiles will simply 
be unable to exist at high enough temperatures to cause any issues with a thermophilic 
process, although obviously thermophiles will remain able to contaminate processes 
inadequately managed.  One example is ethanol production from biomass; when a mesophilic 
process is used contamination is common, if not constant, reducing yields and profits.  
Occasionally this may even result in entire failed fermentation runs (Zeldes et al., 2015).  At 
large scale it is also more energy efficient to run biological processes at higher temperatures 
than 37 oC.  The amount of heat produced by an industrial biological process far exceeds the 
ability to shed heat, leading to extensive cooling needed to ensure that the process remains 
stable.  Cooling is especially expensive when using temperatures below ambient, as is 
necessary with mesophilic processes.  By using a thermophilic organism, this cooling is either 
not necessary or greatly reduced (Barnard et al., 2010; Zeldes et al., 2015). 
Finally, in a reverse from traditional chemistry, using thermophiles allows for volatile products 
or by-products to be removed from the system and collected.  For instance, when using 
thermophilic ADHs with isopropyl alcohol or ethanol as sacrificial substrate, it is very easy to 
drive off the acetone or ethanal produced when operating above their boiling points, 
favourably shifting the equilibrium of the reaction.  Products may also be collected from the 
bioreactor if they are volatile (Zeldes et al., 2015).  This is in contrast to using low boiling-point 
solvents, typically favoured in bench scale chemistry to allow for the easy purification of 
products by rotary evaporation of the solvent.  In some cases hyperthermophiles may be 
preferred to drive off more product, and in others thermophiles may be preferred as high 
temperatures may damage products or impact upon the process.   In addition to the previous 
example of in situ product removal, the alternative is an in situ subsequent chemical or 
enzymatic reaction, as both prevent the reverse reaction by sequestering the product 
(Hilterhaus and Liese, 2009).   Continuing the example of thermophilic ADHs, if cofactor 
regeneration was conducted using a glucose dehydrogenase (GDH), then the gluconolactone 
formed would hydrolyse into gluconic acid in an aqueous environment.  This process is 
accelerated with increasing temperature and when using water as the solvent, the position of 
equilibrium would be very far towards gluconic acid, which would positively affect the original 
ADH catalysed reaction (Goldberg et al., 2007a). 
1.4. HISTORY AND TAXONOMY OF GEOBACILLUS  GENUS 
The Geobacillus genus was first proposed recently, in 2001 (Nazina et al., 2001).  Comprising 
several species previously described as Bacillus, and entirely novel species such as 
Geobacillus uzenensis and Geobacillus subterraneus, this genus was formed on the basis of 
phylogenetic analysis that indicated that this cluster of species formed a group separate from 
the main body of Bacillus species.  It should also be noted that Bacillus as a genus has been 
gradually split over the years prior to this claim, with new genera such as Alicyclobacillus, and 
it was the discovery of additional species which necessitated the formation of a new genus to 
accommodate the genetic heterogeneity in the genus Bacillus. 
The same work indicated that typical analysis by 16S rRNA sequencing is not adequate for the 
full delineation at the species level as the sequence similarity could be as high as 97.3%-99.5% 
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between different species, but could be sufficient to determine the genus of an isolate.  
Further investigation was carried out based upon genetics, physiology and microbiology of 
samples, including but not limited to GC content of DNA, DNA-DNA homology, nutritional 
requirements for growth, cell morphology, and ability of a sample to produce specific acids or 
other biochemicals.   
Subsequent analysis of certain housekeeping genes allows for a more focused annotation of a 
given isolate, allowing a species to be easily annotated with some confidence.  The variance 
between the different species was incredibly small with 16S rRNA as previously noted, 
although with other genes such as recN, there is a similarity of only 84% at the subspecies level 
with G. thermoglucosidasius, 57% similarity at the genus level and a mere 15% at the phylum 
level (Zeigler, 2005).  Similarly, the genes gyrB and parR also prove to be useful in this regard 
(Tourova et al., 2010).  This wide margin of difference allows the easy identification of different 
species within the genus of Geobacillus, and should be used in conjunction with existing 16S 
rRNA methods. 
The Geobacillus genus contains species that are moderately thermophilic, with typical growing 
temperatures between 55 oC and 70 oC.  There has been a gradually increasing level of 
scientific interest in these organisms in recent years, partly due to their thermophilic nature, 
and partly due to their ubiquity.  Geobacillus species have been noted in the Mariana Trench 
(Takami et al., 2004a) at a depth of nearly 11km.  They have also been noted around the world 
in the soil, even in areas of the world that could not support their obligately thermophilic 
nature, and this has been a focus of investigation (Zeigler, 2014).  The answer for this is 
believed to be the longevity of spores of this genus, and in particular their size, which allow the 
spores to be circulated in air currents over very long distances. 
Many species from this genus have been investigated for their potential industrial applications.  
Most obviously, as members of the genus are most often concentrated in areas such as 
compost heaps and oilfields (Fong et al., 2006; Tourova et al., 2008), they have been 
thoroughly investigated for their potential in utilising biomass, specifically degradation of 
lignocellulosic material.  One example is the scrutiny for cellulases (Rastogi et al., 2010; 
Zambare et al., 2011; Assareh et al., 2012), but more typically the focus is on the production of 
ethanol.  In particular G. thermoglucosidasius is most frequently investigated for the 
production of bioethanol in this genus (Fong et al., 2006; Cripps et al., 2009; Tang et al., 2009; 
Chang and Yao, 2011). 
Other uses for this genus have also been proposed, including biosynthesis of silver and gold 
nanoparticles (Mohammed Fayaz et al., 2011; Girilal et al., 2013), suggested to be of benefit to 
PCR efficiency, and the production of antibiotics (Ren et al., 2010).  Also at organism level, heat 
and related stress responses have been investigated (Shih and Pan, 2011).  Given that this 
genus is thermophilic, it may be expected that there would be a reduced heat shock response 
in constituent species; however, a rapid change from 45 oC to 55 oC did result in a notable heat 
shock response in G. thermoglucosidasius, regardless of both temperatures being well within 
the normal growth range of this genus (Tripathy and Maiti, 2014). 
A variety of enzymes are also under investigation from this genus, including nitrile hydratases 
(Chiyanzu et al., 2010), lactonases (Hawwa et al., 2009; Mandrich et al., 2010), lipases 
(Hutchins et al., 2004), enzymes relevant to alkane degradation (Tourova et al., 2008), 
acrylamidases (Cha and Chambliss, 2013), and esterases (Yildirim et al., 2009). 
Given the aforementioned interest in the Geobacillus genus for the production of biofuels and 
the overlap with other industrial fields, alcohol dehydrogenases are among the most 
frequently studied enzymes in this genus.  Examples have been identified from several species 
18 
including G. denitrificans (Liu et al., 2009; Ji et al., 2013), G. stearothermophilus (Guagliardi et 
al., 1996; Ceccarelli et al., 2004; Pennacchio et al., 2013a) and latterly G. thermoglucosidasius 
(Lin et al., 2014).  Despite this interest, however, investigation into alcohol dehydrogenases in 
this genus, and specifically into G. thermoglucosidasius, remains incomplete.  Thus far the best 
analysis is by Lin et al. (2014) who considered several ADHs with the explicit intention to utilise 
them for the production of isobutanol from isobutanal and not to survey the enzymes for their 
wider substrate scope and industrial implications.  In addition, the ADHE equivalent in 
G. thermoglucosidasius has been studied by Extance (2012), with the naming convention 
referring to the E. coli bifunctional ADH.  Lastly, a further ADH, named ADH-I has also been 
isolated and studied by Jeon et al. (2008), activity being noted with primary alcohols up to 
1-octanol, and 2-propanol. 
Moving forward, due to the importance of ADHs (vide infra), it seems likely that the 
Geobacillus genus will be progressively more investigated for novel ADHs given the multiplicity 
of them already annotated in genomes.  It also is probable that the genus will be used as a 
model for investigating thermophilicity, and some work has already been carried out in this 
area (Takami et al., 2004b). 
Enabling technology, specifically the development of genetic tools to allow more sophisticated 
manipulation of Geobacillus species, is a growing field; for instance, shuttle vectors (Taylor et 
al., 2008) have recently been developed.  A recent review by Hussein et al. (2015) on the 
Geobacillus genus clearly demonstrates the strength of the genus and its potential for 
industrial use.  Of particular note is the detailed consideration of the “genetic tool kit” now 
available for use and the exceptionally wide range of industries referred to.  It is certain that 
this genus will continue to develop in usefulness and importance in the near future. 
In terms of biocatalysis, a Geobacillus nitrile hydratase has been immobilised using various 
supports in bead format (Chiyanzu et al., 2010).  This was done due to the relative instability of 
the enzyme, particularly inhibition when exposed to high concentrations of substrate or 
product, which is a relatively common feature of enzymes more broadly.  Moderate success 
was obtained, with an increase in half-life from 55 min to 330 min at 60 oC, and retention of 
activity (86%) after eight recycles.  Furthermore, substrate inhibition was reduced, with a Ki of 
195mM compared to a free enzyme Ki of 101mM.  This was achieved at a cost of a 
deterioration in the kinetic constants from a Vmax of 48.8 µmol mL
-1 min-1 to 4.5 µmol mL-1 min-
1, Km from 10.2mM to 17.3mM and kcat from 37,777 min
-1 to 3,543 min-1.  Thus although 
limited, this success could indicate Geobacillus derived enzymes can be effectively 
immobilised, greatly increasing the applicability of these enzymes to industry. 
 
1.5. ALCOHOL DEHYDROGENASES 
Alcohol Dehydrogenases (EC 1.1.1.1 and 1.1.1.2) are some of the most heavily studied 
enzymes in existence.  They are easy to assay, due to their reliance on either NAD(H) or 
NADP(H) as a cofactor, the reduced forms of which absorb at 340nm and thus can be detected 
in a UV-vis spectrophotometer.  In addition, the reaction that they catalyse, converting an 
aldehyde or ketone to the respective alcohol or vice-versa, is a frequently performed reaction 
and one often used to insert chirality into a molecule, for example in the production of a 
pharmaceutical intermediate.  Finally, they are found in all organisms, irrespective of domain.  
The most famous are likely to be those discovered in Saccharomyces cerevisiae, or Horse Liver 
ADH (HL-ADH), but ADHs in general hold important roles in redox balance and degradation of 
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aldehydes into less toxic alcohols in species ranging from humans to prokaryotes.  They are 
also involved in biodegradation of alkanes (Ji et al., 2013). 
1.5.1. CLASSIFICATION 
There are many ways to classify alcohol dehydrogenases.  However, four main classes of ADH 
will be concentrated upon in this work: Short Chain Dehydrogenase/Reductases (SDR), 
Medium Chain Dehydrogenases/Reductases (MDR), iron containing ADHs and Aldo-Keto 
reductases (AKRs).  Whilst it should be noted that AKRs are not, strictly speaking, ADHs, they 
may perform the same function and will be considered alongside the more traditional ADHs. 
Unhelpfully, these classes are less similar to each other, in terms of sequence identity, than 
they are to other enzyme classes, which makes identification of an ADH quite challenging 
without substantial analysis and making automatic annotation risky to rely upon as it is easily 
possible that an enzyme annotated as an ADH could in fact be a different enzyme class 
altogether.  It is equally possible that the reverse may occur.  Another compounding feature is 
that an enzyme may act as an ADH, but due to limited substrate scope or structure variation, 
may be reclassified as, for example, a cinnamyl-alcohol dehydrogenase (1.1.1.195), 
isopropanol dehydrogenase (1.1.1.80) or methylglyoxal reductase (1.1.1.283) (Ying and Ma, 
2011).  Finally, even ADHs assigned to the same class may exhibit low sequence similarity 
(sequence identities can be as low as 20%), although conserved ADHs within the same genus 
are typically similar (Radianingtyas and Wright, 2003).  Thus, for the purposes of this work, the 
phrase alcohol dehydrogenase will refer to any enzyme interconverting aldehydes, ketones 
and alcohols with the use of cofactors NAD(H) or NADP(H), and may not be solely restricted to 
the enzyme classes 1.1.1.1 or 1.1.1.2. 
 
1.5.1.1. SHORT CHAIN DEHYDROGENASE SUPERFAMILY (SDR) 
These ADHs typically have approximately 250 residues and do not require metal ions for 
activity or structure.  Generally, although not exclusively, these enzymes are associated with 
smaller substrates.  In keeping with the majority of the SDR family, the ADHs typically have 
only one domain and are involved in essential functions, noted due to the ancient nature of 
the SDR superfamily, which is found in all organisms.  The active site is highly conserved, 
consisting of either a triad or tetrad of residues: Tyr, Lys, Ser, (Asn). 
The SDR superfamily can be split into two main groups, classical and extended, of which 
extended SDRs tend to be more consistent due to their high chance of being involved in 
essential functions, whereas the classical SDRs are more varied in their diversity and function 




Figure 2 - Monomer of RasADH.  The apoenzyme is coloured green, and the holo -enzyme coloured 
coral. The holo-enzyme is complexed with NADPH, included in cylinder format with carbon atoms 
shown in grey.  Directly reproduced from (Man et al., 2014b). 
 
One particular example of an SDR is an ADH from Ralstonia sp. DSM 6428 (RasADH), noted for 
its ability to catalyse “bulky-bulky” substrates, i.e. those with large hydrophobic groups either 
side of the ketone (Kulig et al., 2013; Lerchner et al., 2013; Man et al., 2014b).  Comprising 249 
amino acids, RasADH is a homotetramer with the ability to reduce a wide range of complex 
aldehydes and ketones including hydroxyketones, ketoesters and exclusively uses NADPH as 
cofactor (Man et al., 2014b). 
Each monomer consists of a single Rossman fold-type domain with a seven-stranded parallel β-
sheet flanked by three α-helices on each side.  As shown in Figure 2, the addition of the 
cofactor was required to reveal the last helix, identified as α6 in the figure.  It is believed that 
this helix has a key role by acting as a “lid” to the active site once the cofactor has bound.  The 
active site itself is a hydrophobic tunnel, shown in Figure 3, with the nicotinamide ring of 
NADPH sitting at the base of the tunnel.  Tyr150 is the presumed proton donor for the 
reductive ADH-catalysed reaction (Man et al., 2014b), and the other amino acids of the 
catalytic tetrad are noted as Asn112, Ser137 and Lys154 (Lerchner et al., 2013). 
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Figure 3 – (Left) Active site of RasADH in ribbon format, illustrating side-chain components and 
hydrophobic tunnel.  (Right) Active site of RasADH with n-pentyl phenyl ketone modelled using 
AUTODOCK VINA with distances given in angstroms.  Directly reproduced from (Man et al., 2014b). 
With the knowledge that RasADH reduces n-pentyl phenyl ketone into the (S)-alcohol with 
excellent enantiomeric excess, it is possible to say that only the re-face of the ketone would be 
presented to the C4-nicotinamide, which delivers the hydride.  In addition, the carbonyl group 
must be within H-bonding distance of the catalytic tetrad, in particular Ser137 and Tyr150.  
Given this information, the substrate was added to the model, as shown in Figure 3 (Man et 
al., 2014b).  This indicated that Phe205, part of the α6 “lid” helix, was a key amino acid in 
determining substrate scope due to steric repulsion.  Although the chosen substrate was able 
to fit inside the active site, an aromatic group instead of the n-pentyl group would not be able 
to fit.  This is consistent with substrate specificity studies previously conducted (Kulig et al., 
2013).   
Additional work has been done with this enzyme, specifically to alter the cofactor specificity 
from NADPH to NADH.  A key point is that SDRs typically have either an arginine residue or an 
aspartic acid residue at the C-terminus of the second β-strand, with the former giving NADPH 
preference and the latter a preference for NADH (Lerchner et al., 2013).  RasADH does not 
have an aspartic acid residue in the 37th position, and it does have an arginine residue in 
position 38, consistent with the above pattern.  The arginine residue is believed to form a salt 
bridge with the 2’-phosphate group of NADP+, and hydrogen bonds from other nearby residues 
such as Asn15 are also instrumental in assisting with the cofactor specificity.  With the aim of 
destabilising these interactions, appropriate point mutations were introduced based upon 
similar enzymes with preference for NAD+ (Lerchner et al., 2013). 
Using (S)-1-phenylethanol as substrate, a RasADH mutant 
(N15G/G37D/R38V/R39S/A86N/S88A) reduced the KM for NAD
+ from 3.1 to 0.8mM whilst 
reducing activity with NADP+ below detectible limits.  This gain was somewhat mitigated by the 
very large drop in kcat, which dropped from the wild-type value of 99 min
-1 with NADP+ to the 
mutant value of 1.8 min-1 with NAD+.  Similarly, when considering the substrate, the kcat 
dropped from 47 min-1 to 1.38 min-1 (Lerchner et al., 2013). 
Crystal structures can be found in the PDB with references 4BMN for the apo-enzyme and 






1.5.1.2. MEDIUM CHAIN DEHYDROGENASE SUPERFAMILY (MDR) 
This is a more complex family, best described by Hedlund et al. (2010): “The MDRs form a 
protein superfamily whose size and complexity defeats traditional means of subclassification”. 
The superfamily as a whole includes many other enzyme families, which will not be discussed 
in great detail, but include quinone reductases, cinnamyl alcohol dehydrogenases, threonine 
dehydrogenases and polyol dehydrogenases, among others.  Enzymes of this superfamily may 
be split into two major groups; one requires zinc ions for activity (Zn2+) and the other does not.  
Enzymes requiring zinc utilise NAD(H) as cofactor and tend to be dehydrogenases in vivo, and 
those with no need for the metal ion will prefer NADP(H) and tend to be reductases in vivo 
(Hedlund et al., 2010).  Industrially speaking, NAD(H)-using enzymes would be preferred due to 
the relative expense of NADP(H).  However, enzymes with a substrate scope encompassing 
large and complex substrates more useful to industry tend to prefer NADP(H), which is a 
general problem of ADHs.  A typical MDR protein consists of two domains, with the C-terminal 
domain binding the cofactor and an N-terminal domain binding the substrate (Knoll and Pleiss, 
2008; Persson et al., 2008). 
The ADHs in the MDR superfamily are the most heavily studied family of ADHs, largely due to 
the higher number of ADHs (Sulzenbacher et al., 2004).  It is also the family most likely to be 
industrially interesting due to the frequency of larger substrates admitted and the relative 
propensity of enzymes to accept NADH as a cofactor natively.  That said, whilst all ADHs are 
currently classed as zinc-containing and therefore NAD+ using dehydrogenases, this is not 
based on empirical evidence but sequence alignment and prediction.  Further, even in the 
model, there are multiple groupings of ADHs, typically named after their domain, e.g. bacterial 
ADHs, or named after reactions, e.g. 2,3-butanediol dehydrogenase (Knoll and Pleiss, 2008; 
Hedlund et al., 2010).  The variant groupings are not particularly surprising considering it is 
believed that up to six evolutionary events occurred to produce MDR enzymes from SDR 
equivalents, latterly introducing zinc to the enzyme class.  Thus it is only to be expected that 
there is a distinct lack of clarity as to the exact delineation between enzyme families (Jörnvall 
et al., 2013). 
An example of an MDR family ADH is TADH from Thermus sp. ATN1, a thermophilic enzyme 
that utilises NADH to reduce a variety of aldehyde and ketones including 2-pentanone and 
phenylacetone.  It has also demonstrated dismutase ability, i.e. the ability to simultaneously 
catalyse one aldehyde to carboxylic acid and a second molecule to the corresponding alcohol 
(Höllrigl et al., 2008).  TADH was confirmed to be a 347 residue homotetramer, with each 
monomer consisting of two domains, as shown in Figure 4.  The catalytic domain consists of a 
core β-sheet of 10 strands, surrounded by five α-helices.  The nucleotide-binding domain is a 
classical Rossman fold domain comprising a central β-sheet of six strands, with six α-helices 
surrounding it (Man et al., 2014a). 
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Figure 4 – Monomer A of TADH shown in ribbon format, with  NADH and co-ordinating cysteine side 
chains represented in cylinder format.  Carbon atoms are grey and both structural and catalytic zinc  
atoms are represented as grey spheres.  Directly reproduced from (Man et al., 2014a). 
 
 
Figure 5 - Model of phenylacetone in the active site of TADH, created using AUTODOCK-VINA.  
Phenylacetone is shown in ball and stick format, and dashed black lines indicate possible interactions 
between the carbonyl group of the substrate and both the side-chain of Ser40, a putative proton 
donor, and the catalytic zinc atom.  Directly reproduced from (Man et al., 2014a). 
Figure 5 illustrates the active side of TADH.  Of particular note is the placement of the C4 
nicotinamide carbon, which is approximately 4.5 Å from the side-chain oxygen of Ser40, the 
putative proton donor in reductive catalysis.  The placement of the nicotinamide ring is such 
that it presents its pro-(R) hydride to the active site, matching experimental evidence of (S)-
selectivity of TADH.  Additionally, the active site is largely hydrophobic, which assists in the 
binding of similarly hydrophobic substrates (Man et al., 2014a). 
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In comparing this thermophilic ADH with the NADPH-dependent ADH from Thermoanaerobium 
brockii (TbADH), it shares some features, such as Pro275, which is a conserved residue at the 
centre of the dimer interface and has been shown to confer thermostability.  TADH has 25 
proline resides to TbADH’s 21, and TbADH has only 8 salt bridges as part of the dimer interface, 
compared with TADH’s 14.  Increased subunit interactions have been proposed as contributing 
to the increased solvent tolerance of enzymes (Man et al., 2014a). 
As might be expected, there are differences in the cofactor binding loop, with TbADH securing 
the 2’ ribose phosphate of NADPH through interactions with Arg200, Tyr218 and Ser199.  
TADH excludes NADP through the negatively charged Asp200 and hydrophobic Ile202, which 
replaces Ser199 of TbADH.  Lastly, the orientation of the nicotinamide ring in the substrate 
pocket is different, as can be seen in Figure 6.  TbADH has the ring rotated approximately 60° 
down towards the side-chain of Trp110, substantially altering the active site and in particular 
exposing the pro-(S) hydride of the C4 carbon of the ring to the substrate-binding pocket.  It is 
believed that this change may be the reason for small substrates being converted with 
inverted stereoselectivity with TbADH compared to larger substrates, whereas TADH converts 
all substrates to (S)-alcohols. 
 
 
Figure 6 – Superimposition of active sites of TADH and TbADH, with residue side-chains shown in 
cylinder format in green and coral colouring respectively.  Directly reproduced from (Man et al., 
2014a). 
The PDB record for TADH is 4CPD. 
 
1.5.1.3. IRON CONTAINING ADHS 
Despite the naming convention, these ADHs may use either zinc or iron ions for activity, and 
may in fact use both.  There is a much larger range of size for these enzymes, noted from 
approximately 385 residues to over 900.  These enzymes are typically of greater potential than 
any other family in terms of their substrate scope; however, ADHs requiring iron for activity 
commonly have weakly-bound ions, meaning that the ion can dissociate during purification.  
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Some of these enzymes may regain activity with the subsequent addition of iron ions to their 
buffer, others may not (Tamarit et al., 1997).  In the case of those enzymes that can have their 
activity restored, one approach may to be replace Fe2+ ions with Co2+ for purification and then 
replace with Fe2+ again to restore higher levels of activity (Tse et al., 1989). 
If this were not enough, iron containing ADHs are also often oxygen sensitive, highly sensitive 
in many cases, making purification and testing incredibly difficult if not done in the complete 
absence of oxygen.  Some enzymes can regain activity over time if stored in the presence of 
iron (Tamarit et al., 1997), or strictly anaerobically, but this is not true in all cases.  Finally, 
these enzymes are more likely to utilise NADP(H) as cofactor rather than NAD(H), which may 
be an issue for industrial purposes (Radianingtyas and Wright, 2003). 
A particularly well studied example of an iron-containing ADH is ADH2 from Zymomonas 
mobilis (Neale et al., 1986; Mackenzie et al., 1989; Tse et al., 1989; Tamarit et al., 1997; Moon 
et al., 2011).  It is a dimeric, NADH-dependent, ADH with 383 residues.   
A monomer of zmADH2 forms 17 α-helices and 9 β-strands and has two domains, as shown in 
Figure 7.  The first domain forms a globular structure with α/β mixed folding, comprising seven 
β-strands in one β-sheet and two α-helical bundles containing four and two α-helices.  The 
C-terminal domain, also globular in structure, is entirely composed of α-helices in two bundles, 
one of three α-helices and another of eight α-helices.  The C-terminal domain is where the iron 
ion binds, and the cofactor binds in the cleft between the two domains (Moon et al., 2011). 
 
Figure 7 - Monomer of zmADH2 in ribbon form, complexed with iron ion a nd NAD
+
 cofactor.  The iron 
ion is shown as a pink sphere and the bound NAD
+
 as a stick model.  Directly reproduced from (Moon 
et al., 2011). 
Compared to previous ADH families there are two notable differences.  The first is that the 
nicotinamide ring is ambiguously placed, which implies flexibility in this area of the enzyme, 
and could further imply a lack of stereocontrol.  The second is that the cofactor binding site is 
located within a hydrophilic crevice, rather than hydrophobic as has been the case in the 
previous two examples.  Following from the hydrophilic nature of the active site, which is 
exposed to bulk solvent, a water molecule co-ordinates with the iron ion, as shown in Figure 8.  
The last key point with regards to the cofactor is the presence of Asp39, which is not 
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conserved in all similar enzymes.  Asp39 appears to be critical for ensuring NAD+ specificity 
rather than NADP+ specificity, and when it is replaced by glycine in enzymes such as 1,3-
propanediol oxidoreductase, then the specificity switches to NADP+ (Moon et al., 2011). 
 
Figure 8 – (Left) Binding site of the iron metal (pink sphere) in zmADH2.  Note the water molecule (red 
sphere) co-ordinating to the iron.  Carbon is coloured cyan , nitrogen blue and oxygen red; all ball and 
stick models. (Right) Schematic representation of NAD
+
 interaction in the binding pocket, formed 
along the interface of the two domains of the enzyme.  Residues are represented as line models, the 
NAD
+
 as a thick stick model and hydrogen bonds formed between the two are dotted black lines.  
Directly reproduced from (Moon et al., 2011) 
Overall, the active site is likely to be constrained by the hydrophobic residues Phe254 and 
Phe149, in addition to His267.  That said, the modelled ethanol is >3.2Å from His267, which is 
greater than the hydrogen bond distance, implying a lack of substantial direct interaction.  A 
water molecule could act as mediator, and this has been noted elsewhere.  These residues are 
noted in Figure 9 along with other key residues in the active site (Moon et al., 2011). 
 
Figure 9 - Modelling of ethanol as substrate in the active site of zmADH2.  All relevant residues are 
indicated as stick models and labelled.  EtOH is also presented as a stick model, with carbon atoms in 
violet and oxygen in red.  Directly reproduced from (Moon et al., 2011). 
Of additional interest is that bifunctional enzymes, where acetyl-coA is catalysed to ethanol, 
most often have a member of the iron-containing ADH family as their ADH domain.  As the 
ADH from G. thermoglucosidasius has been crystallised (Extance et al., 2013), this is a 
convenient example to use. 
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Figure 10 - Structure of the ADH domain from the bifunctional G. thermoglucosidasius  ADHE with 
front and back views.  The zinc ion is represented by a brown sphere and glycerol is coloured.  The 
missing loop refers to a small section that is too mobile to be accurately determined.  Directly 
reproduced from Extance (2012). 
There appears to be a great similarity between standard iron-containing ADHs and the ADH 
section of ADHE, at least in tertiary and quaternary structure.  Comparing Figure 8 and Figure 
10, it can be seen that both have two domains, one of which is entirely composed of α-helices, 
and the other being a Rossmann-fold type domain, with α-helices either side of a β-pleated 
sheet.  Whilst the latter enzyme contains zinc rather than iron, as mentioned previously, the 
so-called iron-containing alcohol dehydrogenases are able to utilise zinc as cofactor, and may 
retain significant activity with other cofactors as well.  One of the differences is with regard to 
the “missing loop”, which is only conserved in ADHs as part of bifunctional enzymes, and not 
stand alone enzymes; this is taken to mean that it is involved in the co-ordination between the 
AldDH and ADH domains in the bifunctional enzyme and therefore would not be found 




Figure 11 - Metal ion binding site of the ADH domain of the G. thermoglucosidasius  ADHE, overlaid 
with electron density.  Co-ordinating residues are shown in stick form with green carbon atoms; zinc 
ion is represented as a grey sphere and glycerol with blue carbon atoms.  α -Helices are shown as red 
spirals, grey mesh represents the electron density from the final 2Fo-Fc map contoured at 1σ, green 
mesh represents the positive difference ( Fo-Fc) density and magenta mesh the negative difference 
density, contoured at +3σ and -3σ respectively.  Directly reproduced from Extance et al. (2013) with 
permission of the International Union of Crystallography.  See http://journals.iucr.org/ for further 
information.  
Due to the increase in activity when additional metal ions are provided, it is believed that the 
zinc ion is not merely structural, but catalytic, and is believed to polarise the carbonyl of the 
substrate prior to NADH hydride transfer.  The metal ion is octahedrally co-ordinated with 
Asp661, His665, His730, His744 and a glycerol molecule, as shown in Figure 11.  All residues 
are part of the α-helical domain (Extance et al., 2013). 
 
Figure 12 - Depiction of NADP
+
 superimposed into the G. thermoglucosidasius  ADH crystal structure of 
ADHE.  Magenta residue is Asp57 and the orange residue is His298.  Directly reproduced from 
(Extance, 2012). 
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Of particular interest to cofactor specificity is His298, which has been found in similar 
enzymes.  The His298 equivalent allows for NADH specificity; however, when mutated to 
Arginine, specificity alters substantially towards NADPH.  That said, overall activity was 
drastically reduced as well, potentially due to interference with the metal ion (see Figure 12).  
There are also ambiguous signs that Asp57 may be a key residue as well, yet the significant 
distance between this residue and the NADPH phosphate group (18.4Å) would appear to 
preclude such possibilities (Extance, 2012). 
PDB references for zmADH2 are 3OWO (without cofactor), 3OX4 (with cofactor), and reference 
for the ADH section of ADHE from G. thermoglucosidasius is 3ZRD. 
 
1.5.1.4. ALDO-KETO REDUCTASES SUPERFAMILY 
This superfamily contains monomeric enzymes of approximately 320 residues with either 
exclusive preference for NADP(H) as a cofactor, or will accept NAD(H) whilst preferring 
NADP(H).  In rarer cases NADH preference can be found, but almost none are exclusively NADH 
dependent.  As with the previous superfamilies, the AKRs include a wide range of enzyme 
families, including hydroxysteroid dehydrogenases, mannose reductases and potassium 
channel β-subunits.  Another key difference between AKRs and other types of ADHs are that 
they do not adopt a classic Rossmann fold, rather a TIM or (β/α)8  barrel.  AKRs are also more 
often monomeric, but may be dimeric, trimeric, tetrameric or octameric (Di Luccio et al., 2006; 
Lapthorn et al., 2013).  
Examples of AKRs are YtbE and YvgN, both from Bacillus subtilis.  The former is considered an 
essential protein in B. subtilis for the detoxification  of aldehydes (Commichau et al., 2013) and 
the latter has been implicated in formulation of spores (Lei et al., 2009).  Due to their high 
sequence identity (70%), they will be considered as a pair for the purposes of this example. 
AKRs have a typical catalytic tetrad of tyrosine, histidine, aspartate and lysine, which is 
essential for reactions to take place.  In addition, loops β1 and β7 directly interact with each 
other via hydrogen bonding, which forms a “safety belt” to secure the pyrophosphate group of 
the cofactor; it is believed that a conformational change to release NADP+ from this safety belt 
is the rate-limiting step in reactions.  In the case of YvgN, the safety belt is stabilised by a 
hydrogen bond between Lys26 and Gln194, which does not induce a significant conformational 




Figure 13 - Ribbon diagrams of apo YtbE, apo YvgN and holo YvgN coloured in salmon, blue and green 
respectively.  The bound NADPH in holo YvgN is represented by stic ks, and the yellow areas refer to 
FR-1 from Mus musculus, a typical eukaryotic AKR.  Directly reproduced from (Lei et al., 2009) 
Particularly interesting about the structure of these AKRs from B. subtilis is the substantial 
difference when compared to traditional eukaryotic AKRs.  This difference is most easily seen 
in loops β4 and β7, and these define the substrate binding pocket and the cofactor binding 
pocket, respectively (Lei et al., 2009).  These differences are highlighted in Figure 13 above. 
 
 
Figure 14 - (Left) Structures of YvgN (green) and YtbE (cyan) showing the “safety be lt” (dashed line) 
and catalytic tetrad (Tyr54,Lys79, Asp49, His112).  (Right) Superposition of apo YvgN (green) and holo 
YvgN (yellow). 
The catalytic tetrad is Tyr54, Lys79, Asp49 and His112 for YvgN, and Tyr54, Lys83, Asp49 and 
His116 for YtbE.  The former tetrad is shown in Figure 14.  It is believed that a conserved 
hydrogen-bonding network between the catalytic tetrad (as indicated) depresses the pKa of 
tyrosine to enable it to act as an acid to facilitate the hydrogen transfer to the substrate.  The 
His112 residue is buried in a hydrophobic environment consisting of Ile53, Trp81 and Trp113 
and is therefore believed to be responsible for the orientation of the carbonyl in the active site 
via steric hindrance (Lei et al., 2009). 
No substantial shift in secondary structure was noted upon NADPH binding to YvgN although 
Lys232, Lys235 and Arg238 reorientated to form hydrogen bonds with the 2’-phosphate of the 
cofactor.  Trp189 and Phe25 also moved to allow space for the cofactor to bind.  The cofactor 
31 
itself was tightly stabilised by a hydrogen bonding network, the previously mentioned safety 
belt and aromatic stacking interaction with Trp189 (Lei et al., 2009). 
 
 
Figure 15 – Putative substrate binding site of YvgN, which includes three w ater molecules as red 
spheres.  The blue mesh represents electron density with the 2 Fo-Fc density map (σ=1.0).  Directly 
reproduced from (Lei et al., 2009). 
The substrate binding pocket in YvgN is believed to be mainly composed of aromatic and 
apolar residues Phe25, Ile53, Tyr54, Lys79, Trp113, Trp81, His112, Asn82 and hydrophobic 
residues found in the C-terminal loop: Pro269, Leu274, Phe276.  Three water molecules are 
also present in the binding pocket, which are believed to form hydrogen bonds with Tyr54, 
Trp113 and His112, which assist in orientating the carbonyl groups of the substrates during 
reactions (Lei et al., 2009). 
Despite a wide range of accepted substrates, both YvgN and YtbE showed remarkable activity 
with heteroaromatic aldehydes such as 4-nitrobenzaldehyde.  Replacing the 4-nitro group with 
a 4-chloro or 3-nitro group substantially reduced the activity of both enzymes.  Substituting 
with a 2-halogen instead resulted in substantial increases in activity.  From human AKRs it has 
been previously shown that Arg311, positioned in the C-terminal loop, determines the 
substrate specificity via hydrogen bonds with negatively-charged groups on the substrate, yet 
neither YvgN nor YtbE have an equivalent residue.  In common with prokaryotic AKRs, Asn 
82(YvgN)/Asn86 (YtbE) is highly conserved and may have a similar role in determining 
substrate specificity through interaction with the 4-group of the aromatic ring.  YvgN and YtbE 
were similar in substrate scope and structure in this regard (Lei et al., 2009). 
It has also been suggested that AKRs may act as dehydrogenases, i.e. by converting alcohols to 
their respective aldehydes and aldoses, but no activity was noted with a range of substrates 
and NADP+ as cofactor (Lei et al., 2009).  
Further work has been conducted with YtbE, due to its industrially-interesting substrate scope 
(Ni et al., 2011).  The enzyme was investigated for its ability to reduce methyl 
o-chlorobenzyolformate to methyl (R)-o-chloromendelate, a key intermediate in the 
production of (S)-clopidogrel, a treatment for atherosclerosis.  The issue was stability of the 
enzyme in industrially relevant conditions, including thermostability at temperatures above 45 
°C, insufficiently low activity at 20 °C for an economically effective industrial process, substrate 
inhibition, and product inhibition.   A particular problem was product inhibition, which led to 
permanent inactivation of the enzyme through unfolding.  Several additives were tested to 
determine if they could increase the stability of YtbE, including glycerol, glucose and other low-
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molecular weight molecules which previously have shown to strengthen hydrophobic 
interactions among non-polar amino acids as a strategy to stabilise proteins against 
denaturation.  Incubating YtbE with 30% glycerol for 30 minutes led to near complete 
retention of the enzyme activity, best of all additives studied (Xu et al., 2014). 
Given the above structure, the active site is mostly composed of non-polar and aromatic 
residues, which would be amenable to stabilisation through the use of low-molecular weight 
molecules.  The reason why glycerol may be the best stabilising agent could be due to the 
three water molecules normally found inside the active site.  It is plausible that some or all of 
these were replaced with glycerol, which may provide additional stability through increased 
size compared to water.  It is also possible that the additional alcohol groups can simply allow 
for additional hydrogen bonds to be formed or that due to the carbon backbone of the 
molecule, glycerol is able to form hydrogen bonds whilst stabilising itself with more 
hydrophobic interactions with the existing residues in the active site.   A third option is that 
this is merely another example of glycerol stabilising a protein, as it is a well-known generic 
stabiliser (Gekko and Timasheff, 1981; Timasheff, 1992). 
PDB records for these examples are as follows: apo YtbE (3B3D), apo YvgN (3F7J), holo-enzyme 
YvgN (3D3F). 
 
1.5.2. ADVANTAGES AND USES OF ADHS 
All ADHs, irrespective of their family, catalyse the reaction between alcohol and aldehydes 
and/or ketones, with the aid of a cofactor, either NAD(H) or NADP(H).  This is a crucially 
important chemical reaction which is frequently performed throughout the chemical industry, 
in both directions.  In areas such as the pharmaceutical industry, alcohols are preferred as 
products, for this produces a chiral product, which can either be kept as is, or subsequently 
converted into whichever molecule is required (Ziegelmann-Fjeld et al., 2007).  The cosmetic 
industry will usually prefer specific enantiomers of alcohol too, as these may have specific 
fragrances which are needed for different purposes.  Further, alcohols may be preferred as an 
intermediate to esters, which tend to be widely used as fragrances (Welsh, 1989). 
The bioremediation sector is also likely to prefer alcohols as well, but solely due to their safety.  
Although alcohols may remain toxic, they are substantially less toxic than their aldehyde 
counterpart; in areas such as the paper or textile industries, or even wastewater treatment 
facilities, there may be high concentrations of methanal, ethanal and other small aldehydes 
that pose a very substantial health risk, compounded by their volatility. 
More broadly, there are a variety of alcohols considered useful biofuels, bioplastics or key 
intermediates for the chemical industry.  These include isobutanol, butanol, 1,3-propanediol 
and 1,4-butanediol (Jarboe, 2011; Erickson et al., 2012).  Much work has concentrated on the 
biosynthesis of small alcohols, which will typically involve an ADH as the last step. 
Conversely, there can be occasions where the reverse reaction is preferred, with one notable 
example being the raspberry ketone.  In this instance there is no technical reasons, however 
due to legal and consumer choice reasons, it is preferred to have products which can be 
labelled as natural.  Therefore the ketone can be directly extracted from raspberries, but as 
there is only 3.7mg kg-1 available, this ensures a great cost.  There are several potential routes 
available, both biological and chemical, however many do not qualify for the legal standard of 
natural, and therefore cannot be used.  One option is to use rhododendrol, the alcohol 
equivalent, using an ADH to convert the alcohol to the ketone.  The rhododendrol can be 
33 
extracted as the corresponding 2-glycosides from the bark of silver tree, and is converted into 
the requisite alcohol by β-glycosidase.  As the raw material is directly extracted from a natural 
source and a purely biological (i.e. enzymatic) process is followed, this meets legal 
requirements (Welsh, 1989; Edegger et al., 2006; Wenda et al., 2011).   
 
1.5.3. CHALLENGES OF ADHS 
There are several major disadvantages of using ADHs, which afflict most, if not all, enzymes.  
Being adapted to a cellular environment, they are typically adapted to accept a concentration 
of substrate within a narrow band, usually a very low concentration.  Equally there is rarely a 
large amount of product that remains, as enzymes do not work in isolation, being part of a 
metabolic pathway.  Even if substrates and products were not toxic and naturally inhibitory to 
both whole cells and isolated enzymes, the conditions required for an accepted industrial 
process differ wildly from those anticipated in a cell. 
Several options have been considered for improving the stability of ADHs in industrially 
relevant operation conditions.  Firstly is mutagenesis, engineering the enzyme itself to be 
inherently more stable, whether by eliminating substrate inhibition or by otherwise improving 
resistance to the intended industrial conditions (Ziegelmann-Fjeld et al., 2007).  Switching from 
whole cell to isolated enzyme or the reverse can also assist.  If a biosynthetic approach can be 
obtained, then there is less substrate and product exposed to the enzyme, particularly if an 
excretion system is employed so that the final product is obtained from the supernatant rather 
than the cells.  Conversely, if isolated enzymes are used, then weaknesses deriving from a 
whole cell system such as resistance to additives or solvents may be obviated.   
A third option is stabilisation of the enzyme.  This may take many forms, including 
immobilisation of the enzyme which may increase the stability of the enzyme, but also allows 
the enzyme to be recovered with ease, paving the way for reuse of an enzyme (Spickermann et 
al., 2014).  Typically this involves physical adsorption of isolated enzymes (potentially 
reversible) or covalent bonding (essentially irreversible) to solid supports (Hollmann et al., 
2011b).  Other ways of immobilisation include binding enzymes to a support, entrapment or 
encapsulation of the enzyme, and cross-linking (Knezevic-Jugovic et al., 2011).  
A wide range of protocols for stabilising and immobilising enzymes is given by Minteer (2011); 
however, specific options include covalent bonding of reactive amino groups to cyanogen 
bromide activated agarose beads, multipoint covalent attachment to glyoxyl agarose, cross-
linking with glutaraldehyde, and anionic exchange followed by covalent reaction to amino-
epoxy supports (Rocha-Martin et al., 2009).  Further possibilities include forming cross-linked 
enzyme aggregates (CLEAs) by precipitating the enzyme before cross-linking the aggregates, 
potentially with glutaraldehyde as previously mentioned (Sheldon, 2012); linking to amino-
functionalised carriers such as porous glass beads, magnetic particles (magnetite) and 
nanodiamonds, with glutaraldehyde (Goldberg et al., 2008); cross linking with 1-ethyl-3-
(diamino-propyl) carbodiimide (EDAC) to commercial support materials such as Eupergit® 
(Chiyanzu et al., 2010); covalent bonding to amino-epoxy methacrylate resin (Grimaldi et al., 
2016); and whole cell encapsulation in alginate (Kurbanoglu et al., 2011; Leuchs and Greiner, 
2011) or sodium cellulose sulphate (Goldberg et al., 2007a). 
As is implied from the short list above, there are a large number of methods available, but 
immobilising the enzyme or whole cell is not always a positive move.  Stability to reaction 
conditions, thermostability and recoverability of the enzyme may be increased, but 
immobilisation may also result in decreased activity and loss of specificity.  Methods such as 
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crosslinking can be non-specific themselves, resulting in changes to the enzyme.  There is no 
overarching strategy that can always be followed, meaning that each enzyme and process has 
to be considered on a case by case basis. 
ADHs also suffer from an additional issue, cofactor regeneration.  As they rely upon NAD(P)(H) 
to mediate the catalysis of their substrate, and the cofactor is used stoichiometrically, then it is 
necessary to replace the cofactor.  In industrial processes this is particularly important both 
due to the scale of the reaction but also the extreme cost that large quantities of cofactor 
would attract, especially NADPH which is ten times more expensive than NADH.  When in a 
whole cell situation the problem is slightly different as the host organism can regenerate the 
necessary cofactor if it has sufficient glucose or other food source.  The issue then becomes 
whether the demands of the biosynthesis overwhelm the host cell’s ability to regenerate the 
relevant cofactor or whether the particular ADH involved has an affinity for the cofactor 
greater than other enzymes involved in primary metabolism.  It is possible for the drain on 
cofactor to be so substantial that it can interfere with the good running of the cell and cause 
cell death.  The most prominent example of this is furfural, liberated during the processing of 
lignocellulosic feedstocks, it is highly toxic to most organisms used in the processing, and this is 
due to ADHs converting the furfural to furfuryl alcohol, rapidly removing all available NADPH 
from the cell, exhausting all supplies that are necessary for primary metabolism to function 
(Miller et al., 2010).   
There are several methods used to regenerate the cofactor, whether it is NADH or NADPH 
required.  The first is to use a sacrificial second substrate alongside the required substrate.  In 
the case of ADHs, this would typically be either ethanol or isopropanol, small alcohols that can 
be acquired cheaply.  It is even possible to use a small alcohol as a solvent or co-solvent, 
dissolving the actual substrate and/or product into it.  If the ADH in question is resilient to this 
system, and able to accept both substrates, then this can be an elegant situation.  
Furthermore, when using thermophilic ADHs this situation improves dramatically as ethanal 
and acetone are both exceptionally volatile, and therefore are easily removed via an in situ 
recovery system.  This ensures that the system is irreversible and will assist in driving the 
reaction to completion, which is particularly relevant as large molar excesses are often needed 
of the sacrificial substrate to ensure that the primary reaction occurs (Hollmann et al., 2011b; 
Wenda et al., 2011). 
A second option is to use glucose dehydrogenase (GDH) in a two enzyme approach, which 
converts glucose into gluconolactone, which irreversibly hydrolyses into gluconic acid in the 
presence of water.  As glucose is cheap and readily available, and as GDH is able to utilise both 
NAD+ and NADP+ as cofactors, this is a very useful method.  The irreversible second stage 
ensures that the reaction will eventually run to completion, although care may need to be 
taken, as with all cofactor regeneration methods, that the regeneration is not hindering the 
primary reaction by being the rate-determining step.  GDHs are well known and characterised; 
therefore a suitable enzyme can be chosen to work with reaction conditions as required.  The 
major drawback in this case is the pH change which will invariably occur, challenging buffers, 
particularly at larger scales.  Even if the pH change can be controlled, which is possible with 
suitable engineering control systems such as proportional-integral-derivative (PID) control, the 
salt produced will affect the ionic strength and the volume of waste will be quite substantial 
(Huisman et al., 2010). 
Similar to the use of a GDH is the use of a formate dehydrogenase (FDH), which catalyses the 
formation of carbon dioxide from formic acid, which is effectively irreversible due to the ease 
at which the gaseous product can be emitted.  Whilst there still is a pH change, this can be 
35 
more easily remedied through continual addition of formate to the reaction.  FDHs can reduce 
both NAD+ and NADP+ making them useful in both systems (May, 2009; Gao et al., 2014). 
Further options for cofactor regeneration do exist, including electrochemical regeneration, 
photosynthetic based regeneration and alternative enzymes such as lactate dehydrogenase, 
glutamate dehydrogenase, phosphite dehydrogenase, NADH oxidase (Wu et al., 2012)and 
hydrogenase.  Most other enzymes would have similar problems to both the FDH and GDH 
previously mentioned, however as NADH oxidase relies on a continuous supply of oxygen gas 
and the hydrogenase relies upon hydrogen being freely available, both may additionally pose 
issues with regards to diffusion of the gas throughout a large bioreactor as well as fire or 
explosion risk.  The other examples given are less well established and rarely used at industrial 
scale due to the relative ease and the effectiveness of the biological approach, and most often 
ADHs, GDHs, or FDHs (Chenault and Whitesides, 1987; Goldberg et al., 2007a; Moore et al., 
2007; Hilterhaus and Liese, 2009; May, 2009; Huisman et al., 2010; Hall and Bommarius, 2011; 
Hollmann et al., 2011a). 
Cofactor regeneration is a particular issue when using isolated thermophilic enzymes because 
NAD(P)H is not thermostable.  Their thermolability is exacerbated by acidic pH, ionic strength 
and other buffer components such as phosphate and citrate (Wu et al., 1986; Chenault and 
Whitesides, 1987).  The oxidised and reduced forms of the cofactors have different 
degradation pathways and also different sensitivities; NAD(P)H is more easily degraded in 
acidic conditions whereas NAD(P)+ is resistant to acidic conditions but easily degraded in 
alkaline conditions.  Given the nature of redox reactions this makes determining suitable 
reaction conditions extremely difficult (Chenault and Whitesides, 1987).  Often cofactor 
stability is overlooked in favour of regeneration, yet it is clear that even with an effective 
regeneration system, even at moderate temperatures, cofactors will degrade (Wu et al., 1986; 
Chenault and Whitesides, 1987; Pennacchio et al., 2011).  It is imperative that the cofactor is 
stabilised to ensure an effective industrial scale system.   
Several routes are available.  The first is to ensure that there is sufficient enzyme activity and 
cofactor such that loss of cofactor is irrelevant, something particularly done at bench scale 
(Pennacchio et al., 2011, 2013b).  The second is to use the cofactor in the solid phase, which 
massively improves its thermostability (Kulishova et al., 2010); another is to design a cofactor 
regeneration system that is able to regenerate degraded cofactor, and the first steps towards 
this have been done (Honda et al., 2016), but it is an incredibly complex system necessitating 
many more enzymes and only works for NAD+ regeneration thus far.  It is also possible to 
immobilise the cofactor on a solid support, or immobilise the enzymes used for cofactor 
regeneration on a solid support (Rocha-Martín et al., 2012; Gao et al., 2014).  None of these 
options is perfect currently, but this is a continuing area of investigation; the first option is 
probably the most likely to be taken, but this drives up the cost and would potentially not 








1.6. AIMS AND OBJECTIVES OF THE PROJECT 
The aim of this project is to identify novel enzymes, specifically alcohol dehydrogenases, that 
are of potential industrial use.  These enzymes will be acquired from G. thermoglucosidasius 
for two principal reasons.  Firstly, multiple ADHs are already under investigation in the Centre 
for Extremophile Research for their role in ethanol production in vivo and for the potential 
production of butanol.  These previously isolated enzymes are ideal as a starting point to 
determine the potential industrial significance of enzymes from this species.  Secondly, 
G. thermoglucosidasius is a moderate thermophile that is being investigated to determine 
whether it is suitable to produce ethanol from municipal waste at industrial scales.  As part of 
previous investigations it has been determined that numerous ADHs exist and are of unknown 
function and substrate scope.  Given the thermophilicity of G. thermoglucosidasius, these 
enzymes are more likely to be thermophilic and solvent tolerant than mesophilic enzymes.  
These features are in particular demand in industrial processes and were of high importance to 
the project. 
Key objectives for this project are: 
 Identify and isolate genes encoding for putative ADHs, followed by cloning into E. coli 
 Determine the substrate scope of acquired recombinant enzymes 
 Analyse the enzyme kinetics with several substrates of relevance to research or 
industry 
 Identify products using Gas Chromatography (GC) or High Perfomance Liquid 
Chromatography (HPLC) methods, as appropriate 
 Determine stereoselectivity of enzymes using chiral GC methods, as appropriate 
 Evaluate stability of enzymes in industrially-relevant conditions, including 
thermostability and solvent stability 
 Identify prospective applications for enzymes and demonstrate the potential for using 
them in these industrial or research applications by scaling up as necessary to 
determine proof of concept reactions based upon existing or novel reactions 
By achieving these key objectives, it will be possible to ascertain whether 
G. thermoglucosidasius can be a useful source of enzymes for further biotechnological 




2. INVESTIGATIONS WITH AVAILABLE ENZYMES 
Initial results were obtained from Alcohol Dehydrogenases already under investigation.  They 
were all obtained from other members of the Centre for Extremophile Research who were 
examining them for their potential in the biosynthesis of ethanol and higher alcohols as 
biofuels.  All genes were obtained from G. thermoglucosidasius and expressed in E. coli, 
provided as glycerol stocks of the production strain BL21 (DE3), using the plasmid pET28a to 
provide an N-terminal hexa-histidine tag for purification purposes. 
2.1. ADH A 
The first Alcohol Dehydrogenase (ADH) studied, designated ADH A, was in fact one half of the 
bifunctional enzyme externally referenced as AdhE, comprising an N-terminal aldehyde 
dehydrogenase (acetylating) and a C-terminal alcohol dehydrogenase.  Overall it converts 
acetyl-coenzyme A to ethanol via ethanal as an intermediate; the bifunctional enzyme is the 
final step in the biosynthesis of ethanol in G. thermoglucosidasius.  As the ADHE was under 
investigation for the purpose of increasing understanding about the native ethanol production 
system in G. thermoglucosidasius, previous work concentrated solely on ethanal as a substrate 
(Extance, 2012).  
 
 
Figure 16 - SDS-PAGE gel of ADH A fractions post purification from IMAC chromatography column. 
Lane 1: markers, lane 2: total protein, lane 3: soluble fraction, lane 4: insoluble fraction, lane 5: 2
nd
 
flowthrough, lane 6: 0% His-Elute Buffer, lane 7: 10%, lane 8: 30%, lane 9:  100% His-Elute Buffer.  The 
numbers on the left indicate relative molecular masses (Mr) of markers in kDa; the arrow indicates the 
putative ADH, with an expected Mr of 48.6kDa. 
2.1.1. SUBSTRATE SCOPE 
Initial work was with disrupted cell extracts of E. coli BL21 (DE3) pET28a, in order to determine 
if activity was present.  Whilst activity was confirmed with ethanal (data not shown), both cell 
extract and certain substrates absorb at 340nm, the wavelength under examination, causing 
difficulty.  Additionally, even through judicious use of control experiments, interference by 
host alcohol dehydrogenases can never be entirely ruled out, and indeed this has been shown 
to be a major problem in previous work (Atsumi et al., 2010; Jarboe, 2011).  Therefore, the 
decision was made to proceed with purifying the soluble fraction of the cell extracts, using 
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reduce the possibility of interference.  This was facilitated by the N-terminal hexa-histidine tag 
provided by the vector pET28a. 
A substrate screen was then carried out to determine the substrate scope of ADH A, with 
regards to its previously determined activity with ethanal.  In the first instance substrates were 
screened on a volumetric rather than concentration basis. 
 














Table 1 – Relative rate of reaction obtained using ADH A with 10µl substrate in a 1ml assay.  
Additional conditions: 0.2mM NADH, 50mM citric acid, pH 6.0, 50 °C.  
The lack of substrate solubility makes it difficult to compare rates between substrates such as 
ethanal, which is effectively miscible, with sparingly-soluble lengthier substrates.  Specifically, 
by using 10µl substrate, the concentration ranged from approximately 138mM to 45mM.  This 
variation in itself would be problematic, but pentanal and larger substrates have low solubility 
in water, of the order of 10mM and below.  This means that it is not possible to accurately 
ascertain the real concentration of the substrate available to the enzyme, and the value of the 
experiment is limited.   
It is worth noting though that if “excess” substrate is provided to an assay, invoking bilayer 
formation, then the substrate concentration will become limited to the solubility.  Given that 
this is probable in this case, and that solubility decreases in a relatively linear manner with 
increasing molecular mass, then a concomitant reduction in specific activity would be expected 
if this were the sole factor.  As this is not shown in the results, then there is clearly a 
confounding effect involved as the apparent rate of reaction does not reduce in a predictable 
fashion.  For example, there is an increase in the rate of reaction when using heptanal as 
substrate instead of hexanal.  If solubility was the limiting factor on the apparent rate, then 
having less substrate present in the aqueous phase would have resulted a lower rate of 
reaction when using heptanal.  This could be explained by substrate inhibition, where the 
reduced solubility relieved an inhibitory effect caused by excess substrate. 
All subsequent analysis was conducted on a substrate concentration basis, rather than by 
volume.  In addition, where substrate solubility was known, experiments involving that 
particular substrate were kept below that critical value, treating experimental buffers as pure 
water for this purpose.  Finally, smaller substrates were most frequently used in method 
development and analysis, both to ameliorate the experimental conditions, but also due to the 
apparent higher affinity of ADH A for the smallest substrates (i.e. ethanal, propanal, butanal). 
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The wide substrate scope with regards to aldehydes, but none with ketones, is not 
unexpected.  Due to the wide conservation of this particular enzyme and its particular 
relevance to the production of ethanol, it has been widely studied, and this is a notable 
characteristic of this enzyme (Extance, 2012).  That said, activity has only previously been 
noted for shorter aldehydes, up to octanal, and not beyond.  This could be an anomaly peculiar 
to G. thermoglucosidasius, but more likely an artefact of examining the whole enzyme.  The 
aldDH may be limiting, or it could be the scarcity of the larger substrates, e.g. decyl-coenzyme 
A. 
2.1.2. KINETICS 
Once the substrate scope was determined, the kinetic constants of the enzyme were 
considered.  Due to the aforementioned issues, smaller substrates were preferred for this task, 
particularly as they would allow for a large range of substrate concentrations to be studied 
without the necessity of solvents. 
To provide adequate analysis, both Hanes-Woolf and Michaelis-Menten curves were 
calculated, the former indicating the validity of the default assumption of adherence to 
Michaelis-Menten kinetics.  Where necessary, both graphs are fitted assuming substrate 






Equation 2 – Standard Michaelis-Menten equation 
𝑣 =
𝑉𝑚𝑎𝑥[𝑆]





Equation 3 – Michaelis-Menten equation with substrate inhibition 
 
Where: 
v is the rate of reaction 
Vmax is the maximum rate of reaction 
[S] is the substrate concentration 
KM is the Michaelis constant 























Figure 17 – Graph of rate of reaction vs [S] using ADH A and ethanal.  Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 









































Figure 18 - Hanes-Woolf plot ([S]/v vs [S]) for ADH A and ethanal, data fitted assuming substrate 



























Figure 19 - Graph of rate of reaction vs [S] using ADH A and propanal.  Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 




































Figure 20 - Hanes-Woolf plot ([S]/v vs [S]) for ADH A and propanal,  data fitted assuming substrate 

























Figure 21 - Graph of rate of reaction vs [S] using ADH A and butanal.  Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 








































Figure 22 - Hanes-Woolf plot ([S]/v vs [S]) for ADH A and butanal, data fitted assuming substrate 





In all figures error bars represent the standard error, typically derived from triplicate 
experiments.  The kinetic constants for ADH A are as follows: 
Substrate Vmax (U mg
-1) KM (mM) Ki (mM) kcat (min
-1) kcat/KM (mM
-1 min-1) 
Ethanal 143 (±30) 182(±61) 456(±170) 7000 38 
Propanal* 178 (±196) 246 (±326) 70 (±94) 8700 35 
Butanal 62(±12) 18(±7.0) 73(±24) 3000 167 
Table 2 - Kinetic constants calculated For ADH A.  *Very high standard error; data should be 
considered illustrative only.  
The Hanes-Woolf plots and the Michaelis-Menten curves indicate a lack of co-operative 
kinetics and that some level of substrate inhibition is present, as indicated by the decrease in 
enzyme velocity at higher substrate concentrations; the inhibition has contributed to a rather 
large standard error associated with the kinetic constants, it may have been helpful to have 
additional points at both higher and lower substrate concentrations, but particularly at the 
higher end.   
Inhibition leads to a higher than expected Vmax, which in turn leads to higher KM, and therefore 
increased error as it is necessary to have data at substrate concentrations that exceed 3 fold 
higher than the KM, even 10 fold higher in an ideal situation.   Therefore, with a surprisingly 
high KM, even with a very wide range of substrate concentrations, higher concentrations are 
liable to be needed to reduce the error.  This level of error is compounded in the case of the Ki 
values recorded, simply because these values are typically higher than the equivalent KM, and 
consequently require greater substrate concentrations to be fully elucidated. 
Despite the errors noted it appears that ADH has a much improved affinity for butanal than 
ethanal, which was presumed to be its preferred substrate.  The order of magnitude reduction 
in KM is also intriguing because it would seem to indicate a preference for longer chain 
substrates, rather than a tolerance.   The specificity constants calculated reinforce this belief, 
with an overall four-fold increase for butanal over both ethanal and propanal.  This indicates 
that with a mixture of substrates at the same concentration, the rate will be four-fold higher 
with respect to butanal, even though a larger rate could in theory be obtained with either of 
the two other substrates (Eisenthal et al., 2007). 
 
2.1.3. STABILITY ANALYSIS 
In addition to substrate scope, an investigation into the stability of ADH A was conducted, 
primarily considering solvent stability.  DMSO, acetonitrile and hexane were the principal 
solvents tested, as they are frequently used industrially as cosolvents for biocatalytic steps.  
Taken together they represent a range of solvents, due to their miscibility or otherwise with 
aqueous solutions.  In particular hexane is predominantly forming bilayers which may prove 
useful to partitioning substrate and product from the enzyme, whilst DMSO is most likely to 
improve solubility of both in the aqueous phase. 
Using octanal as substrate and DMSO as solvent, 1vol% solvent caused a reduction in observed 
activity of 6%.  With acetonitrile, 14% reduction was noted, and with hexane 10%.  Increasing 
the proportion of hexane proved difficult as it attacked both the cuvette and the parafilm used 
for covering the cuvette whilst inverting.  Further, due to immiscibility, the absorbance when 
using hexane was exceptionally high, resulting in inaccurate or indeterminate readings. 
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With regards to acetonitrile though, increasing to 10vol% and 20vol% resulted in a 75% and 
93% reduction in observed activity respectively, indicating substantial inactivation with 
increasing solvent.  ADH A was more resilient when presented with DMSO, however, with a 
92% reduction in activity only occurring with the addition of 50vol% DMSO.  Whilst it is unlikely 
that an industrial environment would require a 50% DMSO cosolvent, due to the expense and 
the difficulty in separating the solvent from water, it is still useful to know where the 
boundaries lie. 
If such a high volume of DMSO is required for solvating the substrate and/or product, then it 
would probably be better to consider a biphasic reaction, with either the substrate dissolved in 
hexane or similar, or a solvent free system where the substrate itself forms the second phase 
(Straathof et al., 2002; Doukyu and Ogino, 2010).  Typically, if a high concentration of solvent is 
to be used, then it is as an alcohol as a sacrificial substrate, or to work in anhydrous conditions.  
Other options include non-standard solvents and ionic liquids to improve solubility (Schroer et 
al., 2007; Musa et al., 2008; Gu and Jérôme, 2010).  More exotic routes such as gas/solid 
reactors also exist (Kulishova et al., 2010).  High concentrations of solvent may also affect the 
structure of enzymes in unexpected ways, not just in terms of stability.  The substrate scope 
may be affected, as well as enantiospecificity and the enantioselectivity.  This effect is 
particularly noted at near anhydrous conditions, when the enzyme is either lyophilised or the 
reaction is carried out in pure solvent. 
Further to considering specific activities in the presence of solvents, a kinetic analysis was 


























Figure 23 - Graph of rate of reaction vs [S] using ADH A and ethanal in the presence of DMSO.  Data 
fitted to a Michaelis-Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt 
algorithm by Sigmaplot 12.  Conditions: 50mM citric acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay 



































Figure 24 - Hanes-Woolf plot ([S]/v vs [S]) for ADH A and ethanal in the presence of DMSO,  data fitted 
assuming substrate inhibition.  Conditions: 50mM citric acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay 
volume, 10vol% DMSO. 
It is not possible to say definitively whether the addition of DMSO has affected the kinetic 
constants due to the standard error present, again due to the requirement for further data at 
substrate concentrations of 1M and above.  By visual inspection, however, there appears little 
to choose between Figure 17 and Figure 23; this cannot be shown statistically.  The constants 
obtained using DMSO are: Vmax 216 U, KM 40 mM and Ki 243 mM.  It is also worth noting that it 
can be seen from Figure 24 that Michaelis-Menten kinetics is maintained even in the presence 
of the solvent. 
2.1.4. SEQUENCE ALIGNMENT 
To consider the experimental evidence obtained with reference to previous knowledge, the 
amino acid sequence of ADH A was aligned with similar sequences and key amino acids 
highlighted.  Given the availability of a crystal structure for the ADH section of the full enzyme, 
this was something also to be investigated; however, comparing similar sequences became 
rather complex when attempting to align ADH sequences and whole enzyme sequences, so 
two alignments were carried out.  In the first multiple sequence alignment, the nearest 
matches for the entire enzyme were aligned with the whole sequence (ADHE).  All these 
similar sequences had 65% or greater sequence identity with ADH A.  This contrasts with the 
alignment of the ADH section only, which was aligned with the most similar sequences held in 












Figure 25 - Multiple Sequence Alignment (MSA) of G. thermoglucosidasius ADHE enzyme with 
sequences identified using NCBI Seqr Sequence Search. The blue triangle indicates the putative 
catalytic cysteine residue, purple triangles indicate other putative active site residues, and grey 
triangles indicate the metal-binding site, all obtained from the NCBI Conserved Domain Database via 
the Conserved Domain Search.  Green shading indicates 100% conservation, yellow shading indicates 
>80% conservation and red shading indicates >50% conservation of amino acids across selected 
sequences.  Labels refer to NCBI protein sequences from the Reference Sequence (RefSeq) database.  
Sequences aligned using MEGA 6.0 (Tamura et al., 2013) with MUSCLE and visualised using Genedoc 
2.7 (Nicholas et al., 1997).  All sequences are annotated as bifunctional acetal dehyde-CoA/alcohol 
dehydrogenases and are from the genera Geobacillus, Anoxybacillus, Bacillus and Pontibacillus . 
What is striking about this alignment is the very high level of conservation.  Virtually every 
single residue is conserved in at least 15 of the 30 closest sequences; only 25 of the 867 
residues are not.  Given that these enzymes are from the same family and ADHs from the same 
genus are often very similar (>90% sequence identity) this is probably not unusual 
(Radianingtyas and Wright, 2003).   
The least conserved area of the bifunctional enzyme is in the initial 40 amino acids, although 
there are areas throughout the enzyme which are less conserved, e.g. positions 180-200 and 
820-840.  With such high levels of conservation there are few positions where there is any 
difference in any of the highlighted residues – D659Y for WP_032101621.1, from Anoxybacillus 
flavithermus, annotated as a metal binding site; Y626I for WP_059350210.1, from Bacillus 
coahuilensis, annotated as part of the active site; H740G for WP_046526177.1 and 
WP_046526177.1 from two Bacillus spp and also annotated as part of the active site. In all 
three cases the amino acid change is liable to have an effect as only in the case of Y626I are 
both amino acids similar, in this case both classed as hydrophobic.  That said, tyrosine is 
substantially more bulky than isoleucine, which may have an effect. 
In all these cases there could be a substantial effect on either the substrate profile of the 
enzyme or the kinetics.  With the modified residue believed to interact with the metal ion, this 
could also impact upon the stability (e.g. thermostability) in addition to catalytic effects.  As no 




Figure 26 - Multiple Sequence Alignment (MSA) of ADH A (the C-terminal ADH domain of ADHE), using 
the sequence obtained directly from crystal structure 3ZDR.  Purple triangles indicate putative 
substrate binding site, and grey triangles indicate metal binding site , obtained from the NCBI 
Conserved Domain Database via the Conserved Domain Search.  Green shading indicates 100% 
conservation, yellow shading indicates >80% conservation and red shading indicates >50% 
conservation of amino acids across selected sequences.  Labels refer to sequences from PDB with 
associated crystal structures.  Sequences aligned using MEGA 6.0 (Tamura et al., 2013) with MUSCLE 
and visualised using Genedoc 2.7 (Nicholas et al., 1997).  Sequences are annotated as follows: 3BFJ – 
1,3-propanediol oxidoreductase from Klebsiella pneumoniae , 3OWO – Iron dependent ADH from 
Zymomonas mobilis, 2BI4 – Lactaldehyde: 1,2-propanediol oxidoreductase from E. coli (FucO), 5BR4 – 
Lactaldehyde reductase from E. coli, 1RRM – Lactaldehyde reductase from E. coli,  4FR2 – ADH from 
Oenococcus oeni  
Looking more broadly, the second multiple sequence alignment (MSA) considers the closest 
amino acid sequences held on the Protein Data Bank (PDB).  In contrast to the >65% sequence 
identity in the previous MSA, these sequences have 32-35% sequence identity with 3ZDR, the 
sequence reported as part of the crystal structure obtained of the ADH portion, ADH A. 
As can be seen in Figure 26, despite a drop in conserved residues, few changes are made to 
residues noted for their role in either the substrate binding site or the metal binding site.  Y197 
is the first, being generally conserved as phenylalanine, but once (3OWO) being replaced by 
methionine instead, a substantially different amino acid.  The only other different key residue 
is F215, which is replaced variously with methionine and lysine.  Both these positions are 
believed to be related to the substrate binding site and therefore may have a substantial 
effect.  In addition, ADH A (3ZDR) has two areas (positions 140-150 and 330-345) that are 
unique.  These are believed to be due to the bifunctional nature of the full enzyme, and 
therefore are understood to be related to the stabilisation of the full enzyme.  As the 
remainder of the sequences are ADHs only, they do not have these sequences (Extance et al., 
2013). 
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3BFJ may be a 1,3-propanediol dehydrogenase from Klebsiella pneumoniae, but its structure is 
noted to be similar to other ADHs and in particular a member of the iron-containing ADHs (Ma 
et al., 2010).  It also forms a decameric quaternary structure, which although is not in the form 
of a spirosome, it is nonetheless a substantial structure (Marçal et al., 2009).  Despite this 
difference in function, additional investigations with 3BFJ may be of note.  It has been 
discovered that mutating a single residue (D60G or D60A by numbering above, D41 original 
sequence) converts the enzyme from only utilising NADH to one able to utilise both cofactors.  
In the case of D60G, NADPH was preferred to NADH by approximately 1.5 fold, by specificity 
constant, with a 15-fold preference for NAD+ over NADP+ (Ma et al., 2010).   
3OWO is an NAD+ dependent, ethanol producing, oxygen sensitive ADH from Zymomonas 
mobilis.  It is a dimeric enzyme of the iron-containing ADH family implicated in the cytosolic 
respiratory system.  Despite the dimeric form, its structure is noted as similar to other ADHs 
(Moon et al., 2011). 
2BI4 is from E. coli one of the first members of the iron-containing ADH family to be identified 
(Conway and Ingram, 1989) and is involved in the conversion of lactaldehyde to 1,2-
propanediol.  It is specific for S-enantiomers of the diol and aldehyde and is NAD(H) 
dependent.  It also has activity with a range of small aldehydes and alcohols, although KM 
values range from high to very high in all cases indicated, and kcat figures reported are very low 
(Blikstad and Widersten, 2010).  The limitation on substrate size is believed to be due to the 
tertiary structure, which has a “narrow waist”, limiting the size of the substrate admitted to 
the active site.  Further, the same residue as above (D60, native D39) has been determined to 
be key for cofactor specificity (Montella et al., 2005). 
Lastly, 4FR2 is an NADH-dependent dimeric ADH of the iron-containing ADH family from 
Oenococcus oeni.  Whilst the primary substrate was believed to be ethanol, other substrates 
such as 1,2-propanediol and 1,3-propanediol were also accepted, although the latter required 
the addition of NiCl2 and specific activities noted were below 2 U mg
-1 (Elleuche et al., 2013). 
Overall, the most similar amino acid sequences for the full bifunctional enzyme appear to have 
some discrepancies in the key residues believed to be involved with the active site and metal 
binding site, which may have implications for their activity and stability.  With regards to the 
more distant sequences, but most similar obtainable from the PDB, all these sequences are 
iron-containing ADHs, but may be more specifically annotated, e.g. as 1,3-propanediol 
dehydrogenase.  There is some debate as to whether all these enzymes have iron or zinc as 
their metal ion.  ADH A has zinc, but some of the other enzymes differ in this regard, which is 
in keeping with the belief that this family of enzymes are more accurately described as metal-
dependent rather than iron-dependent.  From work done on other enzymes, it appears that 
one key residue is D61, which is crucial to the cofactor dependence of the enzyme.  In addition, 
structural work has indicated that the other residues noted in the MSA are likely to be 
important for activity across all enzymes in the MSA, but given the occasional differences, this 
may not always hold true.  Further, given the substantially different substrate profiles and 
activities it may not be possible to directly compare these enzymes in terms of their function, 
but solely in terms of their structure. 
2.1.5. SUMMARY 
From the data obtained it appears that ADH A not only has a larger substrate scope than 
previously shown in similar enzymes, but may prefer larger substrates than previously 
believed.  This has important implications for continued study of this ADH and the overall 
bifunctional enzyme, ADHE, and for the production of higher alcohols via biosynthesis. 
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If it can be determined whether the AldDH can perform as well as the ADH, then this could 
potentially be a route to the biosynthesis of higher alcohols if suitable precursors can be 
generated in vivo.  These precursors would probably have to derive from fatty acid 
biosynthesis and therefore would be a complex pathway to manipulate. 
Another potential issue is that it is believed that large modifiers such as coenzyme A are 
designed to reduce KM for smaller substrates and to increase specificity downstream i.e. in 
those enzymes where coenzyme A-modified substrates are accepted, the use of the modifiers 
enhances the chances of those enzymes recognising their true substrates.  The drawback of 
this system is that the coenzyme A-accepting enzymes de facto recognise the coenzyme A 
rather than the small substrate and therefore become promiscuous with respect to the small 
substrate.  That said, this system is considered easier to develop and maintain natively than 
having several enzymes in a pathway exclusively recognise a small substrate without 
modification (Bar-Even et al., 2011).  If this were true, however, it could be favourable in that 
the AldDH would be more inclined to recognise other coenzyme A-modified substrates, even if 
its affinity would be lower.   
Speculatively, it would also imply that larger substrates could be imposed upon such enzymes, 
such as the AldDH, if appropriate modifications to the active site were made.  Presumably the 
major reason for reduced affinity of larger substrates is solely physical size of the substrate 
itself, even with coenzyme A having a molecular mass of 767, so the possibility exists of 
engineering a more amenable active site.  Without a crystal structure it is difficult to make a 
judgement; however, coenzyme A is a relatively linear molecule, thus it seems more likely the 
length of the substrate may become an issue, not fitting neatly in the active site, rather than a 
question of the substrate being able to access the active site at all. 
Finally, it should be emphasised that ADH A is one half of a bifunctional enzyme, which means 
that its performance may not be similar in its native state.  In particular, the notably high KM 
values suggested by the recombinant ADH may not be indicative of the behaviour of the native 
enzyme in vivo, and care should be taken when attempting to interpret these results in this 
manner.  What is more telling is the relative change between substrates; that is the key result 













2.2. ADH B 
This enzyme was under investigation to produce 2-butanol from 2-butanone, as a final step of 
an in vivo process shown in Figure 27.  As such, it was already known to be a ketone utilising 
ADH and NADH dependent.   
 
Figure 27  - Butanol pathway under investigation.  Courtesy of Dr Leann Bacon  and Dr Steve Bowden 
(University of Bath, UK), partially reproduced from Cripps et al. (2009). 
On this basis the enzyme was investigated for its potential substrate scope to identify 
additional substrates of interest.  Further, this enzyme was used substantially in methodology 
development, particularly in determining appropriate substrate concentrations to ameliorate 
the quality of kinetic data obtained.  Another principal alteration to the method at this time 
was a switch from polystyrene (PS) cuvettes to poly (methyl (methacrylate)) (PMMA) cuvettes, 
for improved solvent and substrate resistance. 
No work was conducted using disrupted whole cells with this enzyme or any further enzymes 
examined, only purified fractions were tested.  Purification of the enzyme was conducted using 
IMAC, and individual fractions produced were assayed with both ethanal and 2-butanone in 
the presence of NADH.  The N-terminal hexa-histidine tag was not removed prior to assay and 
raw fractions were stored as they were eluted from the column; no further purification or 











Figure 28 - SDS-PAGE gel of ADH B.  Lane 1:  total protein, lane 2: insoluble fraction, lane 3: soluble 
fraction, lane 4: 2
nd
 flowthrough, lane 5: 1% His-Elute buffer, lane 6: 2.5%, lane 7: 5%, lane 8: 10%, 
lane 9: 20%, lane 10: 30%, lane 11: 50%, lane 12: 100% His-Elute buffer, lane 13: Protein markers;  
values provided on right indicate relative molecular masses (M r) of markers in kDa; the arrow 
indicates the putative ADH, with an expected M r of 39.6kDa. 
 
2.2.1. SUBSTRATE SCOPE 
Additional substrates were sourced from literature as examples of those being investigated in 
the past and present due to their industrial relevance.  In this manner simple aldehydes and 
ketones as well as complex substrates were utilised in the initial substrate screen. 
Moreover alcohols were screened, using similar conditions as with the aldehydes and ketones, 
specifically using 50mM citric acid buffer at pH 6.0.  There was one alteration, using 2.5mM 
NAD+ rather than 0.2mM NADH.  This was done to reduce the chance that cofactor limitation 
was interfering with the assays, a consideration that cannot be made when using NADH 
because of the high absorbance; typically 0.2mM or similar concentrations are used when 
















Substrate Specific Activity 
(10mM)  [U mg-1] 
Specific Activity 
(20mM) [U mg-1] 
Ethanal 56.3 n.d. 
2-Butanone 75.9 77.1 
Acetoin* 32.9 50.1 
2-Pentanone 24.7 52.5 
2-Hexanone 1.6 1.5 
3-Hexanone 0.4 2.2 
Ethyl 4-chloroacetoacetate 90.7 80.6 
6-Methyl-5-hepten-2-one - - 
4-Phenyl-2-butanone - - 
2,2,2-Trifluoroacetophenone - - 
Ethyl-2-oxo-4-phenylbutyrate 0.9 - 
Ethyl 4,4,4-trifluoroacetoacetate 0.1 0.2 
Methyl benzoylformate† - - 
2-Decanone - 2.1 
Propanal 79.0 81.3 
Butanal 94.9 110.2 
Pentanal 29.8 35.3 
Hexanal 0.8 0.9 
Table 3 - Initial substrate screen with ADH B.  Substrates assayed at 10mM/20mM concentration 
unless otherwise noted.  *Assayed at 1/2mM. n.d. indicates not determined,”-“ indicates no activity 
noted in assay.  † Substrate absorbs at 340nm, negating assay viability.   Conditions of assay: 50mM 
citric acid, pH 6.0, 0.2mM NADH, 1ml assay volume.  
 
Substrate Specific Activity 
(10mM)  [U mg-1] 
Specific Activity 
(20mM) [U mg-1] 
Ethanol 0.9 1.7 
Propanol 4.5 6.9 
Butanol 2.6 5.2 
Hexanol - - 
2-Propanol 53.5 53.2 
2-Butanol 65.7 61.3 
2-Pentanol 54.9 33.4 
3-Pentanol 16.0 31.2 
1-Phenylethanol - n.d. 
1,2-Propanediol 8.3 18.6 
Glycerol - n.d. 
Table 4 – Alcohol screen using ADH B.  n.d. indicates not determined,”-“ indicates no activity noted in 
assay. Conditions of assay: 50mM citric acid, pH 6.0, 2.5mM NAD
+
, 1ml assay volume. 
On the basis of these screens it was possible to clearly demarcate the substrate scope for this 
enzyme, which was entirely based on size.  With the sole exception of glycerol, all tested 
substrates of five carbons or less in length were accepted, with any larger having residual 
activity at best.  No activity was noted with any aromatic substrate, which isn’t overly 
surprising given the indications of a near absolute cut off in substrate scope after five carbons. 
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2.2.2. INITIAL KINETICS 
After establishing the substrate scope of ADH B, kinetics of various substrates were 
considered.  With this enzyme, the decision was taken to focus primarily on the lower 
substrate concentrations, up to 5mM, to ensure that all substrates tested were significantly 
below the solubility limit.  Additional reasoning is that the average enzyme has a KM in this 
region (Bar-Even et al., 2011), with the median value of approximately 100µM and 60% of all 
KM values recorded fall below 1mM.  Thus a variety of substrates were chosen, and for the first 

























Figure 29 - Graph of rate of reaction vs [S] using ADH B and 2-butanone.  Data fitted to a standard 
Michaelis Menten equation using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 

































Figure 30 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 2-butanone.  Conditions: 50mM citric acid 


























Figure 31 - Graph of rate of reaction vs [S] using ADH B and acetoin.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 
acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 32 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and acetoin.  Conditions: 50mM citric acid pH 



























Figure 33 - Graph of rate of reaction vs [S] using ADH B and ethyl 4 -chloroacetoacetate.  Data fitted to 
a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 
50mM citric acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 34 - Hanes-Woolf plot ([S]/v vs [S]) for ADH B and ethyl 4 -chloroacetoacetate.  Conditions: 























Figure 35 - Graph of rate of reaction vs [S] using ADH B and propanal.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 
acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 36 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and propanal.  Conditions: 50mM citric  acid pH 


























Figure 37 - Graph of rate of reaction vs [S] using ADH B and 2-propanone. Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 







































Figure 38 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 2-propanone, data fitted assuming substrate 

























Figure 39 - Graph of rate of reaction vs [S] using ADH B and 2-butanol.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 
acid pH 6.0, 0.2mM NAD
 +




































Figure 40 - Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 2-butanol.  Conditions: 50mM citric acid pH 
6.0, 0.2mM NAD
+





Substrate Vmax (U mg







2-Butanone 73.4±1.99 0.29±0.03 - 2900 10000 Yes 
Acetoin 67.5±1.72 2.35±0.13 - 2700 1100 Probable 
COBE* 65.3±4.62 3.27±0.41 - 2600 800 Yes 
Propanal 69.4±1.95 0.28±0.03 - 2800 9800 Yes 
2-Propanone 75.5±5.66 0.35±0.05 4.89±0.90 3000 8600 Yes, 
Inhibition 
2-Butanol 54.9±1.61 0.56±0.06 - 2200 3900 Yes 
Table 5 - Summary of kinetics obtained with ADH B.  *COBE is ethyl 4-chloroacetoacetate. “-“ 
indicates not noted.  
 
There are several fascinating points about these results.  Firstly, it is clear that 5mM is an 
insufficiently large substrate concentration to use to determine kinetic constants in this 
particular case.  This can be seen in the specific activities reached for propanal (approximately 
60-70 U mg-1) and the estimated Vmax of 70 U, as these are substantially below the 80 U 
previously noted with 10mM and 20mM substrate concentration.  Whilst variation is to be 
expected, there is a large enough discrepancy to warrant slightly higher substrate 
concentrations wherever possible.   
The similar Vmax results contrast with a comparatively varied set of KM constants obtained, with 
roughly an order of magnitude variation.  On the basis of results thus far, it is not possible to 
state with any certainty whether 2-butanone, 2-propanone or propanal are the most preferred 
substrate, although substrate inhibition was noted with 2-propanone.   Even the specificity 
constants are less than forthcoming, with 2-propanone lagging slightly behind both 2-
butanone and propanal. 
2.2.3. METHODOLOGY DEVELOPMENT 
When conducting the substrate screen previously, raw substrate was used, typically ~1µl in a 
1ml assay.  This was done to allow for a rapid screen.  In the case of kinetics, a stock solution 
was used to decrease the error between any given points by using the same stock solution for 
varied concentrations.  This necessitates using a higher concentration stock solution than the 
concentration intended at assay conditions, which is usually where the issues of solubility 
come to the fore. 
Solubility was not an issue at concentrations of 10mM and below, particularly with the 
substrates chosen.  However, at this stage, the decision was taken to expand the range of 
substrate concentration from 50 fold to 800 fold.  This was done by changing the stock 
solutions used to 100mM instead of 10mM and was carried out to provide additional data at 
higher substrate concentrations; despite the earlier belief that 5mM would be sufficient, this 
appeared not to be the case. 
Additionally, during this work a steady reduction in recovered protein was noticed, ultimately 
resulting in virtually none being obtained.  This correlated with several replacement probes for 
the sonicator used to disrupt cells and anecdotal evidence that each probe was successively 
stronger. This led to the belief that the decreased protein levels were due to the sonicator 
destroying the sample through denaturation caused by excessive heat.  Even though the target 
protein is thermophilic, that doesn’t preclude the possibility that sufficient localised heat was 
generated to denature it, or that it could be indirectly denatured via host cell protein 
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degradation.  Therefore various levels of sonication were tested, all using 21 micron 
wavelength as previously used.  These were 15 seconds on, 15 seconds off for 1, 3 or 5 cycles, 
and 15 seconds on, 30 seconds off, also with 1, 3 or 5 cycles.  Previously 5 cycles of 15 seconds 
had been used, with 15 seconds rest in between each cycle.  
On the basis of the test, the results of which are shown in Figure 41, it was decided to continue 
with five cycles of sonication but introduce a 30 second gap between cycles rather than 15.  
This decision was taken because there appeared to be insufficient sonication with one cycle to 
lyse the cells and little difference between three or five cycles with regards to a decrease due 
to over sonication.  When comparing the 15 or 30 second rest phase there was a clear 
reduction in protein in the soluble fraction when a shorter rest phase was used.   
As the sample for the test was derived from a single cell pellet to remove variability, there was 
a smaller volume in each sample than normally would be used.  This meant it was likely that 
these samples were receiving more energy than could be expected in a normal situation.  
Hence five cycles were chosen on the basis that this would prevent under sonication whilst 




Figure 41 - SDS PAGE gel of Insoluble and Soluble Fractions subjected to sonication at diffe rent levels.  
I = insoluble, S=soluble fractions, M = markers.  Arranged in increasing number of cycles , 1, 3 or 5; 15 
seconds between cycles to the left of the line, 30 seconds between cycles on the right.  Arrow 
indicates ADH B expression. 
 
2.2.4. ADDITIONAL KINETICS 
With sufficient active enzyme now being recovered, further work concentrated upon 
increasing the substrate concentrations used and working with larger substrates.  In addition 
results were modelled using the Hill Equation, Equation 4 below, in specific cases where 
negative cooperativity was suspected: 







Equation 4 – Generic form of the Hill Equation.  
Where h is the Hill coefficient.  When h=1, standard Michaelis-Menten kinetics are 
demonstrated; when h>1, positive cooperativity is indicated and when h<1, negative 
cooperativity is shown.   
As certain Hanes-Woolf plots were non-linear at the left of the plot, tailing downwards from 
the linear point, this can indicate negative cooperativity because a lower than linear Hanes-
Woolf plot indicates a higher than expected rate of reaction for the substrate concentration 
under study.  Therefore, by replotting the same data using the Hill equation and considering 
the fitness of the data for this equation, it can be seen whether negative cooperativity is 
present.  It should also be stated that this is not the only potential reason for the non-linear 
Hanes Woolf plots.   
One common alternative explanation is an unrecorded background rate as this would have a 
proportionately larger effect at lower substrate concentrations due to the lower actual rate 
recorded.  Care was taken to ensure adequate controls were done to preclude this possibility, 
but it is always worth considering nonetheless. 
The most intriguing results are those obtained with pentanal (Figure 54 and Figure 55), 2-
pentanone (Figure 52 and Figure 53), 3-pentanone (Figure 56 and Figure 57) and 2,3-
pentanedione (Figure 58 and Figure 59), as these apparently depart from standard Michaelis-
Menten kinetics.  Equally surprising is that 3-methylbutanal (Figure 62 and Figure 63) and 1-
penten-3-one (Figure 60 and Figure 61) remain firmly demonstrating Michaelis-Menten 
kinetics.  Taken together these results are somewhat equivocal and require further 
explanation. 
The results with 3-methylbutanal could be explained if overall physical bulk of the substrate 
was irrelevant, with merely the length of the substrate being the key factor.  This could also 
potentially explain 1-penten-3-one as the double bond would shorten the length marginally, 
but equally the charge of the double bond could be beneficial by inducing a better fit with 
more charged amino acids in the active site. 
In general, it appears that the smallest substrate accepted, ethanal, displays perfect Michaelis-
Menten kinetics.  Larger substrates demonstrate substrate inhibition, but remain within 
Michaelis-Menten limits.  Further increases in substrate size result in loss of Michaelis-Menten 
























Figure 42 - Graph of rate of reaction vs [S] using ADH B and ethanal.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 


































Figure 43 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and ethanal.  Conditions: 50mM citric acid pH 

























Figure 44- Graph of rate of reaction vs [S] using ADH B and NAD
+
.  Data fitted to a Michaelis-Menten 
curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric acid pH 
6.0, 10mM 2-butanol, 50 °C, 1ml assay volume.  
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Figure 45 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and NAD
+
.  Conditions: 50mM citric acid pH 6.0, 




























Figure 46 - Graph of rate of reaction vs [S] using ADH B and 2-butanone.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 
acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 47 - Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 2-butanone.  Conditions: 50mM citric acid pH 



























Figure 48 - Graph of rate of reaction vs [S] using ADH B and butanal.  Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 




































Figure 49 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and butanal,  data fitted assuming substrate 





























Figure 50 - Graph of rate of reaction vs [S] using ADH B and 2-butanone.  Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 
12.  Conditions: 50mM citric acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 51 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 2-butanone, data fitted assuming substrate 



























Figure 52 - Graph of rate of reaction vs [S] using ADH B and 2-pentanone.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 





































Figure 53 - Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 2-pentanone.  Conditions: 50mM citric acid 
























Figure 54 - Graph of rate of reaction vs [S] using ADH B and pentanal.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 






































Figure 55 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and pentanal.  Condi tions: 50mM citric acid pH 

























Figure 56 - Graph of rate of reaction vs [S] using ADH B and 3-pentanone.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM citric 
acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 57 - Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 3-pentanone.  Conditions: 50mM citric acid 

























Figure 58 - Graph of rate of reaction vs [S] using ADH B and 2,3-pentanedione.  Data fitted to a 
Michaelis-Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 
50mM citric acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 59 - Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 2,3-pentanedione.  Conditions: 50mM citric 


























Figure 60 - Graph of rate of reaction vs [S] using ADH B and 1-penten-3-one.  Data fitted to a 
Michaelis-Menten, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by 
Sigmaplot 12.  Conditions: 50mM citric acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 61 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 1-penten-3-one, data fitted assuming 
























Figure 62 - Graph of rate of reaction vs [S] using ADH B and 3-methylbutanal.  Data fitted to a  
Michaelis-Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 
50mM citric acid pH 6.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 63 – Hanes-Woolf plot ([S]/v vs [S]) for ADH B and 3-methylbutanal.  Conditions: 50mM citric 



















Ethanal 75.0±1.5 0.66±0.07 - 3000 4500 Yes 
NAD
+
* 51.4±3.3 0.015±0.004 - 2000 140000 Yes 
NADH** 64.2±3.1 0.024±0.004 - 2500 110000 Yes 
Butanal 146±7 2.71±0.31 98.4±14.9 5800 2100 Yes, with 
inhibition 
2-Butanone 147±6 0.907±0.119 132±26 5800 6400 Yes, with 
inhibition 
2-Pentanone 75.6±2.8 22.4±2.2 - 3000 130 No 
Pentanal 102±13 59.6±14.4 - 4000 70 No 
3-Pentanone 108±8 40.6±6.8 - 4300 110 No 
2,3-Pentanedione 91.0±10.6 77.1±15.5 - 3600 50 No 
1-penten-3-one 71.6±4.8 6.15±0.86 135±30 2800 460 Yes, with 
inhibition 
3-Methylbutanal 67.7±7.5 145±28 - 2700 20 Yes 
Table 6 - Further Kinetics Data Summarised.  *Cofactor Kinetics, Using 2 -butanone as substrate.  
**Cofactor Kinetics, using 2-butanol as substrate. 
Comparing Table 6 with Table 5, particularly the entries in both for 2-butanone, it can be seen 
that the use of higher concentrations of substrates is justified.  Whereas a Vmax of 73 U mg
-1 
was originally noted, with no inhibition, when investigating the use of higher substrate 
concentrations, substrate inhibition was noted, and the estimate of Vmax approximately 
doubled.  Further, the estimate of KM has trebled.  Given the wider range of substrate 
concentrations used, it is more likely that the second experiment is more representative. 
The exception to this is the cofactor kinetics, which appear to be substantially different from 
what may be expected.  Their Vmax should be more in keeping with the substrate equivalent; 
this has been attributed to assaying with a large enough concentration of substrates such that 
inhibition has affected the Vmax.  It is of note that both cofactors have approximately equal 
kinetic constants though, as at the assay conditions it could be reasonably expected that a bias 
towards the alcohol forming reaction would be noted due to the mildly acidic pH of the assay. 
Whilst there are several cases of deviation from Michaelis-Menten kinetics, the calculated 
kinetic constants have been retained and these should be considered with caution.  Some 
useful comparisons can still be made though; for example butanal and 2-butanone have 
identical estimates for Vmax, yet differ on the KM, albeit not by a great deal.  This slightly 
increased affinity for the ketone over the aldehyde of equivalent length is mirrored in 
pentanal/pentanones, with the exception of 1-penten-3-one, which has a substantially lower 
KM.  
Comparisons are most easily made using the specificity constants, which reflect a three-fold 
bias towards 2-butanone as opposed to butanal, paralleled with a similar two-fold gap 
between pentanal and 2-pentanone.   A slight difference is also apparent between 2-
pentanone and 3-pentanone, with the former being preferred in that case.  Perhaps most 
surprising is the prominently high value for 1-penten-3-one and the prominently low figure for 
3-methylbutanal, 460 and 20 mM-1 min-1 respectively.  The considerable difference in activity 
with C4 and C5 substrates is starkly shown as well, even the high specificity constant of 1-
penten-3-one is an order of magnitude lower than 2-butanone.   
Due to the above cases where it was suspected that the apparent deviation from Michaelis-
Menten kinetics was caused by negative cooperativity, the same data were reanalysed using 











131(±79) 157(±181) 0.87(±0.14) 5200 30 
2-Pentanone 75.4(±5.2) 21.2(±3.9) 0.95(±0.08) 3000 140 
3-Pentanone 134(±44) 66.7(±50.0) 0.87(±0.14) 5300 80 
Pentanal 933 4383 0.67(±0.14) 37000 10 
Table 7 - Summary of supplementary kinetic analysis using the Hill Equation.   
From the data in Table 7, it is obvious that aside from pentanal there is no strong case for 
negative cooperativity with ADH B as h values are approximately 1, within error. Even in the 
case of pentanal the evidence is somewhat forced, with evidently erroneous kinetic constants.  
Further work will have to be undertaken to determine the exact reasons for the apparent 
deviations from Michaelis-Menten kinetics. 
As this work was not intended to provide an exhaustive analysis of the kinetic constants and it 
was not intended to provide a mechanistic analysis, this issue is not catastrophic, and the 
above estimations are adequate for the purpose required.  This is specifically the 
determination of the substrate scope, and an estimation of the relative affinities of the 
enzyme for the substrates analysed. 
 
2.2.5. FURTHER WORK WITH ADH B 
Stability was another feature of interest of ADH B, with thermostability, solvent stability, 
substrate inhibition and storage lifetime considered.   Due to the thermophilicity of the native 
species it was naturally assumed that the enzyme would demonstrate similar thermophilicity 
or better.  In  addition, it is widely believed that thermophilic enzymes are more likely to 
demonstrate solvent resistance (Simpson and Cowan, 1992; Cowan, 1997; Vieille et al., 2001).  
Storage stability would come under a similar heading, as this is meant to encompass long-term 
storage in chilled conditions; thus thermophilic enzymes should be more stable in these 
conditions than mesophilic enzymes.  Additional causes of degradation whilst stored would be 
the storage buffer, i.e. chemical stability, or oxygen sensitivity and issues of concentration.  
Chemical stability is inherently linked with other forms of stability previously mentioned; 
oxygen sensitivity has little bearing on long term storage (>1 week), as if an enzyme is oxygen 
sensitive, it will likely inactivate within minutes or hours, comfortably within the timescales of 
purification (Ma and Adams, 1999; Ying et al., 2009).  The concentration of the enzyme was 
noted but not specifically studied – all enzymes studied were generally eluted in the broad 
range of 0.1-1.0 mg ml-1 as estimated by the Bradford assay.  Dilutions were sometimes 
necessary for effective assays, but no issues were observed with dilutions and for storage 
stability work only original eluted fractions were studied. 
Thermostability was the first aspect studied; 50µl aliquots of ADH B were held at 70 oC in 
microcentrifuge tubes to little effect.  Samples held for up to one hour had identical rates to a 
standard sample, but those held for longer were damaged by evaporation, even inside sealed 
tubes.   Subsequent work utilised different methods, using a PCR machine to statically incubate 
samples as it has a heated lid to prevent evaporation of the samples.  This also had the extra 
benefit of allowing finer control over temperature and the possibility of incubating different 
samples at a variety of temperatures simultaneously. 
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Solvent resistance was somewhat more varied.  With DMSO, any quantity immediately 
inactivated ADH B; even 1vol% was enough to negate all activity.   With acetonitrile there is 
little effect upon the addition of 10vol%, with 141 U mg-1 activity compared to 153 U mg-1 in 
the absence of solvent, but substantial reductions at higher volumes.  Ethyl acetate proved to 
be somewhat more variable, with an initial drop in activity followed by an apparent rise at 
higher volumes.  As ethyl acetate is only soluble up to 8vol%, larger amounts induce bilayer 
formation.  As an enzyme is likely to be constrained to the aqueous phase, this de facto 
increases the concentration of the enzyme, which leads to an apparently higher activity.  
Normalised activities indicated that the further addition of ethyl acetate beyond the solubility 
limit resulted in no change to the activity. 
 
Solvent Rate (10vol%)  
[U mg-1] 
Rate (20vol%)  
[U mg-1] 
Rate (30vol%)  
[U mg-1] 
DMSO - n.d. n.d. 
Ethyl Acetate* 132 154 (136) 177 (138) 
Acetonitrile 141 112 53 
Table 8 – Summary of solvent resistance data obtained with ADH B  and 2-butanone, 153 U mg
-1
 is 
baseline rate.  *Ethyl acetate maximum solubility is 8vol%, thus bilayer formed at higher 
concentrations.  Numbers in brackets refer  to normalised activities, assuming enzyme is dispersed 
solely in the aqueous phase.  
Next, using 2-butanone as substrate, increasingly large concentrations of substrate were used 
to look at the extent of substrate inhibition.  Using a baseline of 10mM concentration, 2-
butanone was considered at 1M, 2M, 3M and neat (95%) concentrations.  In the last case, only 
the 5µl of enzyme and the 50µl of NADH were added to neat 2-butanone.  From a baseline of 
146 U mg-1 at 10mM 2-butanone, as expected there was a large drop at 1M concentration to 
52 U mg-1.  This was expected from the estimated KM of 1mM and Ki of 132mM calculated 
previously. 
More surprisingly, activity was still retained at 2M concentration (38 U mg-1) and even 3M (27 
U mg-1).  At this point the solubility limit had been reached; therefore no further intermediary 
stages were tested.  Using 95vol% 2-butanone resulted in an unusable assay.  The belief was 
that the NADH was unable to dissolve fully or disperse in the 2-butanone, resulting in no 
absorbance being detected.  The subsequent addition of 200µl buffer to the cuvette allowed 
for the NADH to be detected and a rate recorded.  The rate of 63 U mg-1 was substantially 
higher than expected; it appears that the high level of substrate was interfering with the assay.  
In particular as an incredibly high absorbance was recorded it is likely that both cofactor and 
enzyme were dissolved solely into the aqueous phase, resulting in the concentrating effect 
noted earlier.  What was interesting though, is that irrespective of the concentration of 2-
butanone, as long as sufficient water was present, activity was maintained throughout.   This is 
an important characteristic for an enzyme to be used industrially, and even though heavy 
substrate inhibition was present, a high enough rate was still maintained, particularly for a 
native enzyme. 
Due to the frequency of using 2-butanone and ethanal as substrates, and the study of ADH B 
over a period of months using the same sample, it was possible to look retrospectively at the 
storage stability of the enzyme.  Typically one or other of the standard substrates was used as 
a type of control to ensure activity remained over the long term.  As this was a retrospective 
analysis, there were relatively few points to analyse, and in the case of 2-butanone no 
degradation was noted due to the scatter of the data available. 
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Figure 64 – Graph of specific activities of ADH B recorded with ethanal in assays conducted after 
different periods of static incubation at 4 °C.  Assay conditions: 50mM citric acid pH 6.0, 50 °C, 0.2mM 
NADH, 1ml volume assay.  
Given the estimate of the rate of degradation provided in Table 9, it is possible to determine 
an estimate for the half-life of the enzyme in storage conditions.   The definition of the half-life 







Equation 5 - Definition of Half-Life 
Where λ is the decay constant. 
𝑁𝑡 = 𝑁0𝑒
−𝜆𝑡  
Equation 6 - Exponential Decay Formula 
Where Nt is the current activity of the enzyme, N0 is the initial rate of the enzyme and t is the 
number of days since purification, in this specific case. 
As Figure 64 provides an estimate of the gradient, or the decay constant, of 0.0009, which can 











770 days is obviously only an estimate, but considering that the 2-butanone results were 
unable to give a decay rate of any kind, it was likely that any half-life was likely to be relatively 
high.  In terms of stability, it can be stated unequivocally that ADH B is extremely stable in the 
elution buffer and stored at 4 oC.  As this buffer contains substantial amounts of imidazole, 
y = 56.687e-9E-04x 
10
100
















Time since purification (days) 
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which can have a stabilising effect on enzymes, this could be a major factor.  Other possibilities 
are the high salt content of the buffer, or the pH and temperature alone.  As detailed studies 
were not carried out on long term storage stability, it isn’t possible to state if the stability is 
inherent or dependent on the buffer.  That said, it would not be unexpected if a thermophilic 
enzyme were to be stable over the long term whilst chilled, as long as the storage buffer was 
not a net negative on stability.  Additionally, no activity was lost when ADH B was inadvertently 
stored at room temperature overnight. 
Lastly, alternative substrates were also screened.  In most cases, these were additional 
aldehydes and ketones, but two specific cases were also tested, L-serine and L-threonine.  This 
was due to the annotation of ADH B as a Threonine Dehydrogenase.   A summary of these 














Ethyl 4,4,4-trifluoroacetoacetate Yes 
Table 9 - Summary of secondary screen of substrates; substrates tested at concentrations from 10-
100mM. 
2.2.6. SEQUENCE ALIGNMENT 
For this multiple sequence alignment it was possible to include both closely related sequences 
from the NCBI database and the most closely related sequences held by the PDB.  Ten of each 










Figure 65 - Multiple Sequence Alignment of ADH B with most similar sequences associated with crystal 
structures and most similar sequences from the NCBI RefSeq database.  Orange triangles indicate 
NAD(P) binding site.  Black triangles indicate catalytic Zn binding sit e.  Grey triangles indicate 
structural Zn binding site.  Purple triangle indicates a dual NAD(P) and catalytic Zn binding site. All 
these sites provided via the NCBI Conserved Domain Database and obtained through the Conserved 
Domain Search.  Green shading indicates 100% conservation, yellow shading indicates >80% 
conservation and red shading indicates >50% conservation of amino acids across selected sequences.   
Labels refer to crystal structures from the PDB or proteins from the NCBI RefSeq Database.  Pro teins 
are all annotated as ADHs from genera Bacillus, Geobacillus, Marinobacterium, Cohnella  and 
Alicyclobacillus. The crystal structures are annotated as follows:  4CPD is an ADH from Thermus sp. 
ATN1, 1YKF is a NADP
+
 dependent ADH from Thermoanaerobium brockii, 1PED is a secondary ADH 
from Clostridium beijerinki , 1Y9A is an ADH from Entamoeba histolotica , 1H2B is an ADH from 
Aeropyrum pernix, 2DFV is a Threonine Dehydrogenase (TDH) from Pyrococcus horikoshii, 2D8A is a 
putative TDH from Pyrococcus horikoshii, 1E3J is a Sorbitol Dehydrogenase from Bemisia tabaci, 3GFB 
is a TDH from Thermococcus kodakarensis , 4ILK is an ADH from E. coli.  Sequences aligned using MEGA 
6.0 (Tamura et al., 2013) with MUSCLE and visualised using Genedoc 2.7 (Nicholas et al., 1997). 
 
Though there are few residues absolutely conserved across sequences with such little 
homology, it is noticeable that all three residues noted as part of the catalytic zinc binding site 
are all maintained, along with an appreciable number of adjacent residues.  Given that most 
but not all of the sequences have been annotated as ADHs, it might reasonably be assumed 
that the structural rather than the catalytic zinc might be conserved because ADHs, TDHs and 
sorbitol DHs are all in the same protein family, the medium chain dehydrogenase superfamily 
(Hedlund et al., 2010).  This is not the case though; the residues associated with the structural 
zinc are moderately well conserved, but not in the case of three ADHs. 
Some of the residues associated with the NAD(P)H binding site are even less well conserved, 
with the least similar sequences from the PDB differing in approximately half of these residues.  
It should also be noted that the sequences from the NCBI database are very similar to ADH B 
and only differ in one case at one position – G307K. 
Examining the top five sequences from the PDB may provide more information about ADH B.  
4CPD is a solvent-resistant ADH from Thermus sp. ATN1 that exclusively produces 
(S)-enantiomer alcohols.  It is NADH dependent and has also demonstrated dismutase activity.  
Its substrate scope is wide and includes primary and secondary aliphatic alcohols, cyclic 
alcohols and aromatic alcohols, as well as their aldehyde and ketone equivalents.   In the 
reductive direction, high activity was constrained to aldehydes and cyclic ketones.  It is also a 
homotetramer (Höllrigl et al., 2008).  The structural zinc is co-ordinated to several residues - 
C89, C92, C95 and C103 as numbered originally, corresponding to C114, C117, C120, C128 in 
Figure 65.  The catalytic zinc is co-ordinated to C38 (59), H59 (85), D152 (178) and a water 
molecule, which are as above, but differ with regards to S40 (61) which is shown in Figure 65.  
This residue is instead the presumed proton donor rather than necessarily co-ordinated to the 
zinc ion, but nevertheless remains crucial to catalysis.  The remainder of the active site is 
hydrophobic and consists of residues I49 (73), F85 (110), V108 (133), F115 (140), V268 (305), 
L282 (320), V283 (324) L292 (333), and potentially Y111 (136) with the hydrophobic nature of 
the active site lending itself well to binding hydrophobic substrates.  H43 (64), D200 (232), 
R201 (233), R205 (237), V244 (281) and V260 (300) are key for cofactor binding (Man et al., 
2014a).  The active site is not annotated on the MSA, but the putative cofactor binding 
residues only partially match. 
1YKF is a tetrameric NADPH-dependent ADH from Thermoanaerobium brockii, one of the first 
crystal structures to be obtained from prokaryotic ADHs, and also one of the first NADPH 
dependent dehydrogenases.  Cofactor specificity is dependent on positions GSR198-200 and 
Y218 by the original sequence numbering, corresponding to positions 232-234 and 254 in 
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Figure 65.  These residues bind the phosphate of the NADPH, which is prohibited in 4CPD due 
to the presence of D200 (232) which is a negatively-charged residue and binds to NADH 
instead, and I202 (234) which is hydrophobic and the equivalent residue to S199 in this 
enzyme (Korkhin et al., 1998; Man et al., 2014a). These positions are not all noted as being 
involved in cofactor binding, according to the NCBI database, but are conserved among three 
of the ADHs.  Catalytic activity is co-ordinated by residues Q60 (85) and S39 (63), again partially 
disagreeing with the notation above.  D150 (179) is also believed to be critical to determining 
the enantiospecificity of the enzyme; in this case no preference is predicted (Korkhin et al., 
1998; Radianingtyas and Wright, 2003).  When used to catalyse the production of 2,3-
butanediol from (R)-acetoin, the enzyme exclusively produced (R,R)-2,3-butanediol (Yan et al., 
2009).  Elsewhere the situation is more complex, with the concentration of 2-propanol (the 
sacrificial substrate) affecting the kinetics in terms of the enantiomeric excess over the course 
of the reaction but ultimately a racemic mixture is produced, as predicted.  It is also possible to 
affect the enantiomeric excess by altering the temperature of the reaction or using solvents 
(Yang et al., 1997). 
1PED is a tetrameric NADPH-dependent ADH from Clostridium beijerinckii.  Similar to 1YKF in 
many ways, including sequence identity, structure and history, its crystal structure was 
determined at the same time as 1YKF and they were revealed to have very similar 3D 
structures and 75% sequence identity.  In this case the catalytic zinc is co-ordinated by C37 
(59), H59 (84), D150 (179) and Q60 (85), although the latter residue retracts from the zinc 
upon the addition of the co-factor.  As previously, D150 (179) is key for determining the 
enantiospecificity of the enzyme and again no preference is predicted from the orientation.  All 
other structural features of 1PED are identical to 1YKF (Korkhin et al., 1998).  1PED has a 
relatively constrained substrate scope, but includes primary and secondary alcohols and their 
respective aldehydes and ketones; the largest substrate tested was 2-pentanone.  The largest 
turnover numbers were obtained with aldehydes; however, the specificity constants were 
larger with the ketones, with ethanal and acetone the most preferred, respectively.  Under the 
conditions tested there was little activity with corresponding alcohols (Ismaiel et al., 1993). 
1Y9A is a tetrameric NADP+ dependent ADH from Entamoeba histolytica, the only eukaryote of 
the five enzymes.  It has activity with isopropanol, ethanol, acetone and ethanal, with its 
presumed purpose being in ethanol production from glucose in anaerobic conditions (Kumar 
et al., 1992).  Subsequent work attempted to determine if there was a specific cause for the 
relative thermolability of 1Y9A compared to 1YKF, despite their high sequence identity.  A 
single residue was significant in this regard, with P275D (314) substantially increasing the 
thermostability of 1Y9A and the reverse significantly reducing the thermostability of 1YKF.  
This residue is found in the dimerization interface and is believed that the proline residue is 
able to increase the hydrophobic interactions (Goihberg et al., 2008).  
Lastly, the only representative of the Archaea in the top 5 is 1H2B.  This is an NADH-dependent 
tetrameric ADH from Aeropyrum pernix with a broad substrate scope of alcohols, aldehydes 
and ketones, but with preference for cyclic substrates.  With respect to alcohols it is most 
active with C4-C5 primary and secondary alcohols and large cyclic alcohols such as 
cycloheptanol and cyclooctanol.  Particularly important residues noted include D218 (232), 
which is thought to determine the cofactor specificity.  It is highly conserved in NADH-
dependent ADHs, but replaced with glycine in NADPH-dependent enzymes.  Other key residues 
for cofactor binding include R354 (355), V262 (281), V219 (233) and H55 (60).  The catalytic 
zinc ion is co-ordinated to C54 (59), H79 (84) and D168 (182) with an additional residue, E80 
(85) binding in the absence of bound inhibitor or substrate.  The structural zinc ion is co-
ordinated with C112 (117), C115 (120) , C123 (128) and D109 (114), but is only present part of 
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the time; in the absence of the ion, C123 and C115 form a disulphide bond (Guy et al., 2003; 
Littlechild, 2011). 
Overall, it is not surprising that the annotation with respect to the active site, metal ion co-
ordination and cofactor binding is not entirely reliable – this is to be expected of all automatic 
annotations.  That said, the majority of noted residues are believed to be involved in the areas 
annotated, so it is not entirely wide of the mark.  Highlights of the above information include 
the potential to raise the Tm of ADH B by altering a single residue, in this case H314P.  Further, 
having a substrate scope limited by size would seem to be in keeping with the above examples, 
as would the cofactor specificity, with D232 indicating a preference for NADH.  The 
enantiospecificity of ADH B has not been considered experimentally; however, should further 
work include crystallisation, then residue D179 is one that could indicate any preference.  That 
said, if similar enzymes are considered, then ADH B likely has little to no enantiospecificity. 
2.2.7. SUMMARY 
ADH B is an alcohol dehydrogenase limited to five carbon length substrates only.  Given this 
restriction, with the sole exception of glycerol, all substrates were accepted, including 
halogenated, branched and functionally diverse aldehydes and ketones. 
With substantial solvent tolerance and resistance, it is a prime candidate to consider for 
industrial use, particularly with regards to ethyl 4-chloroacetoacetate, an intermediate in the 
production of statins. 
High thermostability is another feature of this enzyme, with no irreversible denaturation noted 
after one hour incubation at 70 oC.  This is a particular area that should be considered further, 
as all experiments were conducted at 50 oC; therefore rates may be more favourable at higher 
temperatures. 
Whilst the foundations of extreme storage stability have not been determined, it is clear that 
with an estimated half-life of 770 days, ADH B can be stored for very lengthy periods of time 
without resorting to methods such as lyophilisation. 
Finally, as ADHs generally have a rather large bias towards aldehydes or ketones as substrates, 
typically at least an order of magnitude variance in specificity constant, it is surprising that only 











2.3. ADH C 
ADH C was previously under investigation as an acetoin reductase, to be used as part of the 
same metabolic pathway indicated in Figure 27.  Using the same assay conditions with ADH C 
as with previous enzymes resulted in no detectable activity, and necessitated changing buffer 
from citric acid (pH 6.0) to sodium phosphate (pH 7.0).  This was attributed to citric acid’s 
ability to chelate metal ions rather than the pH change.  As ADH C is annotated as a zinc 
related ADH, it is certainly plausible that citric acid could chelate the zinc required for activity. 
Previous work had confirmed activity with acetoin, and therefore the full substrate scope was 
sought.  Looking at similar substrates in terms of size and functional groups, activity was 
additionally seen with 2,3-butanedione and 2,3-pentanedione.   As the diketones had activity, 
the equivalent monoketones were considered; however, no activity was noted with 2-
butanone, acetone, butanal, 3-pentanone or the less similar 2,4-dimethyl-3-pentanone and 4-
phenyl-2-butanone. 
No further substrates were available for testing, and due to the limited substrate scope no 
further work was conducted with this enzyme.  Its lack of activity in citric acid buffer prompted 
a full change to sodium phosphate in subsequent assays with other enzymes, to preclude the 
possibility that other metal-dependent enzymes may falsely appear to be inactive. 
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3. INVESTIGATIONS WITH NOVEL ENZYMES 
All genes referred to in this section were identified, isolated and cloned into E. coli BL21 (DE3), 
using pET28a to provide an N-terminal hexa-histidine tag, as part of the investigation.  They 
were selected on the basis of their annotation and similarity to alcohol dehydrogenases with 
industrially relevant substrate profiles.  As relying on such annotation is imprecise at best, it is 
necessary to approach each enzyme with an open mind and determine its substrate scope 
independently.   
Due to the potential imprecision of the annotation and the potential for cloning of the relevant 
genes to fail, the initial list of putative ADHs was drawn up with very loose boundaries.  Whilst 
it was accepted that this may include some false positives, it was believed that this would 
minimise false negative results.  This initial list comprised a total of 61 potential targets which 
was eventually reduced to an initial batch of six genes.  After only two of these genes were 
successfully cloned into E. coli, a further batch of ten genes was added.  Of the sixteen putative 
ADHs targeted, a total of 14 have been successfully cloned and expressed, but due to time 
constraints fewer have been assayed and characterised, the details of which are contained in 
this chapter. 
ADHs were chosen for cloning on the basis of annotation and the likelihood that the substrates 
accepted by the enzymes would be of industrial interest.  Therefore enzymes annotated as 
being aryl-alcohol dehydrogenases were given higher priority than those believed to accept 
small aldehydes.  Enzymes conserved in related species and genera and consistently annotated 
as accepting larger substrates were also prioritised.  Finally, enzymes annotated as being Aldo-
Keto Reductases or part of the Medium Chain Dehydrogenase/Reductase family were 
prioritised over Short Chain Dehydrogenase/Reductase and iron-containing ADHs. 
3.1. ADH D 
The gene coding for ADH D was initially isolated in the first batch of targets, and ADH D was 
one of two proteins to be successfully produced recombinantly from that batch.  Figure 66 is 















Figure 66 - SDS PAGE gel of ADH D.  Lane 1: insoluble fraction, lane 2: soluble fraction, lane 3: 2
nd
 
flowthrough, lane 4: 0% His-Elute Buffer, lane 5: 1%, lane 6: 2.5%, lane 7: 5%, lane 8: 10%, lane 9: 
30%, lane 10: 100% His-Elute Buffer, lane 12: Protein markers.  The numbers on the right indicate 
relative molecular masses (M r) of markers in kDa; the arrow indicates the putative ADH, with an 
expected Mr of 38.0 kDa 
 
Despite early testing indicating activity with several substrates, further work was deferred in 
favour of ADH B because of the latter’s preference for NADH as cofactor rather than NADPH.  
As refinement of the experimental procedure was required, it was preferred to do this with an 
NADH utilising enzyme rather than NADPH for cost considerations.  The preliminary assay data 




Ethyl 4-chloroacetoacetate Yes 
Ethyl 2-oxo-4-phenylbutyrate Yes 
4-phenyl-2-butanone No 















Ethyl pyruvate Yes 
Ethyl acetoacetate No 





















6 Methyl-5-hepten-2-one Yes 
Table 10 - Initial screen of ADH D.  Conditions: 0.2mM NADPH as cofactor, 50mM Sodium Phosphate, 
pH 7.0, 1ml assay volume, 50 °C.  
 
This wide ranging initial screen formed the basis of an enhanced screening protocol, based 
around primary and secondary substrate screening.  A standard group of substrates were 
compiled, incorporating linear, branched, cyclic and aromatic aldehydes, ketones, diketones, 
alpha, beta and gamma keto-esters, their acid equivalents, halogenated substrates and 
industrially relevant examples of the above.  The range of substrates included in the primary 
substrate screen was deliberately chosen in stark contrast to previous methods that utilised a 
very limited initial screen.  The range and varied complexity of the substrates, whilst keeping 
to a relatively limited number of substrates, allowed for a comprehensive opening salvo of 
substrates to give the maximal chances of determining whether an enzyme demonstrated 
activity whilst reducing the volume of assays to a practicable level.  Given that any specific 
enzyme annotated as an alcohol dehydrogenase may not in reality be an ADH, may have 
particular preferences with regards to substrates or assay conditions, may not express or 
purify in an active form, or may be unstable, the effectiveness of a screening protocol is 
paramount to the success of the research.  Specific substrates were chosen based upon their 
prevalence in literature, ease of acquisition, ease of assay and lack of superfluous functionality 
in addition to their variety.  Therefore the standard small aldehyde was butanal rather than 
ethanal as used previously due to the latter’s high evaporation rate, difficulty in creating 
accurate stock solutions and potential for degradation.  A small number of previously studied 
industrially relevant substrates were retained as well; all those that were easily assayed were 
kept. 
Based upon the results of the primary screen, additional substrates were considered on a case-
by-case basis for each enzyme with regards to activities detected and availability of substrates.  
Typically this would be done in order to delineate the exact substrates that could be accepted 
by an enzyme and those that would not.  Generally, however, this proved to be more difficult 
than anticipated, with individual substrates being impossible to assay due to interference or 
lack of solubility.  Below in Table 11 and Table 12 are the full data acquired from the substrate 


















Ethyl acetoacetate 0.5 
Benzaldehyde 6.9 
Pyruvate - 
Ethyl pyruvate 3.0 








Ethyl 4-chloroacetoacetate 2.6 
Ethyl 4,4,4-trifluoroacetoacetate - 
2',3',4',5',6'-Pentafluoroacetophenone - 
Table 11 - Primary substrate screen of ADH D, using NADPH as cofactor.  








Ethyl acetoacetate 0.6 
Methyl acetoacetate 0.4 
Ethyl 4-chloroacetoacetate* 4.9 
Ethyl 2-chloroacetoacetate 9.4 
Methyl 4-chloroacetoacetate 3.4 











Table 12 - Secondary substrate screen of ADH D. *Repeat from primary screen, benzoin interfered 
with assay allowing qualitative analysis of activity only. 4 -nitrobenzaldehyde interfered with assay. 
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From the screening it was determined that ADH D was a broad range alcohol dehydrogenase, 
accepting both aldehydes and certain ketones.  Of particular note was the inability to accept 
basic monoketones, which was highlighted as a potential benefit in the case of cofactor 
recycling, allowing for sacrificial substrates such as acetone to be utilised in a two enzyme, two 
substrate cofactor recycling system. 
Diketones and chlorinated substrates were accepted well, but fluorinated substrates were 
poorly tolerated, if accepted at all.  Substrate size was not a concern either, with large and 
bulky substrates such as 5-norbornene-2-carboxaldehyde, 1-phenyl-1,2-propanedione and 
benzoin being accepted along with glyoxal and even methanal.  Interestingly, diketones had to 
be adjacent; diketones with the carbonyl groups spread across the molecule were not 
accepted; for example 2,5-hexanedione had no activity with ADH D whereas 2,3-hexanedione 
did. 
Activity appears to be higher with chlorinated substrates, or those with additional localised 
electronegativity, for example in the case of ketoesters; this is characteristic of alcohol 
dehydrogenases. 
As is typical for an enzyme with a wide substrate scope, specific activities were relatively low.  
Potentially possible that substrate inhibition was a root cause, but unlikely at 10mM 
concentrations; in either case, this is something that was examined in an investigation of the 
enzyme’s kinetics. 
3.1.1. KINETICS 
Several substrates were chosen from the screening on the basis of higher activities amongst 
the substrates tested.   With the assumption that an enzyme would have comparatively high 
activity with a native substrate or a well-accepted substrate at a concentration of 10mM, it 
was noted that recorded activities would decrease when considering the kinetics.  Therefore, 
previously obtained rates were considered to be at the upper end of the scale, necessitating 
utilising substrates with rates unlikely to be reduced to background noise during the course of 
the investigation.   
Due to the low solubility of several substrates in buffer, stock solutions of these substrates 
were made up in a relevant solvent that dissolved into buffer.  Solvents were tested on a 
substrate by substrate basis, but typically were DMSO, acetonitrile or ethyl acetate, and these 
solvents comprised a final amount of 5vol% or below, depending on previously determined 
solvent sensitivity in a preliminary solvent screen.  Stock solutions were generally in the range 
of 100mM to 1M concentrations irrespective of the substrate and solvent.  Final 
concentrations of substrate varied, but the aim was to have ten separate concentrations 
tested as a minimum.  Interim results were graphically displayed, and the experiment ended 
with a given substrate when either it was apparent that near Vmax had been obtained when 
working in increasing concentrations, or where a sufficient curve had been recorded, when 
working in decreasing concentrations. 
Normally substrate concentrations were chosen starting with 10 or 20mM as a maximum 
concentration, working downwards to complete an entire Michaelis-Menten curve and define 
the Michaelis constant, but buffer soluble substrates frequently were studied at higher 
concentrations.   On occasion though, these concentrations were insufficient for substrates in 

























Figure 67 – Graph of rate of reaction vs [S] using ADH D and butanal.   Data fitted to a Michaelis-
Menten curve equation using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM 
sodium phosphate pH 7.0, 0.2mM NADPH, 50 °C, 1ml assay volume.  
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Figure 68 - Hanes-Woolf plot ([S]/v vs [S]) for ADH D and butanal.  Conditions: 50mM sodium 





























Figure 69 - Graph of rate of reaction vs [S] using ADH D and 1-phenyl-1,2-propanedione in 
acetonitrile.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 

































Figure 70 - Hanes-Woolf plot ([S]/v vs [S]) for ADH D and 1-phenyl-1,2-propanedione in acetonitrile.  



























Figure 71 - Graph of rate of reaction vs [S] using ADH D and 4-chlorobenzaldehyde in acetonitrile.  
Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  


































Figure 72 - Hanes-Woolf plot ([S]/v vs [S]) for ADH D and 4-chlorobenzaldehyde in acetonitrile.   

























Figure 73 - Graph of rate of reaction vs [S] using ADH D and NADPH.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 




































Figure 74 - Hanes-Woolf plot ([S]/v vs [S]) for ADH D and NADPH.  Conditions: 50mM sodium 




























Figure 75 - Graph of rate of reaction vs [S] using ADH D and 5-norbornene-2-carboxaldehyde in 
acetonitrile.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 
Sigmaplot 12.  Conditions: 50mM sodium phosphate pH 7.0, 0.2mM NADPH, 50 °C, 1ml assay volume.  
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Figure 76 - Hanes-Woolf plot ([S]/v vs [S]) for ADH D and 5-norbornene-2-carboxaldehyde in 



























Figure 77 - Graph of rate of reaction vs [S] using ADH D and ethyl 4 -chloroacetoacetate in acetonitrile.  
Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  




































Figure 78 - Hanes-Woolf plot ([S]/v vs [S]) for ADH D and ethyl 4-chloroacetoacetate in acetonitrile.  
























Figure 79 - Graph of rate of reaction vs [S] using ADH D and ethyl 2 -oxo-4-phenylbutyrate in ethyl 
acetate.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 




































Figure 80 - Hanes-Woolf plot ([S]/v vs [S]) for ADH D and ethyl 2-oxo-4-phenylbutyrate in ethyl 




Substrate Vmax (U mg
-1) KM (mM) kcat (min
-1) kcat/KM 
(mM-1 min-1) 
Butanal 15.86(±0.57) 3.50(±0.54) 600 170 
1-Phenyl-1,2-
propanedione 
13.36(±0.27) 0.21(±0.02) 510 2400 
4-Chlorobenzaldehyde 33.41(±2.33) 7.04(±1.15) 1300 180 
NADPH 7.47(±0.11) 1x10-4(±3x10-4) 290 2800000 
5-Norbornene-2-
carboxaldehyde 
10.12(±0.30) 0.14(±0.02) 390 2700 
Ethyl 4-
chloroacetoacetate 
4.07(±0.24) 6.42(±0.85) 160 24 
Ethyl-2-oxo-4-
phenylbutyrate 
5.97(±0.38) 0.88(±0.19) 230 260 
Table 13 - Summary of kinetic data with ADH D. 
 
All substrates chosen for ADH D have some industrial relevance, with the exception of butanal, 
which is an example substrate.  Whilst this ADH will only accept NADPH rather than the less 
costly NADH as a cofactor, it was not possible to determine accurate kinetic constants due to 
the incredibly low KM; due to the assay measuring decrease in absorbance of the cofactor 
there is a natural limit on the level of cofactor that can be realistically examined.  Although 
speculative, the estimated specificity constant for the cofactor does not exceed the diffusion 
limit and therefore should not be immediately discounted due to its apparent size.  In 
particular, as the affinity for cofactors in general is much higher than substrates and given that 
enzymes using NADPH generally have lower Michaelis constants than those using NADH, a 
specificity constant of 2,800,000 mM-1 min-1 remains plausible (Bar-Even et al., 2011). 
Interestingly, although it appears that this enzyme has a greater affinity for larger substrates, 
this is not the case.  For example, the highest affinity noted was for 5-norbornene-2-
carboxaldehyde, yet ethyl 2-oxo-4-phenylbutyrate is a larger molecule and ADH D has a lower 
affinity for this substrate; indeed the specificity constant is a full order of magnitude below.  
Lastly, given that butanal has a similar specificity constant to ethyl 2-oxo-4-phenylbutyrate and 
is the smallest substrate tested at this stage, there does not appear to be any particular bias 
towards larger substrates in this regard. 
As all these substrates aside from butanal are either aromatic or are halogenated, or both, 
there is no obvious pattern with regards to electronegativity near the target carbonyl group, 
with both phenyl  and chlorinated substrates not noticeably affecting the kinetic parameters.  
Frequently ADHs are more active with substituted substrates, particularly halogenated 
substrates, and ADH D appears to be following this trend.  Helpfully, this is beneficial as 
traditional chemical transformations typically are challenged by additional substituents, either 
not working as required or requiring additional method steps for adequate protection to 
ensure the desired product. 
3.1.2. STABILITY ANALYSIS AND TERTIARY SCREENING 
In the case of thermostability, aliquots of ADH D were tested for their resilience at 
temperatures above the standard growing temperature of G. thermoglucosidasius, which is 
60oC.  No activity was recorded at 81oC or 90oC; however, a steady reduction in activity was 
noted at 70oC.  In fact, an apparent two step reduction was noted, with a faster reduction in 
100 
the first hour, which then stabilises to a near full retention of activity thereafter.  This could 
indicate a multiple step denaturation process whereby the first stage results in a partially 
active enzyme structure and the second stage is a full denaturation where all activity is lost. 
Importantly, the first step must be irreversible as samples were not tested immediately after 
incubation and were all kept on ice until testing.  As both preliminary work with hexanal and a 
repeat with furfural record this “two step”, with both indicating a faster reduction in activity 
over the first hour; this raises confidence that this is not an artefact of one particular 
experimental run or substrate. 
 
 
Figure 81 - Thermostability data acquired storing enzyme samples at 70
o
C in PCR machine.  No activity 




C; hexanal and furfural used as substrates, NADPH used as 
cofactor.  Zero point removed from furfural data for trend line purposes. 
Another potential explanation for the above data is that the initial reduction is caused by a 
denaturation of a second enzyme, a mesophilic host ADH.  Whilst this is theoretically possible, 
the ADH was electrophoretically pure, as shown in Figure 66, therefore this is unlikely to be 
the case. 
Assuming the second rate is the longer term “stable” reduction in rate of activity, then the 










= 2,310 𝑚𝑖𝑛𝑠 
With an estimated half-life of 2310 minutes, or 38.5 hours, at 70oC it is clear that ADH D is still 
operational at the upper limits of G. thermoglucosidasius growing temperature.  Similarly, with 
no activity recorded at 81oC, which is above the temperature at which the organism can live, 
there appears to be little discrepancy between the enzyme and species. 
y = e-0.004x 
R² = 0.8552 y = 0.7944e-3E-04x 
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The poor correlation between the trend line calculated in Figure 81 and the raw data for 
thermostability of ADH D is concerning but likely to be caused by the relatively low 
degradation rate combined with a high rate of noise.  Thus additional work with lengthier 
timescales, perhaps over days, would reveal whether the estimate is overstating or even 
understating the half-life of this enzyme. 
Because of ADH D’s interesting substrate scope and potential for industrial application, a full 
tertiary screen was conducted.  This screen comprised an extensive list of potential 
denaturants, buffers, solvents and ions to provide some indication of ADH D’s operational 
capacity.  In essence this is a feasibility study into the ability of ADH D to maintain activity in a 
range of situations as well as a partial optimisation with respect to buffer/pH and additive ions.   
Assay Condition Relative Activity (%) 
pH 5.0 Sodium Acetate 83 
pH 5.0 Succinate 94 
pH 6.0 Citrate 109 
pH 6.0 Succinate 104 
pH 6.5 MES 82 
pH 6.5 Citrate 112 
pH 7.0 Sodium Phosphate 100 
pH 7.0 MOPS 87 
pH 7.5 Sodium Phosphate 85 
pH 7.5 Imidazole 95 
pH 8.0 Sodium Phosphate 67 
pH 8.0 HEPES 57 
pH 8.5 Borate 56 
pH 8.5 Bicine 49 
pH 9.0 Borate 40 
pH 9.0 Bicine 35 
Unbuffered 108 
Table 14 - Tertiary screen with ADH D (buffers) - all tested with 10mM butanal as substrate, averages 
of duplicate assays.  
As expected, lower pH was a benefit to the studied reaction whereas alkaline pH values caused 
a relatively steep drop in recorded activity.  That said, the enzyme was relatively insensitive to 
the buffers used, with only assays run in MES having a notable reduction in activity with a 30% 
differential between the MES assays and those run in citrate.  Unsurprisingly, the highest 
activity recorded was at pH 6.5, using citrate as buffer.  As a relatively benign buffer and its 
wide buffering range, this is very useful.  It should also be stated that it is valuable to know 









Additive Dose (vol%) Relative Activity (%) 
10% SDS 1 - 
500mM EDTA (pH8.0, water) 0.2 96 
 2.0 88 
Triton X-100 1 93 
 10 92 
PEG 600 1 99 
 10 75 
DMSO 1 85 
 5 72 
 10 58 
 20 33 
 50 - 
Ethyl Acetate* 1 102 
 5 114 
 10 105 
 20 105† 
Acetonitrile 1 99 
 5 115 
 10 120 
 20 95 
 50 27 
Cyclopentyl Methyl Ether* 1 102 
 5 100 
 10 96 
 20 102† 
Table 15 - Tertiary screen with ADH D (additives and solvents) - All tested using 10mM furfural as 
solvent and pH 7.0 sodium phosphate. *Ethyl acetate and CPME form bilayers, impacting upon assays.  
For example, ethyl acetate above 8% forms a bilayer, indicating solvent saturation, potentially 
affecting observed rates and at high levels distorting assays.  All values are averages of duplicate 
assays, except those marked †, which are single assays and have solvent effects on  the assay. 
Several generic additives were tested to examine their effects upon ADH D, as well as several 
solvents.  In the case of the additives, it appears that a low quantity of a benign substance such 
as PEG 600 is well tolerated; however, greater volumes may prove problematic, with a 25% 
reduction in activity upon the addition of 10vol%.  Predictably, the addition of a more 
aggressive additive such as SDS resulted in the loss of all activity.  A small loss of activity (~7-
8%) was noted with the addition of another surfactant, Triton X-100, indicating that at least 
some surfactants may be well tolerated by ADH D.  Given that SDS is an anionic surfactant and 
Triton is a non-ionic surfactant, it seems likely that this is the cause of the difference in 
tolerance. 
The high acceptance of EDTA provides further evidence that ADH D is resistant to the chelation 
of metals, either indicating that it does not rely upon the use of metal ions such as zinc or iron 
for activity, or that any metal ions relied upon are very tightly bound to the enzyme and 






Ion Dose (vol%) Relative Activity (%) 
100mM FeCl2 1 91 
 10 75 
100mM ZnCl2 1 85 
 10 88 
100mM MnCl2 1 92 
 10 87 
100mM MgCl2 1 89 
 10 93 
100mM NiCl2 1 89 
 10 90 
Table 16 - Tertiary screen with ADH D (ions) - All tested using 10mM furfural and pH 6.5 c itrate buffer.  
Necessary to alter buffer composition due to reaction of ions with sodium phosphate buffer.  Note 
high absorbance of ions at 10mM Concentration. 
 
In order to test the addition of ions as additives to the assay, a change of buffer was needed as 
sodium phosphate reacts with the chlorides forming [ion] phosphate and an opaque assay due 
to the insolubility of those phosphates.  From the previous work citric acid was chosen as the 
optimal buffer studied to carry out this work.  With the benefit of hindsight, this was an 
unsuitable buffer to choose due to the aforementioned chelation ability of citric acid.  
However, it is unlikely that all of the relevant ion is chelated.  Therefore, the concentration of 
ion expected is likely to be an overestimate.  As the original concentrations of added ions are 
rather high, this is less of an issue than it could be, although the quantification of the additives 
is now impossible. 
Buffer suitability aside, it appears that there is little effect of additional ions, with the 
exception of the high dose of iron.  Given that previous additives such as EDTA had little effect 
it was expected that metal ions were not required for activity, and therefore the addition of 
more should have little effect.  This is precisely what is seen here.   
Another important point is that there is likely to be traces of nickel present as part of the 
purification using a nickel based column.  Although only a very small concentration could be 
present, this could be sufficient to cause issues when considering an equally low concentration 
of enzyme, which is only present at nanomolar or micromolar concentration when purified.  
Due to the relative concentrations of the citric acid and added ions though, this source of 
contamination can be entirely discounted.  The quantity of nickel present is orders of 
magnitude lower than both the citric acid and the added ions, which are approximately the 
same; the lower concentration is five times less than the citric acid, and the higher roughly 
double. 
 
3.1.3. OPTIMAL TEMPERATURE AND MELTING POINT 
Another area of study is the determination of the optimal temperature and melting point of 
ADH D.  Whereas previously the residual activity of the enzyme was calculated after a specific 
length of time incubated at high temperatures, cooling down and then assaying at a fixed 
temperature, the optimal temperature is investigated by running identical assays at a range of 
temperatures to record the specific activity obtained.   
As there is a general increase in activity as the temperature is increased, roughly doubling 
every ten degrees increase, and there is a known point at which the enzyme activity is no 
104 
longer retained, then there will be a point whereby the degradation of the enzyme outweighs 
the steady increase in activity, and an inflection point will be found, which is termed the 
optimal temperature.  Whilst it is unlikely that any process would run close to the optimal 
temperature, despite the name, it is a convenient piece of information to know as the absolute 
fastest rate can be determined.  Further, based upon the data from the temperature screen, it 
will be possible to estimate the rate of reaction at any given temperature.  Combined with 
stability information at the same temperature it would be possible to use the information 
gathered to optimise a process for a given substrate at a required temperature. 
 
Figure 82 - Optimal temperature study with ADH D, using butanal as substrate and NADPH as cofactor.  
The figure above indicates the likely optimal temperature to be 70oC, which is appropriate in 
view of the previous thermostability analysis and the growth range of G. thermoglucosidasius.  
Whilst the boiling point of butanal, the substrate used, is 74oC, the length of time of a standard 
assay is unlikely to affect proceedings very much; the study was using 10mM butanal, 
approximately 3KM.  Between the high solubility of the substrate and the brevity of the assays 
including the preincubation phase and the covering of the cuvette during the assay, 
evaporation can be neglected. 
A further analysis was conducted to evaluate the thermal stability of enzymes.  Called a 
thermal shift analysis, the technique exploits a dye that is able to bind to hydrophobic 
residues.  Upon binding it is strongly fluorescent and is then strongly quenched by water.  
Thus, by monitoring excitation at 470nm and emission at 550nm, it is possible to identify when 
proteins are denaturing by considering the derivative of the fluorescence.  When the inflection 
point of the derivative is reached, i.e. when the increase in dye binding has reached and 
passed its maximum, this is the melting point.  This depends entirely on the easily detectable 
increase in fluorescence when the dye binds to the protein.   
The results from this revealed two inflection points, at 76.7oC and 81.2oC, indicative of a two 
stage denaturation process.  The thermostability investigation determined that there was no 
activity after even five minutes incubated at 81oC, but substantial activity after incubation at 
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the significance of a two-step denaturation system.  It is likely that the first step is a reversible 
stage, with the second being irreversible.  As the dye method would probably preclude 
attempting to partially unfold the enzyme by heating part way and cooling, the best method of 
investigating this is likely to be dependent on the assumption that activity will correlate with 
structure.  If heating the enzyme to 77oC briefly before cooling allows for activity to be 
retained, and heating to 81oC does not, then it is likely that the first stage is irreversible.  If 
activity is not retained, then this will not indicate anything as it is possible for activity to be lost 
without an irreversible conformational change. 
It is crucial to note that this method only reveals the exposure of hydrophobic regions of the 
enzyme which can bind to the dye, and the effectiveness of binding.  Whilst this is generally 
sufficient because the exposure of hydrophobic regions of a protein, normally deeply buried, is 
correlated with and taken to imply denaturation, some ambiguity can remain.  For instance, 
initial exposure of hydrophobic areas could actually indicate a breakdown of polymerisation, 
i.e. a previously dimeric or multimeric enzyme initially loses coherency and breaks down to a 
monomeric form.  This enzyme may or may not be active as a monomer, perhaps even more 
active, but in all cases would not represent full denaturation of the enzyme, merely loss of 
quaternary structure.  The only way to definitively determine irreversible denaturation is via 
other structural work such as circular dichroism or differential scanning calorimetry. 
 
3.1.4. CHEMICAL ANALYSIS 
In the first instance, several assays were analysed by GC/MS in an end point analysis to provide 
proof of the products and a quantitative measure of conversion.  There is no difference 
between the assays studied by this method to those previously run in a cuvette using a 
spectrophotometer with the exception of the cofactor regeneration system used.  A two 
enzyme, two substrate system was utilised via the addition of a thermostable glucose 




Substrate 1 Hour 16 Hours 
5-Norbornene-2-carboxaldehyde* 95% 74% 
Butanal** 31% 17% 
Furfural 51% 59% 
Methylbenzoylformate - - 
Ethyl-2-oxo-4-phenylbutyrate 49% 65% 
4-Phenyl-2-butanone 0% 0% 
Decanal 3% Activity 
Benzaldehyde 1% Activity 
4-Chlorobenzaldehyde 31% 63% 
1-Phenyl-1,2-propanedione† 24% 29%/9% 
2',3',4',5',6'-Pentafluoroacetophenone 2% 5% 
Ethyl 4-chloroacetoacetate N/A - 
Ethyl acetoacetate N/A 4% 
Acetophenone N/A 0% 
2,3-Pentanedione N/A 10%/38% 
2,3-Butanedione N/A 56% 
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Table 17 - Summary of GC/MS analysed assays.  All assays conducted for one hour  or at 16 hours at 
50
o
C. N/A indicates not tested, “-“ indicates unsuitable substrate for GC/MS analysis. *Used 20µl 
instead of 10µl of enzyme in 1 hour assay.  **Suspected evaporation of substrate. 
†
Two products 
detected, individual conversions provided after 16 hours.  
As the substrates tested by GC/MS were chosen on the basis of activity among all ADHs tested, 
there are some that were expected to have no activity, for example acetophenone.  
Methylbenzoylformate is a substrate of industrial relevance that was unsuitable for testing by 
spectrophotometer due to absorbance at the same wavelength as NAD(P)H, but was analysed 
by GC/MS as an alternative method of testing; however this also proved unsuitable. 
Overall there is only one surprise in terms of activity, and that is 2',3',4',5',6'-
pentafluoroacetophenone, which was believed to have no activity after assaying, but product 
was detected by GC/MS.  In general those substrates with which ADH D had the highest initial 
rate had higher conversions after a longer period of time, although none demonstrated 
quantitative conversion.  It is likely that additional conversion would be noted by using higher 
concentrations of enzyme, something apparent from the 5-norbornene-2-carboxaldehyde 
entry where double the enzyme was inadvertently used for the one hour assay, resulting in a 
greater conversion than the 16 hour assay.  It is not immediately clear whether the enzyme or 
another aspect of the assay degrades over the course of the 16 hour period, but it is likely that 
cofactor degradation is the root cause; at elevated temperature the half of life of NADPH can 
range from under three hours to over 28 hours in phosphate buffer, depending on the ionic 
strength (Wu et al., 1986).  Those estimates were at 41oC, so they are liable to be 
overestimates.  It would also seem that NADH is almost invariably more stable than NADPH, 
another reason for its preference in industrial settings. 
When diketones were tested as substrates, two products were detected, both expected 
products if only one ketone were converted to an alcohol, and no diols were recorded.  For 
example, in the case of 2,3-pentanedione, both 2-hydroxy-3-pentanone and 3-hydroxy-2-
pentanone were detected, but no 2,3-pentanediol.  A particular problem with the variety of 
potential products from using a diketone as substrate is that the usual external standard 
method was ineffective, i.e. using a known concentration of the product to produce standard 
curves with which to measure the quantity of the unknown conversions.  In this case, an 
assumption was made that both forms of the singly transformed product were equivalently 
detected by the GC/MS in order to convert the detected signal into a useful form.  This 
assumption produced good mass balances, certainly as good as those substrates with relevant 
standard curves, if not better. 
The detection of both singly converted products implies that ADH D is promiscuous with 
respect to accepting either ketone as a substrate, but unable to utilise the second ketone on 
the same molecule.  This is particularly surprising in the example of 2,3-butanone, as the only 
product detected was acetoin.  Given the symmetrical nature of the substrate, it is surprising 
that a hydroxyketone is not an acceptable substrate.   
If the relative proportions of the products gleaned from diketone substrates represent final 
conversions, ADH D has a bias of 3:1 in favour of 1-hydroxy-1-phenyl-2-propanone compared 
to the alternative, and a bias of 4:1 in favour of 2-hydroxy-3-pentanone.  Whilst a less than 
exemplary result, it is at least better than a complete lack of bias and perhaps could be 








Figure 83 - Multiple Sequence Alignment of ADH D with most similar protein sequences associated 
with crystal structures and obtained from the PDB and most similar protein sequences obtained from 
the NCBI RefSeq Database using NCBI Seqr Sequence Search.  Green shading indicates 100% 
conservation, yellow shading indicates >80% conservat ion and red shading indicates >50% 
conservation of amino acids across selected sequences.   Labels refer to crystal structures from the 
PDB or proteins from the NCBI RefSeq Database.  Purple triangles indicate amino acids involved in the 
active site and orange triangles indicate the catalytic tetrad as indicated by the NCBI CDD.  All these 
sites provided via the NCBI Conserved Domain Database and obtained through the Conserved Domain 
Search.  All protein sequences annotated as Voltage-Gated potassium channel beta subunit from the 
genera Geobacillus and Anoxybacillus; the crystal structures are as follows: 3EAU, 1QRQ, 2A79, 1EXB 
are all voltage-gated potassium channel beta subunit from Rattus norvegius, 1ZSX is a voltage-gated 
potassium channel beta subunit f rom Homo sapiens, 4XK2 is an AKR from Polaromonas sp. JS666 , 3ERP 
is a putative oxidoreductase from Salmonella typhimurium, 3N6Q is the crystal structure of YghZ, a 
methylglyoxal reductase from E. coli, 4AUB is an AKR (AKR14A1) from E. coli, 1PYF is an AKR (AKR11A) 
from B. subtilis.  Sequences aligned using MEGA 6.0 (Tamura et al., 2013) with MUSCLE and visualised 
using Genedoc 2.7 (Nicholas et al., 1997). 
The four closest crystal structures appear to be the same protein crystallised at different times 
and, thus shall be considered a single entry for the purposes of discussion.  Work relating to 
1ZSX, 4XK2 and 3ERP remains unpublished and therefore cannot be examined beyond visual 
inspection of the MSA.  
3EAU is a member of the Shaker family voltage-dependent potassium channel, which are 
critical for allowing the flow of potassium ions out of cells, modulating electrical activity.  In 
humans, loss of function mutations have been associated with serious conditions including 
atrial fibrillation.  In addition, two of three mammalian beta subunits of the channel complex 
are also tetrameric NADPH-dependent AKRs of unknown function  (Long et al., 2005; Pan et al., 
2008).  Work done with 2A79 has elucidated the probable in vivo function of the AKR as 
modulating the inactivation of the potassium channel and identified activity with 4-
carboxybenzaldehyde and 4-cyanobenzaldehyde.  Further, the catalytic tetrad is identified as 
D85, Y90, K118 and N158, corresponding to D100, Y105, K136 and N176 in Figure 86 (Weng et 
al., 2006).  This matches with the residues referred to by the NCBI database, but in the case of 
ADH D, it is H176, not N176, which is conserved in all AKRs in the MSA aside from voltage-
dependent potassium channel beta subunits.  This is consistent with some AKR families which 
differ in their catalytic residues at this position, with the histidine being crucial to substrate 
specificity.  This position remains conserved as either a histidine or a asparagine in all AKR 
families (Weng et al., 2006). 
Two differences have also been noted between traditional AKRs and those found as part of 
potassium channels.  The first is that the cofactor is much more exposed to free solvent in 
AKRs other than the potassium channel and the second is that AKRs typically have a more 
enclosed active site (Gulbis et al., 1999).  This could be the reason behind the poor activity 
noted with the substrates noted above, a second reason could be that the AKR in this case is 
not the primary purpose of the protein complex, i.e. the purpose of the enzyme is not to 
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produce aldehydes, ketones or alcohols, but rather to act as a method of oxidising the NADPH 
as necessary (Gulbis et al., 1999).  One theory is that the redox state of the cell is the trigger 
with 4-oxononenal, a product of oxidative stress, also having activity (Weng et al., 2006). 
Given the painfully slow rates of reaction (kcat of 0.073 and 0.082 min
-1 with 4-
carboxybenzaldehyde and 4-cyanobenzaldehyde respectively) and the focus with these 
proteins on their medical implications instead of their biotechnological usefulness (Weng et al., 
2006), it is probably more instructive to consider the remainder of the crystal structures.  That 
said, there are some key residue differences which may be important as they are annotated as 
forming part of the active site, and thus may be the reason for the poor activity.  Using ADH D 
as reference point these residues are E208R, Q268C and S331P and the residues found in ADH 
D are conserved in the most similar proteins, albeit their annotation is also voltage-gated 
potassium channel beta subunits.  Given the general pattern of residues that are conserved 
amongst ADH D, the proteins, and the most similar crystal structures (3EAU, 1QRQ, 2A79, 1EXB 
and 1ZSX) it appears that the annotation may be correct and there is a difference between 
voltage-gated potassium channel beta subunits from microbial and mammalian sources.  Yet 
as this particular protein is only found in plants, insects and mammals (Weng et al., 2006), and 
the gene encoding ADH D is located in a gene cluster annotated to be associated with sugar 
uptake and transport it seems more likely that potassium and sugar channels have structural 
similarities and that those microbial proteins annotated as involved in potassium transport are 
in fact involved with sugar transport.  Speculatively this could imply that ADH D’s activity is 
incidental to G. thermoglucosidasius and its main purpose is to allow for the transport of 
sugars and the AKR function is to recycle cofactor as required.  Alternatively, the structural 
similarities could have no implication on function and the in vivo function for ADH D is as an 
aldose reductase. 
3N6Q and 4AUB are the apo and holo forms of an octomeric methylglyoxal reductase from 
E. coli, alternatively known as YghZ and AKR14A1.    It can catalyse a range of substrates 
including methylglyoxal and isatin, a diketone, and has been implicated in the metabolism of 
glycerol (Totir et al., 2012; Lapthorn et al., 2013).  This range of substrates is notably similar to 
the range determined with ADH D. 
Lastly 1PYF is an AKR from B. subtilis, known as iolS or AKR11A.  It was believed to be involved 
in the breakdown of inositol and other polyols; however, no activity was detected with 
inositol, glucose, fructose or xylose.  Activity was detected with DL-glyceraldehyde, D-
erythrose, 9,10-phenanthrenequionone and methylglyoxal but Michaelis constants were in 
excess of 200mM and kcat 2-3 sec
-1, making it a rather poor enzyme (Ehrensberger and Wilson, 
2004).   
A peculiarity of this enzyme is at position 68 in Figure 83, annotated as an active site residue.  
In 1PYF it is asparagine, whereas in all other cases it is tryptophan.  This results in a drastically 
different positioning of the cofactor, which is only permitted due to the removal of the bulky 
tryptophan.  Ultimately this results in a reversal of the facing of the cofactor, resulting in the 4-
pro-S hydrogen being positioned towards the presumed substrate binding site rather than the 
4-pro-R hydrogen more typical of AKRs (Ehrensberger and Wilson, 2004).   
Another key feature is that the C-terminus of 1PYF is unusually short, with additional residues 
more frequently being noted, forming a 14 residue C-terminal loop which is believed to 
interact with the active site, perhaps guiding or otherwise manipulating substrates into the 
active site.  The lack of loop opens the active site, and the few enzymes lacking this loop 
appear to have poor activity, similar to the potassium channels previously discussed.  This is 
compounded by an active site that remains predominantly hydrophobic even though solvent 
accessible.  One example is that AKRs have a key catalytic step in which a lysine residue 
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activates a tyrosine residue by depressing its pKa, and thereby allowing proton donation.  In 
1PYF a water molecule inserts between the two residues which substantially hinders the 
activating effect (Ehrensberger and Wilson, 2004).  Thus it might be beneficial to determine 
activity with 1PYF in a hydrophobic environment to see if an increased rate of reaction occurs. 
A third feature is that typically AKRs have a “safety belt” which holds the cofactor in place via 
hydrogen bonds, resulting in conformational change upon binding of the cofactor.  This is 
almost entirely absent in 1PYF (Ehrensberger and Wilson, 2004).  Limited activity with NADH is 
attributed to E217, corresponding to E277.  This is a unique residue among the enzymes in the 
MSA, with R277 being the most popular. 
Further residues of interest include positions 204, 205, 206, 208, K214 and K281, 
corresponding to positions 264, 265, 266, 268, K274, K352.  The latter two lysines are not 
previously annotated as involved with the active site.  Importantly 1PYF is unique in the MSA 
at some of these positions, specifically S264F, Q268V and S352K.  The significance of these 
changes cannot be predicted but taken together are likely to be substantial given that they are 
associated with the active site and particularly the cofactor.  The most obvious speculation is 
that these residue changes are part of the difference in activity between ADH D and 1PYF. 
To conclude, ADH D appears to be the founding member of a new subfamily of AKRs, 
specifically AKR6D1.  As such the most similar crystal structures have low sequence identity, 
being annotated as other subfamilies of AKRs, notably AKR11 and AKR14.  Despite annotation 
suggesting that ADH D is a voltage-dependent potassium channel beta subunit, a more 
appropriate role is likely to be in mannitol or other sugar uptake or metabolism.  That said, 
insights from related sequences imply that the C-terminus is important for activity and that 
position 68 is of interest when determining enantiospecificity.  To elucidate whether either 
insight is correct it would be necessary to obtain a crystal structure of ADH D directly.  Should 
no C-terminal loop be present, it may then be possible to add one based upon the existing 
sequences. 
With reference to in vivo activity and function the intriguing possibility is that AKR activity is 
incidental rather than the primary function.  This proposal depends on the assumptions that 
ADH D has an in vivo role of sugar uptake regulation and that said function operates in a 
similar manner to that of a potassium channel.  This may be an area for future investigation. 
 
3.1.6. SUMMARY OF ADH D 
ADH D is a classic alcohol dehydrogenase with broad acceptance of aldehydes and ketones.  
Whilst unable to utilise basic ketones, the enzyme is able to accept branched aldehydes, cyclic 
and aromatic aldehydes, complex ketones and basic diketones.  Chlorinated substrates are 
well accepted, but fluorinated substrates much less so.  With demonstrated activity utilising 
substrates of a very wide range of molecular mass and composition including several of 
industrial interest such as 5-norbornene-2-carboxaldehyde and 1-phenyl-1,2-propanedione, 
ADH D has shown promise. 
A potential operating temperature of 70-75oC and wide buffer and pH toleration are benefits 
of this enzyme, and NADPH and non-specific product formation when using diketones are the 
challenges of this enzyme. 
It is likely this enzyme will be of most assistance when utilised with large substrates with 
multiple functionalities but only one available ketone group. 
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3.2. ADH E 
The second of two enzymes produced in the initial batch, ADH E was under investigation as it 
was thought to be to be involved with propanal degradation.  No problems were noted with 




Figure 84 - SDS PAGE gel of ADH E.  Lane 1: insoluble fraction, lane 2: soluble fraction, lane 3: 2
nd
 
flowthrough, lane 4: 0% His-Elute Buffer, lane 5: 1%, lane 6: 2.5%, lane 7: 5%, lane 8: 10%,  lane 9: 
30%, lane 10: 100% His-Elute Buffer, lane 12: Protein markers.  The numbers on the right indicate 
relative molecular masses (M r) of markers in kDa; the arrow indicates the putative ADH, with an 
expected Mr of 45.4kDa. 
 
3.2.1. SPECIFIC ACTIVITIES, SUBSTRATE SCOPE, CONVERSIONS 
As performed previously, a broad range of substrates were tested with ADH E as part of a 
primary screen.  Difficulty was noted with using raw enzyme containing fractions due to the 
extreme rate of reaction and radical variation in recorded activities principally due to the low 
volume of enzyme used in assays.  Dilutions proved only moderately useful in combatting this 
issue, with discrepancies between expected activities from using one tenth of the enzyme, and 
actual activities recorded.  It was not established whether the root cause of this issue was the 
small volume of raw enzyme needed, or if the reduction in enzyme concentration resulted in 


























Ethyl acetoacetate - 
Benzaldehyde 2.6 
Pyruvate - 
Ethyl pyruvate - 
















Table 18 - Primary screen for ADH E; substrates tested at 10mM concentration using NADH as 
cofactor. 
Whilst initial assays indicated that ADH E could utilise either NADH or NADPH as cofactor, it 
had a very substantial preference for NADH, which was also more cost effective and therefore 
likely to be the preferred cofactor moving forward. 
Very high activities were recorded with small aldehydes, as well as lower activities with furfural 
and benzaldehyde.  Surprisingly, despite no activity with any other ketones, ADH E had some 
activity with 2,3-pentanedione.  There is no obvious reason why this is the case, as no activity 
with halogenated substrates or ketoesters makes it less likely that electron density is 
particularly important for this enzyme. 
Based upon these results, a secondary screen composed of a range of smaller aldehydes as 
well as lengthier ones for comparison indicated activity with standard aldehydes, but not 
where the substrate’s carbon backbone is branched, as in the case of 3-methylbutanal.  The 
previous belief that the substrate scope was independent of electron density was reinforced 
by a lack of activity with 4-chlorobenzaldehyde, yet benzaldehyde had a low activity.  It may be 
the case that physical bulk was an issue though, as 5-norbornene-2-carboxaldehyde was 




















Table 19 - Secondary screen with ADH E, Substrates tested at 10mM concentration using NADH as 
cofactor.  * Repeat from Primary screen. 
The apparent activity with diketones was rather surprising.  Despite enzyme proportionality 
studies indicating high correlation between enzyme concentration and activity, the actual 
activity recorded remains very low and therefore on the limit of detection for the experimental 
method.  Thus it is not beyond reasonable doubt that perhaps there is very low activity with 
2,3-butanedione, but not detectable without considering other methods of study, more 
concentrated enzyme, or end point assays. 
3.2.2. KINETICS 
The substrates chosen for kinetic study were all short chain aldehydes, as these were the 
substrates with which ADH E had the greatest activity.  In addition to substrates previously 
studied, methanal was also studied. 
Ethanal and propanal have been plotted assuming that substrate inhibition does not exist, 
although it is certainly borderline in these cases.  This is despite both methanal and butanal 
exhibiting clear signs of inhibition.  As this enzyme was implicated in propanal degradation 
through its placement in the genome, it is hypothesised that propanal is likely to be the native 
substrate, and similar substrates are effectively inadvertent secondary substrates, i.e. the 
enzyme is promiscuous with respect to the length of substrate it accepts.   
With methanal being a very harsh substrate to many enzymes, and butanal being longer than 
the anticipated native substrate, it is to be expected that they may exhibit signs of substrate 
inhibition.  The inhibition noted in the case of butanal was particularly severe, with optimal 
activity being constrained to a very narrow range of concentrations. 
As ADH E accepted both cofactors, both were tested as well, but all substrate kinetics was 



























Figure 85 - Graph of rate of reaction vs [S] using ADH E and propanal .  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 

































Figure 86 - Hanes-Woolf plot ([S]/v vs [S]) for ADH E and propanal.  Conditions: 50mM sodi um 

























Figure 87 - Graph of rate of reaction vs [S] using ADH E and methanal.  Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 







































Figure 88 - Hanes-Woolf plot ([S]/v vs [S]) for ADH E and methanal, data fitted assuming substrate 




























Figure 89 - Graph of rate of reaction vs [S] using ADH E and ethanal.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 
phosphate pH 7.0, 0.2mM NADH, 50 °C, 1ml assay volume.  
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Figure 90 - Hanes-Woolf plot ([S]/v vs [S]) for ADH E and ethanal.  Conditions: 50mM sodium 



























Figure 91 - Graph of rate of reaction vs [S] using ADH E and NADH.  Data fitted to a Michaelis-Menten 
curve fitted using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 
phosphate pH 7.0, 10mM propanal, 50 °C, 1ml assay volume.  
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Figure 92- Hanes-Woolf plot ([S]/v vs [S]) for ADH E and NADH.  Conditions: 50mM sodium phosphate 


























Figure 93 - Graph of rate of reaction vs [S] using ADH E and NADPH.  Data fitted to a Michaelis-Menten 
curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 
phosphate pH 7.0, 10mM propanal, 50 °C, 1ml assay volume.  
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Figure 94 - Hanes-Woolf plot ([S]/v vs [S]) for ADH E and NADPH.  Conditions: 50mM sodium 



























Figure 95 - Graph of rate of reaction vs [S] using ADH E and butanal.  Data fitted to a Michaelis-
Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by Sigmaplot 





































Figure 96 - Hanes-Woolf plot ([S]/v vs [S]) for ADH E and butanal.   Data fitted assuming substrate 






Substrate Vmax (U mg
-1) KM (mM) Ki (mM) kcat (min
-1) kcat/KM  
(mM-1 min-1) 
Propanal 320(±6) 1.18(±0.10)  15000 12000 
Methanal 73.9(±24.0) 57.8(±28.8) 160(±89) 2400 58 
Ethanal 331(±8) 2.76(±0.22)  15000 5400 
NADH 298(±9) 0.05(±0.005)  14000 270000 
NADPH 19.6(±1.62) 0.38(±0.06)  890 2300 
Butanal 281(±9) 0.23(±0.03) 52.1(±6.1) 13000 55000 
Table 20 - Summary of kinetic data with ADH E. 
As expected, the kinetics indicated a very large bias towards using NADH as cofactor, two 
orders of magnitude difference in the specificity constant.  Additionally, the best substrates 
tested were ethanal and propanal, if inhibition is discounted.  However, relying solely on the 
specificity constant would imply that butanal is a more favoured substrate than any other 
tested. 
This unusual circumstance could suggest that whilst ADH E is indeed part of an aldehyde 
degradation pathway, it has a preference for longer substrates, with a concomitant reduction 
in Michaelis constant, which is observable for methanal through butanal.  With the exception 
of methanal, the Vmax values obtained are close enough to be considered identical, definitely 
within their respective standard error values. 
With reference to the specific activities recorded, it is apparent that either the ethanal and 
propanal Vmax values are under-estimated, or the specific activities are over-estimated, as they 
do not match appropriately. Further work is needed to identify the root cause of this; 
however, the Vmax is likely to be more accurate due to the number of readings from which it is 
based.  More intriguingly though, is the hexanal and octanal values of 99 and 281 U mg-1 
respectively. Although all specific activities are reported in the presence of 10mM substrate, 
not all substrates will dissolve to that concentration.  Whereas in kinetics experiments solvents 
are used to aid dissolution of substrates, they are avoided almost entirely in screening to 
prevent solvents from affecting the rates recorded; occasional exceptions exist for solid 
substrates.  Liquid substrates are added in a pure form, and sufficiently mixed to ensure a 
saturating concentration is present. 
As the saturating concentration of most substrates is not known in the buffers used, using pure 
water as substitute is viable in some cases, but not all.  Using existing solubility studies by way 
of example, it is also important to note that the solubility of many aldehydes can reach a 
minimum at the assay temperature of 50oC, which is a regrettable but unavoidable 
circumstance. 
With reference to the butanal kinetics and to the hexanal and octanal specific activities, it 
seems apparent that ADH E has approximately the same Vmax for aldehydes ethanal through at 
least to octanal, but probably higher aldehydes as well.  Therefore it could be predicted that 
KM and Ki values will drop fairly substantially the larger the substrate gets, leading to the 
situation whereby ADH E will be incredibly active with larger substrates, but only at minute 
concentrations.  The decanal specific activity may indicate that by that length of substrate this 
no longer occurs, or that by that point there is insufficient substrate for a true reading to be 
observed.  Further work, particularly additional kinetics with longer substrates, will need to be 
carried out to substantiate these predictions. 
Given that branching of the carbon chain results in lack of activity, and cyclic and aromatic 
substrates are generally ignored, then it appears that ADH E is restricted to linear aldehydes 
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only, excepting furfural and incidental activity with benzaldehyde.  If the diketone activity is in 
fact true activity, then it would follow that only linear diketones would be accepted.  That said, 
the rate obtained from these diketones is very low, although it would be of interest to 
determine their kinetic constants to see if they follow the same pattern as the aldehydes.  
Further work with furfural would also be useful, as this substrate is of particular interest as it 
acts as a toxin in the biodegradation of lignocelluosic feedstocks (Chang and Yao, 2011; Ji et al., 
2011; Joshi et al., 2011). 
3.2.3. STABILITY ANALYSIS 
Initial thermostability analysis considered only two timepoints, 5 minutes and one hour and 
with two temperatures, 70 and 80 oC.  Testing with 10mM furfural indicated 61% and 31% 
activity was retained after five minutes incubation at 70 and 80 oC respectively.  None was 
detected after one hour at either temperature. 
Preliminary solvent work was similar, only testing a pair of solvents at relatively low 
concentrations.  The results are tabulated below. 




1 70 85 60 
5 37 89 35 
10 39 83 n.d. 
Table 21 - Solvent stability analysis of ADH E, n.d. indicates not determined 
On the basis of these assays, ethyl acetate was chosen as solvent for stock solutions of 
substrate where it was necessary. 
An in-depth investigation into the stability of this enzyme was not carried out due to the 
limited substrate scope, particularly with regards to ketones.  However, on the basis of results 
obtained it appears that this enzyme is somewhat less resistant to solvents and temperature 
when compared to others studied. 
3.2.4. OPTIMAL TEMPERATURE AND MELTING TEMPERATURE 
One area that was examined was the optimal temperature, which had to be carried out with 
butanal rather a smaller aldehyde due to the boiling point of ethanal and propanal.  Comparing 
the Michaelis-Menten curve obtained previously and the activity noted at 50 oC in the optimal 
temperature study, it is obvious that substantial activity was lost.  This is believed to be due to 
the use of a diluted enzyme fraction to reduce the observed rate of reaction to recordable 
levels. 
That said, the temperature curve indicates that the optimal temperature is likely either 70 or 
75 oC, which is approximately where expected; although ADH E has no long term stability at 
such high temperatures, it certainly will be able to survive sufficiently for initial rates to be 
determined.  As there is little reduction in activity at 75 oC, it would be preferable to repeat the 
thermostability test at higher temperatures, 80 or 85 oC to ensure conclusively that this is the 
optimal temperature.  Alternative substrates would have to be used, due to the boiling point 
of butanal at 74 oC. 
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Figure 97 - Optimal Temperature study of ADH E, using NADH as cofactor and 10mM Butanal as 
substrate. 
The thermal shift assay provided an inflection point at 80.3 °C, the highest point of all enzymes 
tested, excluding the second point of ADH D.  The longer term thermostability of this enzyme 
would contrast with its apparent high Tm, as the brief testing done indicated a half-life of 
minutes at 70 °C and seconds or less at 80 °C.  This is an area that should be examined in 
greater detail in the future to elucidate the useful thermostability of this enzyme for industrial 
purposes. 
3.2.5. CHEMICAL ANALYSIS 
Due to the enzyme accepting both cofactors, at least to a limited degree, assays were run with 
both cofactors and then analysed to see if there was a difference over a longer time period 
than the initial rates. 
As envisaged, activity was noted with butanal, furfural and decanal, at least initially.  The 
overnight assay did not produce a detectable quantity of decanol which is concerning.  
Similarly, low activity was noted with 4-chlorobenzaldehyde in the one hour assay, but not in 
the 16 hour assay.  This is particularly interesting as the previous work did not indicate any 
activity with this substrate. 
Whilst quantitative analysis was occasionally variable, presence or absence of product is 
relatively easy to detect by GC/MS.  It is also worth noting that ethyl acetate was used where 





























Temperature of assay (oC) 
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 Conversion 
Substrate 1 Hour 16 Hours 
 NADH NADPH NADH NADPH 
5-Norbornene-2-carboxaldehyde N/A N/A 0% 0% 
Butanal* 32% 11% 27% 2% 
Furfural Activity Activity 28% 1% 
Methylbenzoyl formate - - - - 
Decanal 2% 0% 0% 0% 
Benzaldehyde 0% 0% 0% 0% 
4-Chlorobenzaldehyde 2% 0% 0% 0% 
2,3-Pentanedione N/A N/A 0% 0% 
2,3-Butanedione N/A N/A 0% 0% 
Table 22 - Summary of GC/MS data obtained with ADH E .  N/A indicates not tested, “-“ indicates 
substrate unsuitable for analysis.  *Evaporation suspected with this substrate.  
In particular, the entries for benzaldehyde and decanal suffered from poor signal detection on 
the 16 hour assay, which may have obfuscated some activity in the case of decanal and NADH. 
Finally, it appears that activity noted with diketones was in fact illusionary, perhaps 
benzaldehyde too.  Previously noted as on the limit of detection, it may be the case that in this 
particular instance that the change in absorbance was incidental or unrelated to real 
enzymatic activity.   
 
3.2.6. SEQUENCE ALIGNMENT 
The MSA conducted for ADH E was slightly different to others carried out due to the lack of 
protein sequences identified through the NCBI Seqr Sequence Search as this only provides 
sequences with >70% identity to the sequence provided.  Thus the ten closest sequences were 
obtained using a standard BLAST search using the Reference Sequence database.  Compared to 







Figure 98 - Multiple Sequence Alignment of ADH E with most similar protein sequences associated 
with crystal structures and obtained from the PDB and most similar protein sequences obtained from 
the NCBI RefSeq Database.  Green shading indicates 100% conservation, yellow shading indicates 
>80% conservation and red shading indicates >50% conservation of amino acids across selected 
sequences.   Labels refer to crystal structures from the PDB or proteins from the NCBI RefSeq 
Database.  Proteins are annotated as ADHs from the genera Geobacillus, Bacillus, Anaerosalibacter 
and Clostridium.  Crystal structures are annotated as follows: 3ZDR is a the ADH domain of a 
bifunctional ADHE dehydrogenase from G. thermoglucosidasius, 2BI4 is a lactaldehyde:1,2-
propanediol oxidoreductase from E. coli, 3OWO is an iron dependent ADH from Zymomonas mobilis, 
1RRM is a lactaldehyde reductase from E. coli, 3BFJ is a 1,3-propanediol dehydrogenase from 
Klebsiella pneumoniae , 4FR2 is an ADH from Oenococcus oeni, 3IV7 is an iron containing ADH from 
Cornyebacterium glutamicum , 3JZD is a putative ADH from Ralstonia eutrophia , 4QRS is the aldehyde 
reductase YqhD from E. coli, 1VLJ is a butanol dehydrogenase from Thermotoga maritima . Purple 
triangles indicate the putative active site residues and grey triangles indicate the metal binding site .  
All these sites provided via the NCBI Conserved Domain Database and obtained through the Conserved 
Domain Search.  Sequences aligned using MEGA 6.0 (Tamura et al., 2013) with MUSCLE and visualised 
using Genedoc 2.7 (Nicholas et al., 1997). 
 
With no highly similar proteins in the NCBI database, there is significantly less conservation 
among the sequences aligned, with very few residues conserved among all proteins in the 
MSA.  In particular, aside from the first two entries, WP_013876900.1 and WP_013400812.1, 
which are from Geobacillus species and are near identical, the next sequences have 63% 
identity, indicating that ADH E is relatively unusual and notably different from any other ADH 
studied. 
Another point of interest is that the nearest crystal structure is 3ZDR, or ADH A.  As ADH A was 
also studied as part of this work, its substrate scope is well known, and restricted to linear 
aldehydes.  The metal co-ordination site is D225, H229, H294, H308, which correspond to 
D240, H244, H314, H328.  With one exception at one site, all these are conserved in ADH E and 
in all sequences in the MSA.  Cofactor specificity appears to be controlled by D57 (D66) which 
clashes with the phosphate group of NADP(H) (Extance, 2012).  This site is also annotated as 
part of the active site. 
2BI4 is an NADH dependent lactaldehyde reductase from E. coli, also known as FucO.  It is a 
dimer and the first reported structure for an iron-containing ADH that has been shown to 
contain iron.  Although 2BI4 has a greater affinity for zinc than iron, zinc severely inhibits the 
enzyme.  Similar to 3ZDR, the metal co-ordination site is identified and the cofactor specificity 
is dependent on D39 (D66).  The NAD+ binding site was experimentally confirmed to be GGS96-
98 (GGS130-132) by considering the mutant G97E (G131E) which had no detectible activity or 
NAD+ binding.  A second mutant D39G (D61G) resulted in 2BI4 being able to utilise NADPH and 
NADH, with affinity roughly equal.  There was a substantial drop in kcat when using NADPH as 
cofactor though; 104 s-1 when using NADH and 31 s-1 when using NADPH.  It is believed that 
K40, T41, Q44 (K62, T63, Q66) may provide a pocket for the phosphate group to bind and it is 
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solely the D39 (D61) residue that hinders (Montella et al., 2005).  Given that these residues are 
similar to ADH E, which already has activity with NADPH, the same mutation may allow for 
similar results.  2BI4 is a highly stereospecific enzyme, with preference for S-1,2-propanediol, 
and also regiospecific for the oxidation of primary alcohols.  It has a limited substrate scope, 
able to catalyse primary alcohols, diols and triols, but only aliphatic examples.  Rates of 
reaction are also very poor, with the highest kcat of 4 s
-1 with 1,2-ethanediol (KM of 51mM) 
(Blikstad and Widersten, 2010).   
3OWO is the apo form of a dimeric, NADH dependent, ADH from Zymomonas mobilis.  It is a 
member of the iron-containing family of ADHs, oxygen sensitive, and believed to be a key 
enzyme in the cytosolic respiratory system, converting ethanal to ethanol and providing 
necessary NADH.  As may be expected given the conservation of the residues, the same motif 
is indicated as the cofactor binding site and D39 (D61) is again considered the principal reason 
3OWO is NADH dependent and not NADPH dependent.  Key residues for substrate binding are 
believed to be F149 and F254 (F195 and F302), which sterically regulate the substrate 
molecule, in this case ethanol (Moon et al., 2011).  These residues are conserved in ADH E, and 
therefore may be relevant with regards to the substrate scope of this enzyme. 
1RRM is a lactaldehyde reductase from E. coli, but has not been published.   
3BFJ is a decameric 1,3-propanediol dehydrogenase from Klebsiella pneumoniae.  It is NAD 
dependent, iron-containing, and is proposed as a key enzyme in the use of glycerol.  As with 
previous enzymes, three histidine residues and one aspartic acid residue are metal co-
ordinating.  The substantial difference with this enzyme is the decameric quaternary structure, 
in which there are five dimers.  Two interactions mediate this, the first is ionic between D322 
and R333 (D383 and R394), the second is a hydrogen bond between N314 and G317 (N375 and 
G378).  None of these four residues are conserved in ADH E, but are typically conserved in 1,3-
propanediol dehydrogenases (Marçal et al., 2009).  
Lastly, 4FR2 is a dimeric NADH dependent ADH From Oenococcus oeni.  Although a member of 
the iron-containing ADH family, the active enzyme contains nickel and is entirely inhibited by 
zinc.  It is the first crystal structure from a gram-positive bacteria and can catalyse a range of 
small aldehydes and alcohols including 1,2-propanediol, 1,3-propanediol, glycerol, 2-propanol 
and butanal.  Identical residues to those previously noted have been identified as key for 
cofactor specificity and binding (Elleuche et al., 2013). 
In conclusion, ADH E is an unusual enzyme, with few sequences with >70% sequence identity 
on record.  The most similar enzymes are either 1,2-propanediol dehydrogenases or 1,3-
propanediol dehydrogenases, typically with the ability to accept varied small substrates such 
as glycerol and butanol, but with very weak rates of reaction and high Michaelis constants.  
ADH E has a turnover number between ten and one hundred times higher than similar 
enzymes noted above, each with their most preferred substrates and cofactors.  Given ADH E’s 
observed activity with larger substrates, including octanal and furfural, it seems likely that it is 
a different ADH to those detailed above.  Speculatively, the change in substrate scope could be 
mediated by residues annotated as part of the active site and are not conserved such as I207 
and L225.  
Despite this, the conserved residues and experimental evidence obtained with other enzymes 
imply it may be possible to drastically alter the cofactor specificity with a single mutation, 
D61G, perhaps allowing substantial activity with both cofactors simultaneously.  This would be 
a very significant advance as it would allow ADH E to become a more useful thermophilic 
enzyme for cofactor regeneration.  More tentatively, there may be opportunity to remove 
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NADPH activity entirely and increase NADH activity by manipulating residues believed to assist 
in NADPH binding. 
It would be interesting to determine whether a metal ion is used by ADH E, given the range of 
metal ions that utilised by related enzymes, it may be instructive to examine this area.  
Another question that arises from the MSA is if the sequence for ADH E is entirely accurate.  It 
is possible that an additional four amino acids have been appended to the N-terminus, but this 
is not entirely clear.  As an N-terminal His tag has been used in this investigation it is highly 
unlikely to have affected the enzyme beyond any effect the tag has already caused, but it is 
worth noting regardless. 
 
3.2.7. SUMMARY 
ADH E is an alcohol dehydrogenase with very high activity with short chain aldehydes.  Due to 
this particular substrate scope detailed investigations were not carried out; however, with 
substantial potential in the detoxification of furfural and in bioremediation of short-chain 
aldehydes, this enzyme has significant capability.  Additional benefit may be gained as part of a 
two enzyme, two substrate cofactor regeneration system.  Due to the enzyme’s ability to 
utilise both cofactors, ADH E demonstrates usefulness as a multipurpose regeneration system 
with high proficiency at producing the necessary reduced cofactors for a variety of industrial 
and research purposes. 
Although a thermophilic enzyme, it is not especially resistant to high temperatures over long 
timescales, but demonstrates short-term resistance to temperatures higher than would be 
expected given the growing temperature of G. thermoglucosidasius.  This is reflected in 
variable solvent resistance too, with apparent immunity to ethyl acetate at low 
concentrations, suitable for cosolvent purposes but sensitive to both acetonitrile and DMSO. 
With regards to native activity, it seems highly likely that ADH E is involved in propanal 
reduction yet may equally be involved in breaking down a variety of minimally soluble higher 
aldehydes.  Speculatively, these aldehydes may interfere with the cell membrane and 
therefore may need to be converted to alcohols to prevent damage.  
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3.3. ADH F 
The first enzyme to be tested from a second group of putative ADHs, ADH F expressed and 
generally purified without issue, as shown below in a SDS-PAGE gel.  On occasion, however, 
expression was substantial enough to overwhelm the column used for purification, resulting in 
infrequent minor contaminants, which would counter-intuitively appear at greater 
concentrations of imidazole in the elution buffer.  This was attributed to these contaminating 
proteins being “locked in” to the column by ADH F, by its surrounding of the column.  
Therefore in early elutions some ADH F washed off, exposing the other proteins to the 
imidazole containing buffer, and eluting later than would otherwise be expected. 
 
 
Figure 99 - SDS PAGE gel of ADH F.  Lane 1: insoluble fraction, lane 2: soluble fraction, lane 3: 2
nd
  
flowthrough,  lane 4: 0% His-Elute Buffer, lane 5: 1%, lane 6: 2.5%, lane 7: 5%, lane 8: 10%, lane 9: 
30%, lane 10: 100% His-Elute Buffer, lane 12: protein markers.  The numbers on the right indicate 
relative molecular masses (Mr) of markers in kDa; the arrow indicates the putative ADH, with an 
expected Mr of 34kDa. 
3.3.1. SPECIFIC ACTIVITIES, SUBSTRATE SCOPE, CONVERSIONS 
As is customary, a primary substrate screen was conducted using the same substrates as with 
previous enzymes.  Similar to ADH D, a wide range of substrates were accepted by this 
enzyme.  Unique among all enzymes tested though, was the apparent ability of ADH F to utilise 
both cofactors to a similar degree, and thus the primary screen was conducted twice, once 

















Substrate Specific Activity  
(U mg-1) [NADH] 
Specific Activity  
(U mg-1) [NADPH] 
Butanal 1.10 5.45 
Decanal 0.33 1.52 
2-Butanone - - 
2-Decanone - - 
3-Pentanone - - 
Isobutanal 1.18 5.29 
Cyclohexanone - 0.91 
Furfural 3.14 8.84 
Acetophenone - 0.33 
Ethyl acetoacetate 0.12 1.31 
Benzaldehyde 4.75 8.35 
Pyruvate - 0.14 
Ethyl pyruvate 6.36 3.42 
Ethyl levulinate - 0.12 
Levulinate - - 
α-Tetralone - - 
3-Methyl-2-butanone - 0.07 
2,3-Pentanedione 16.52 10.75 
Ethyl 2-oxo-4-phenylbutyrate 1.60 3.94 
4-Phenyl-2-butanone - 0.27 
1-Phenyl-1,2-propanedione 20.74 11.45 
2,2,2-Trifluoroacetophenone 2.51 9.44 
Ethyl 4-chloroacetoacetate 5.18 1.84 
Ethyl 4,4,4-trifluoroacetoacetate 0.69 2.83 
2',3',4',5',6'-Pentafluoroacetophenone 0.30 2.84 
Table 23 - Primary screen of ADH F with both cofactors. 
It was not clear from these data which cofactor was preferred by ADH F, as although the 
majority of rates were higher with NADPH, there were substantial improvements in a few 
cases with NADH, such as 1-phenyl-1,2-propanedione and ethyl 4-chloroacetoacetate. 
Also notable is that with NADPH, ADH F lacked activity with very few substrates in the screen, 
specifically monoketones, tetralone and levulinate.  Based around the tendency of this enzyme 
to prefer diketones, a variety were collected for the secondary screen, along with several 
aldehydes and related industrially relevant substrates such as halogenated acetophenones.  
Structurally similar substrates such as methyl acetoacetate were also added to see if activity 










Substrate Specific Activity 
(U mg-1) [NADH] 
Specific Activity 
(U mg-1) [NADPH] 
Methanal 0.14 - 
Propanal 0.65 - 
Hexanal 5.10 0.60 
Octanal 6.69 2.28 
2,3-Butanedione 15.86 24.36 
2,5-Hexanedione - - 
2,3-Hexanedione 19.82 21.80 
2,3-Heptanedione 21.13 32.80 
3,4-Hexanedione 8.29 1.50 
3-Methylbutanal - - 
Cycloheptanone - - 
2,2’,4’-Trichloroacetophenone* 2.38 - 
4’-Chloroacetophenone 0.18 - 
4’-Bromoacetophenone 0.37 - 
2-Chloroacetophenone 0.24 - 
Methyl acetoacetate 0.56 - 
Ethyl 2-chloroacetoacetate 11.85 11.15 
4-Chlorobenzaldehyde 5.23 3.97 
Glyoxal 12.38 13.83 
Propiophenone - - 
5-Norbornene-2-carboxaldehyde 9.97 6.65 
Benzoin - - 
Benzil* 0.27 - 
Benzophenone* - - 
Table 24 - Secondary screen of ADH F with both cofactors. *These substrates tested at 1mM 
concentration, from 100mM stock solution prepar ed in DMSO. 
This enzyme demonstrated activity with almost every substrate provided to it.  Limitation in 
size is only apparent with benzophenone, although perhaps even this may be averted with 
higher concentrations of substrate.  All solid substrates were prepared in DMSO for test, and 
due to poor solubility even then some were tested at 1mM concentration. 
Branched aldehydes and other excessively large substrates, specifically 3-methylbutanal and 
propiophenone, were also unsuitable for ADH F.  Furthermore, it is shown that diketones must 
be adjacent, as 2,5-hexanone was equally unsuitable.  Aside from this, there was noticeable 
activity with every substrate, with at least one cofactor, if not both. 
One particular quirk of ADH F was with butanal, using NADPH as cofactor.  The activity 
reported only occurred after a substantial lag phase, where little or no activity was recorded.  
This was not attributable to product activation, as premixing 1-butanol with the enzyme had 
no effect upon assays.  Additionally, this behaviour was not noted when using any other 
aldehyde or NADH as cofactor. 
Overall though, based solely upon the screening, ADH F demonstrated an extensive substrate 
scope, including all industrially relevant substrates tested and analogues of commercially 
useful structures.  The ability to use NADH as well as NADPH and reasonable rates of activity 





As with the substrate screening, kinetics were carried out in duplicate, with both NADH and 
NADPH used as cofactors for each substrate tested.  For this reason only five substrates were 
considered, with each cofactor being examined in addition to this.  Contrasting with other 
enzymes studied, the majority of substrates used for kinetics work had poor solubility in buffer 
and therefore stock solutions were prepared in solvent.  In this case acetonitrile was used.   
Noted previously, there is often a non-existent operating range for substrate concentration 
when analysing the kinetics using substrates that are virtually insoluble in buffers.  Solvent 
concentrations were carefully monitored in accordance with previously determined resistance 
studies; however, in some cases it was impossible to avoid using higher than desired solvent 
concentrations in order to provide enough substrate to the assay.  These cases are where the 
substrate concentration exceeded 20mM, which corresponds to a 2vol% solvent concentration 
in the assay.  At the other end of the spectrum, to accommodate particularly low substrate 
concentrations, e.g. 1-phenyl-1,2-propanedione, which necessitated having concentrations as 


































Figure 100 - Graph of rate of reaction vs [S] using ADH F and 1 -phenyl-1,2-propanedione in 
acetonitrile.  Data fitted to a Michaelis-Menten curve, assuming substrate inhibition, using the 
Levenberg-Marquardt algorithm by Sigmaplot 12.   Conditions: 50mM sodium phosphate pH 7.0, 





































Figure 101 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and 1-phenyl-1,2-propanedione in acetonitrile, 
data fitted assuming substrate inhibition.  Conditions: 50mM sodium phosphate pH 7.0, 0.2mM NADH, 
































Figure 102 - Graph of rate of reaction vs [S] using ADH F and 1 -phenyl-1,2-propanedione in 
acetonitrile.  Data fitted to a Michaelis-Menten curve, assuming substrate inhibition, using the 
Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium phosphate pH 7.0, 




































Figure 103 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and 1-phenyl-1,2-propanedione in acetonitrile, 
data fitted assuming substrate inhibition.  Conditions: 50mM sodium phosphate pH 7.0, 0.2mM 


























Figure 104 - Graph of rate of reaction vs [S] using ADH F and furfural.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 

































Figure 105 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and furfural.  Conditions: 50mM sodium 




























Figure 106 - Graph of rate of reaction vs [S] using ADH F and furfural.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 



































Figure 107 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and furfural.  Conditions: 50mM sodium 

























Figure 108 - Graph of rate of reaction vs [S] using ADH F and 3,4-hexanedione in acetonitrile.  Data 
fitted to a Michaelis-Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt 




































Figure 109 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and 3,4-hexanedione in acetonitrile, data fitted 
assuming substrate inhibition.  Conditions: 50mM sodium phosphate pH 7.0, 0.2mM NADPH, 50 °C, 


























Figure 110 - Graph of rate of reaction vs [S] using ADH F and 3,4-hexanedione in acetonitrile.  Data 
fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  
































Figure 111 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and 3,4-hexanedione in acetonitrile.  Conditions: 


























Figure 112 - Graph of rate of reaction vs [S] using ADH F and 2,2,2 -trifluoroacetophenone in 
acetonitrile.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 


































Figure 113 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and 2,2,2-trifluoroacetophenone in acetonitrile.   

























Figure 114 - Graph of rate of reaction vs [S] using ADH F and 2,2,2 -trifluoroacetophenone in 
acetonitrile.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 

































Figure 115 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and 2,2,2-trifluoroacetophenone in acetonitrile.  



























Figure 116 - Graph of rate of reaction vs [S] using ADH F and ethyl 2 -oxo-4-phenylbutyrate in 
acetonitrile.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 


































Figure 117 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and ethyl 2-oxo-4-phenylbutyrate in acetonitrile.  

























Figure 118 - Graph of rate of reaction vs [S] using ADH F and ethyl 2 -oxo-4-phenylbutyrate in 
acetonitrile.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 



































Figure 119 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and ethyl 2-oxo-4-phenylbutyrate in acetonitrile.  


























Figure 120 - Graph of rate of reaction vs [S] using ADH F and NADPH.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 







































Figure 121 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and NADPH.  Conditions: 50mM sodium 























Figure 122 - Graph of rate of reaction vs [S] using ADH F and NADH.  Data fitted to a Michaelis-Menten 
curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 
phosphate pH 7.0, 10mM 1-phenyl-1,2-propanedione in acetonitrile, 50 °C, 1ml assay volume.  
Hanes-Woolf
[Substrate] (mM)

































Figure 123 - Hanes-Woolf plot ([S]/v vs [S]) for ADH F and NADH.  Conditions: 50mM sodium 





















NADH 28.26±0.94 0.099±0.013 46.8±9.8 960 9700 
1-phenyl-1,2-
propanedione 
NADPH 16.02±0.52 0.010±0.003 18.0±4.3 550 54000 
Furfural NADH 6.58±0.39 10.07±1.61 - 220 22 
Furfural NADPH 10.34±0.37 1.54±0.24 - 350 230 
3,4-Hexanedione NADH 9.31±0.82 16.65±2.83 - 320 19 
3,4-Hexanedione
†
 NADPH 40.19±16.90 16.81±8.40 7.11±4.08 1400 81 
2,2,2-
trifluoroacetophenone 
NADH 9.99±0.80 12.27±2.21 - 340 28 
2,2,2-
trifluoroacetophenone 
NADPH 10.55±0.46 1.74±0.29 - 360 206 
Ethyl-2-oxo-4-
phenylbutyrate 
NADH 2.45±0.17 3.70±0.68 - 83 23 
Ethyl 2-oxo-4-
phenylbutyrate 
NADPH 5.22±0.16 1.05±0.16 - 180 169 
NADH - 66.87±3.89 0.44±0.04 - 2300 5200 
NADPH - 13.21±0.70 0.013±0.002 - 450 35000 
Table 25 - Summary of kinetic data with ADH F. 
 †  
Results illustrative only.  Due to limitation of solvent  
resistance, it was not possible to get sufficiently concentrated subst rate for improved data.  
An assortment of noteworthy results was revealed in this area.  Initially, the discrepancy 
between cofactors was exacerbated as first one was preferred, then the other, depending on 
the substrate involved.  Regrettably the cofactor kinetics were done last, which disclosed the 
root cause – an exceptionally high KM value for NADH, as well as a much higher Vmax.  Typically 
cofactors are used at a concentration of 0.2mM, and this work was no exception.  This is to 
minimise absorption, or at least to constrain it to a region where there is highest confidence in 
the values obtained.  By the nature of measuring absorbance figures, particularly the 
logarithmic scale by which they are measured, it is recommended to remain below an 
absorbance of 2, and preferentially below 1.5, in order to have absolute confidence in the 
figure that is recorded.  This is compounded when, as is frequently the case during this 
investigation, substrates also absorb at the monitored wavelength of 340nm.  This has led to a 
generally accepted concentration of 0.2mM NAD(P)H. 
Due to frequent substrate absorbance, it was not typical to run any assay with more than 
0.2mM cofactor, even if the spectrophotometer was theoretically able to provide accurate 
readings at that level.  Therefore, having a cofactor with a KM value in excess of 0.4mM was 
most troubling, as this would countermand the assumption made with all assays of this type 
that the cofactor is in excess at all times, kinetically speaking.  Although it is not ideal to note 
that the cofactor is not acceptably in excess for these kinetics, it is not an uncommon issue to 
encounter.  Typically a NADH KM is higher than for NADPH, and it is important to note that ADH 
F has a much greater affinity for NADPH than NADH.  Consequently it isn’t surprising given the 
ability of the enzyme to use both cofactors, that the Michaelis constant for NADH is so high.   
The only other issue was where higher substrate concentrations would have been instructive, 
e.g. 3,4-hexanedione with NADPH as cofactor.  The Hanes-Woolf plot indicates substrate 
inhibition is present; however the kinetics provided by the software package are obviously 
erroneous and misleading.  Forcing a fit to the standard Michaelis-Menten equation without 
inhibition gives a Vmax of 11.4 and KM of 3.0.  By visual inspection of the data these kinetic 
constants are likely to be approximately correct.  This was another occasion where an 
additional reading at 30mM may have been helpful, although further points above this may 
145 
have been required to get enough to be analysed appropriately.  The reason this was not done 
was due to the potential effects of the solvent upon the reaction. 
It is surprising that Michaelis constants are lower and particularly that specificity constants 
recorded with 1-phenyl-1,2-propanedione are higher than those recorded for cofactors.  
Typically cofactor specificity constants are substantially higher than those of the substrates.  
Whilst native substrates cannot be inferred directly from kinetic data, these data provide a 
relatively strong signal that whatever the native role of this enzyme, 1-phenyl-1,2-
propanedione is a very highly preferred substrate.  
 
3.3.3. STABILITY ANALYSIS 
Due to the importance of ADH F, a tertiary screen was conducted, in an identical manner to 
ADH D, to elucidate potential operating conditions for the enzyme. 
 
Assay Condition Relative Activity (%) 
pH 5.0 Sodium Acetate 47 
pH 5.0 Succinate 48 
pH 6.0 Citrate 59 
pH 6.0 Succinate 47 
pH 6.5 MES 71 
pH 6.5 Citrate 86 
pH 7.0 Sodium Phosphate 100 
pH 7.0 MOPS 21 
pH 7.5 Sodium Phosphate 82 
pH 7.5 Imidazole 80 
pH 8.0 Sodium Phosphate 57 
pH 8.0 HEPES 48 
pH 8.5 Borate 37 
pH 8.5 Bicine 29 
pH 9.0 Borate 26 
pH 9.0 Bicine 23 
Unbuffered 77 
Table 26 - Tertiary screen with ADH F (buffers) - all tested with 10mM furfural as substrate, NADPH as 
cofactor, averages of duplicate assays.  
First buffers and pH were considered, and in opposition to what was expected, there was no 
benefit observed of using an acidic pH, at least with the buffers studied.  No buffer improved 
upon the assay buffer, sodium phosphate, with MOPS being a particularly poor buffer, with a 
five-fold reduction in activity at the same pH as Sodium Phosphate.  Whilst there was slight 
variation depending on the buffer at different pH values, there was almost as big a drop at 
acidic pH as there was at alkaline, which was quite surprising as generally it would be expected 
that an acidic pH would increase the activity. 
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Additive Dose (vol%) Relative Activity (%) 
10% SDS 1 - 
400mM EDTA 0.25 105 
 2.5 70 
Triton X-100 1 116 
 10 101 
PEG 600† 1 96 
 10 38 
DMSO 1 96 
 5 74 
 10 66 
 20 33 
 50 - 
 93 - 
Ethyl Acetate* 1 90 
 5 77 
 10 52 
 20 49 
Acetonitrile 1 93 
 5 76 
 10 58 
 20 35 
 50 7 
 93 - 
Cyclopentyl Methyl Ether* 1 88 
 5 73 
 10 60 
 20 64 
 50 (Solvent Distortion) 
Hexane* 1 116 (115) 
 5 115 (110) 
 10 115 (104) 
 20  125 (100)  
 50 155 (78) 
 93 (Solvent Distortion) 
Table 27 - Tertiary screen with ADH F (additives and solvents) - all tested using 10mM furfural as 
substrate, NADPH as cofactor and pH 7.0 sodium phosphate. *Ethyl acetate, CPME and hexane all 
form bilayers, impacting upon assays.  For example, ethyl acetate above 8% forms a bilayer, indicating 
solvent saturation, potentially affecting observed rates and at high levels distorting assays. 
Normalised activities are provided in brackets.  †PEG 600 c ontrol registered a rate of 16%.  All values 
averages of duplicate assays.  
Additives had a negative effect on rates of activity, with SDS again suppressing all activity.  
EDTA was tolerated at low concentration, but at the higher concentration tested reduced 
activity by 30%.  Triton was well tolerated, but PEG600 notably reduced activity at the higher 
concentration tested. 
The solvent study is of particular interest, given that these were not the first assays conducted 
with ADH F.  In this case, with furfural as substrate, all solvents aside from hexane are poorly 
tolerated.  Hexane may even provide a boost at lower quantities, with a 15% increase in 
activity noted at 1vol%.  The higher readings for increased volumes are likely an artefact of the 
immiscibility of the solvent in the buffer.  The reason furfural was chosen for this study was 
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because of its solubility in the buffer, hence allowing all the assays to be conducted from the 
same stock solution. 
The problem is that this work does not compare to earlier solvent work which was done in 
order to carry out previous work that required substrates to be dissolved in solvent.  The first 
initial solvent screen was carried out using butanal as substrate, again due to ease of use.  This 
work indicated no particular solvent resistance for DMSO or ethyl acetate; however, those 
assays were done using PMMA cuvettes, which were determined to lack solvent resistance 
themselves. 
Upon repetition of the work in quartz cuvettes in preparation for the secondary screen, DMSO 
appears to have little effect at a concentration of 10vol%, ethyl acetate at 1%, and acetonitrile 
at 1%.  On that basis, the secondary screen uses DMSO to produce stock solutions as required.  
Upon moving to kinetics, it was immediately apparent that DMSO does inhibit, when using 
1-phenyl-1,2-propanedione as substrate. 
More rigorous testing with that substrate reveals that DMSO is only suitable for kinetics 
analysis, i.e. no observed effect on the activity, up to 1vol%, and in fact acetonitrile is the most 
suitable solvent with no observed effect up to 2vol%. 
Comparing the latter experiments with the entries in Table 27 it would seem that there is more 
variation than would be expected.  Whilst the focus is different between an operational 
solvent screen whereby small amounts of solvent are added and no effect is permitted, and a 
high level broad scan of solvent ratios, there shouldn’t be a huge variance between the two 
where they overlap.  As the difference between the two is in the substrate choice, this could 
well be the important discrepancy. 
Furfural and butanal are notably weaker substrates for ADH F than 1-phenyl-1,2-
propanedione; therefore, the potential implication is that apparent solvent resistance is 
dependent on the relative strength of the substrate.  Stated more accurately, for a given 
enzyme, stronger substrates may provide protection against solvent denaturation through by 
being more likely to be bound to the enzyme at any given point.  More frequent and stronger 
binding may strengthen the enzyme against denaturing effects. This would be apparent as 
substrate dependent solvent effects, and is something that should be investigated further. 
In terms of overall solvent resistance, with all solvents tested there was a 50% residual activity 
after adding either 10vol% or 20vol%, which indicates potential usefulness with these solvents 
as co-solvents.  Of particular interest would be CPME, as this solvent is absolutely immiscible 
with water, marketed as such and as the next generation green solvent.  Therefore, of all the 




Ion Dose (vol%) Relative Activity (%) 
100mM FeCl2 1 92 
 10 51 
100mM ZnCl2 1 107 
 10 117 
100mM MnCl2 1 106 
 10 102 
100mM MgCl2 1 104 
 10 108 
100mM NiCl2 1 106 
 10 102 
Table 28 - Tertiary screen with ADH F (ions) - All tested using 10mM furfural and pH 6.5 citrate buffer.  
Necessary to alter buffer composition due to reaction of ions with sodium phosphate buffer.  Note 
high absorbance of ions at 10mM concentration. 
As noted with ADH D, the choice of buffer was distinctly unhelpful when considering ions; 
however, it appears that only iron and zinc had an appreciable effect upon activity.  Zinc with a 
minor increase in activity and iron with a substantial decrease would indicate that ADH F is zinc 
dependent.  This correlates well with EDTA having a detrimental effect upon activity. 
 
Figure 124 - Optimal temperature study with ADH F using NADPH as cofactor and butanal as substrate  
The optimal temperature study indicated an optimal temperature of 70 oC.  Compared to the 
operating temperature of G. thermoglucosidasius, this would mean that this enzyme could 
work well across the entire range, with only a minor loss at 75 oC, and broadly the same 






























Figure 125 - Preliminary thermostability test, conducted at 60 
o
C, with 10mM furfural as substrate and 
NADPH as cofactor.  
Initial thermostability experiments were conducted over three hours; in contrast to previous 
studies carried out at 70 oC or higher, this was carried out at 60 oC, the standard growth 










= 173 𝑚𝑖𝑛𝑠 
With an estimated half-life of approximately three hours, long term stability at this 
temperature would appear to be limited.  Compared to ADH D, there is a substantial reduction 
in stability, from a half-life of 38.5 hours at 70 oC to three hours at 60 oC.   
On the basis of this data an extended thermostability experiment was carried out, due to the 
potential of this enzyme.  In addition glycerol was added to a final quantity of 50vol% with a 
duplicate test.  As glycerol is known to improve the stability of enzymes in some cases, this was 
done to indicate whether the addition of additives may augment the thermostability of the 
enzyme.  Furthermore, by adding the glycerol it was anticipated that this may aid in reducing 
intrapoint variability by increasing the viscosity and therefore dispersing the enzyme more fully 
within the aliquot. 
y = e-0.004x 
R² = 0.8708 
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100%



















Figure 126 - Extended thermostability test at 60 
o
C using furfural, NADPH as cofactor. 
 
Over the course of 52 hours aliquots were tested for activity, with neither the standard or 
50vol% glycerol samples degrading at the same level as noted previously.  Although there was 
reduced variation in the glycerol run, the run without glycerol was substantially more stable 
across the time period analysed.  Even with the heightened variation, it is clear that ADH F is 
more stable without additives. 












= 139 ℎ𝑜𝑢𝑟𝑠 
Thus the estimate for ADH F stability at 60 oC is 41 hours when 50vol% glycerol is added, and 
139 hours when not.  This is much more in line with ADH D, and represents substantial stability 
at the likely native temperature. 
The thermal shift assay for ADH F indicated an inflection point at 76.0 °C, slightly above the 
previously determined Topt of 70 °C.   
 
3.3.4. CHEMICAL ANALYSIS 
Finally, assays with ADH F were analysed by GC/MS as previously, to determine conversions 
produced during these assays and to provide an indication of the products produced.  Due to 
the previously uncovered activity with multiple substrates of interest, this is a particularly 
important area of study. 
 
 
y = e-0.005x 
R² = 0.5991 
y = e-0.017x 
R² = 0.9486 
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Substrate 1 Hour 16 Hours 
 NADH NADPH NADH NADPH 
5-Norbornene-2-carboxaldehyde* 13% 78% 18% 36% 
Butanal** 7% 22% 5% 13% 
Furfural 30% 44% Activity Activity 
Methyl benzoylformate - - - - 
Decanal 0% 1% 0% 0% 
Benzaldehyde 0% 3% Activity Activity 
4-Chlorobenzaldehyde 5% 17% 8% 35% 
2,3-Pentanedione N/A N/A 5%/23% 9%/45% 
2,3-Butanedione N/A N/A 25% 58% 
Ethyl-2-oxo-4-phenylbutyrate 33% 39% 62% 64% 
4-Phenyl-2-butanone 0% 0% 0% 0% 
1-Phenyl-1,2-propanedione 9% 16% 18%/6% N/A 
2',3',4',5',6'-
Pentafluoroacetophenone 
2% 7% 3% 14% 
Acetophenone N/A N/A 1% 1% 
Ethyl 4-chloroacetoacetate - - - - 
Ethyl acetoacetate N/A N/A N/A 6% 
2,2,2-trifluoroacetophenone N/A N/A 14% 48% 
Table 29 - Summary of GC/MS data with ADH F.  N/A indicates an assay was not run, "-" indicates 
substrate unsuitable for GC/MS analysis. *1 hour assay was run using double enzyme, ** substrate 
evaporation suspected.  
 
Allowing for the same problems with analysing data as previously noted, with respect to 
furfural, decanal and benzaldehyde, activity was confirmed with all substrates with the 
exception of 4-phenyl-2-butanone, which was expected.  Interestingly, despite a lack of activity 
noted in previous assays, activity was noted with acetophenone.   
In keeping with previous work, all assays were conducted with both cofactors independently.  
The only exceptions to this were 1-phenyl-1,2-propanedione with NADPH and ethyl 
acetoacetate with NADH, in these instances the data were unrecoverable.  It is also important 
to note that 0.2mM cofactor was used, which appears to bias conversion in favour of NADPH, 
with the sole exception of ethyl 2-oxo-4-phenylbutyrate where there is approximately the 
same conversion after one hour and 16 hours.  This could only occur if the limitation is 
somehow cofactor based, i.e. if cofactor regeneration was not a contributing factor, then it 
would be expected that all assays would have roughly the same conversion irrespective of 
cofactor used.   
Proceeding on the basis that both ADH F and glucose dehydrogenase enzymes used in the 
assays are thermostable, then that leaves either the substrates or the cofactor itself as not 
thermostable.  At 50 oC glucose is stable and the majority of substrates tested are also stable, 
the prominent exception being butanal.  Accordingly, as previously suggested, it would appear 
that cofactor stability is the major issue which is not allowing complete conversion.  All the 
other aspects may degrade partially over time, particularly over 16 hours, but it appears 
implausible they would prohibit complete conversion; the only other issue would be the 
position of equilibrium. 
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Similar to ADH D, there was a 3:1 ratio in observed product with 1-phenyl-1,2-propanedione, 
with the larger proportion being 1-hydroxy-1-phenyl-2-propanone.  No diol was observed.  
Contrastingly though, when 2,3-pentanedione was considered, instead of a 4:1 ratio as per 
ADH D, ADH F displayed a 5:1 bias in favour of 2-hydroxy-3-pentanone.  Again, no diol was 
observed.  Lastly, with regards to 2,3-butanedione, only acetoin was noted, no diol. 
The lack of activity with both ketone groups on the same molecule, even where diketones are 
preferred to the exclusion of monoketones, cannot be a result of cofactor degradation.  Even 
where cofactor is limiting, there would still be a small amount of diol present.  Whilst not 
impossible, it is exceptionally unlikely that the diol could be present, but below the limit of 
detection on the grounds that alcohols were virtually always detected with signal strength an 
order of magnitude greater than their equivalent ketones. 
3.3.5. SEQUENCE ALIGNMENT 
After ADH E, this sequence alignment is much more in keeping with the previous alignments, 
with a high level of sequence similarity, particularly with the most similar proteins in the NCBI 
RefSeq Database.  Particular highlights though are the two most similar crystal structures, 





Figure 127 - Multiple Sequence Alignment of ADH F with most similar protein sequences associated 
with crystal structures in the PDB and most similar protein sequences from the NCBI RefSeq Database 
obtained using the NCBI Seqr Sequence Search.  Green shading indicates 100% conservation, yellow 
shading indicates >80% conservation and red shading indicates >50% conservation of amino acids 
across selected sequences.   Labels refer to crystal structures from the PDB or proteins from the NCBI 
RefSeq Database.  All similar proteins are annotated as glyoxal reductases from the genera 
Geobacillus, Bacillus, and Anoxybacillus.  Crystal structures are annotated as: 3B3D is an AKR (YtbE) 
from B. subtilis, 3F7J is an AKR (YvgN) from B. subtilis, 4FZI is a prostaglandin F synthase from 
Typanosoma cruzi, 4F40 is a prostaglandin F synthase from Leishmania major, 1VBJ is a prostaglandin 
F synthase from Trypanosoma brucei, 4Q3M is an AKR from a Medee basin deep-sea metagenome, 
3O0K is an AKR from Brucella melitensis,  1MZR is an AKR (DkgA) from E. coli, 3WBW is an unknown 
oxidoreductase (Gox444) from Gluconobacter oxydans , 1VP5 is a 2,5-diketo-D-gluconic acid reductase 
(TM1009) from Thermotoga maritima .  Purple triangles indicate the active site residues and orange 
triangles indicate the catalytic triad.  All these sites provided via NCBI Conserved Domain Database 
and obtained through the Conserved Domain Search.   Sequences aligned using MEGA 6.0 (Tamura et 
al., 2013) with MUSCLE and visualised using Genedoc 2.7 (Nicholas et al., 1997). 
 
3B3D and 3F7J are NADPH dependent AKRs from B. subtilis, also known as YtbE (AKR5G2), and 
YvgN (AKR5G1).  The former is an essential enzyme, i.e. required for growth, as it is necessary 
for the removal of toxic aldehydes (Commichau et al., 2013).  The latter is involved with 
sporulation, but both have broad substrate scopes, from glyoxal to benzaldehyde derivatives.  
They have high (~70%) sequence identity with each other, in addition to being the most similar 
crystal structures to ADH F (Lei et al., 2009). 
As has been mentioned previously, many AKRs have a “safety belt” to secure the cofactor.  In 
such enzymes, the conformational change of the safety belt to release the NADP+ is believed to 
be rate-limiting.  In YvgN the residues involved are K26 and Q194, corresponding to K74 and 
Q258; no significant conformational change was noted.  In the case of YtbE, as there was a 
different residue (K74Q), no belt was observed (Lei et al., 2009).  ADH F has K74, but Q258R, 
and therefore isn’t clear a priori whether ADH F has a safety belt.  The catalytic triad is as 
annotated in Figure 127: D97, Y102, K131 and H164.  Unsurprisingly, these residues are 
identical throughout the MSA.  
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Although both YvgN and YtbE have a breadth of substrates, they prefer ortho-substituted 
rather than para-substituted benzaldehydes.  It is believed that N134, which is conserved in 
ADH F, may interact with the 4-group and thereby influence substrate specificity.  Of the 
substrates examined both enzymes preferred 2-chlorobenzaldehyde and 2,4-
chlorobenzaldehyde and less preferred benzaldehyde, methylglyoxal and glyceraldehyde as 
substrates.  No activity at all was detected with sugars such as glucose and fructose (Lei et al., 
2009). 
YtbE in particular has been taken forward for additional investigation, extending its substrate 
scope to include 2-chloroacetophenone, 2,2,2-trifluoroacetophenone, ethyl 4-
chloroacetoacetate and ethyl pyruvate, among others.  It was also determined to be 
monomeric in structure.  Another important feature is that the enzyme is exceptionally 
enantioselective, affording several substrates tested (including ethyl acetoacetate, ethyl 
pyruvate) as >99% enantiomeric excess.   With the exception of ethyl-2-oxo-4-phenylbutyrate, 
all products are S-alcohols (Ni et al., 2011).  Latterly YtbE has been investigated to perform the 
asymmetric reduction of o-chlorobenzoylformate to (R)-o-chloromandelate as a key 
intermediate in the production of (S)-clopidogrel, a medication for atherosclerosis.  In 
particular stabilising additives have been sought, to reduce the rate of degradation in 
preparation for an industrial scale operation.  Another route considered was to drop the 
operating temperature as low as 20 °C to improve the lifetime of the enzyme (Xu et al., 2014).  
Given the demand for this process and the poor thermostability of YtbE it would seem to be a 
high priority route for future investigation.  With the enhanced thermostability of ADH F and 
the demonstrated activity with similar substrates, this is a path of interest. 
4FZI, 4F40 and 1VBJ are prostaglandin F synthases, another type of NADPH dependent AKR.  
4FZI is the apo form of a prostaglandin F synthase from Trypanosoma cruzi, 4F40 is the apo 
form of a prostaglandin F synthase from Leishmania major, and 1VBJ is the same enzyme from 
Trypanosoma brucei.  Position 258 is key to stabilising the phosphate of NADPH, whether a 
serine or glutamine residue, which is important due to the relative flexibility of this area, which 
is exacerbated by a conformational change upon cofactor binding.  Thus by virtue of the 
cofactor binding to the enzyme becomes more stable (Moen et al., 2015).  It is worth noting 
that this is the same residue referred to in YtbE and YvgN studies as being relevant to the 
“safety belt”. 
To conclude, ADH F is the only ADH studied that has such similar crystal structures, due mainly 
to their being from B. subtilis.  With such closely related structures it would be prudent to use 
them as an example, particularly as the major noted problem with YtbE was a lack of 
thermostability, whereas a thermophilic enzyme is substantially more likely to be suitable.  As 
the catalytic tetrad is well defined and conserved, it is doubtful whether progress can be made 
in terms of determining any structural features, at least until a crystal structure is obtained.  
Two residues that may be of interest are M257 and R258, which are the only residues to be 
annotated as part of the active site and not be conserved, thus potentially those residues may 
be key to the substrate scope of ADH F.  
3.3.6. SUMMARY 
ADH F is by far the most interesting alcohol dehydrogenase isolated as part of this 
investigation.  With exceptional substrate scope and relatively high activity across the range, 
and the ability to use both NADH and NADPH, it is a promising enzyme for industrial use.  
Activity has specifically been confirmed with aliphatic, cyclic and aromatic aldehydes, 
diketones, alpha and beta ketoesters, as well as chlorinated and fluorinated examples of the 
above. 
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Further investigation is required in order to determine the exact products produced, and 
engineering of the enzyme may be necessary to promote a preferred product over another 
where multiple ketones are present on a substrate.  As monoketones are not substrates for 
this enzyme, in the absence of another electron withdrawing group, it would seem to be 
obligatory for that group to be present to enable reaction.  Thus, whilst it may prove that 
diketones, in particular 1-phenyl-1,2-propanedione, may be the preferred substrates for this 
enzyme, it may be beneficial to utilise this enzyme with substrates that only have one available 
ketone to reduce by-product formation. 
Some activity loss with higher levels of solvent has been noted, but this is less relevant when 

























3.4. ADH G 
The final ADH studied in detail is ADH G.  Although expressed well, it did not purify cleanly, as 
shown below.  The band corresponding to the larger protein was believed to be the actual 
protein; however, after considering the sequence alignments in Section 3.4.5, it can be seen 
that the original sequence was inaccurate.  Specifically the start codon was misannotated, 
leading to the incorporation of 34 additional amino acids at the N-terminus of the protein, 
which likely includes a ribosome binding site, and leading to two produced proteins.  Thus the 
smaller band indicates the expected protein, and the larger includes these extra amino acids.  
For the purposes of activity, it was assumed that all protein was identical and active, an 
assumption that is not ideal, but suffices for an initial investigation.   
 
 
Figure 128 - SDS PAGE gel of ADH G.  Lane 1: insoluble fraction, lane 2: soluble fraction, lane 3: 2
nd
 
flowthrough, lane 4: 0% His-Elute Buffer, lane 5: 1%, lane 6: 2.5%, lane 7: 5%,  lane 8: 10%, lane 9:  
30%,  lane 10: 100% His-Elute Buffer, lane 12: protein markers.  The numbers on the right indicate 
relative molecular masses (M r) of markers in kDa; the arrow indicates the putative ADH, with an 
expected Mr of 49.4kDa. 
 
3.4.1. SPECIFIC ACTIVITIES, SUBSTRATE SCOPE, CONVERSIONS 
As is usual, a primary and secondary substrate screen was run, with the primary substrate 
screen using the same substrates as previous. 
Based upon preliminary work it was determined that ADH G utilised NADPH exclusively, and 
therefore this cofactor was used throughout.  From the primary screen it was determined that 
the enzyme was an aldehyde reductase, with no ability to use ketones as substrates.  All 
aldehydes tested had some activity, although this varied.  Therefore, for the secondary screen 
several linear aldehydes and all other non-linear aldehydes were tested, to determine the 



























Ethyl acetoacetate - 
Benzaldehyde 2.3 
Pyruvate - 
Ethyl pyruvate - 









Ethyl 4-chloroacetoacetate - 
Ethyl 4,4,4-trifluoroacetoacetate - 
2',3',4',5',6'-Pentafluoroacetophenone - 
Figure 129 - Primary screen of ADH G with NADPH as cofactor.  
 







4-Nitrobenzaldehyde (Substrate Interference) 
Glyoxal 2.6 
5-Norbornene-2-carboxaldehyde 6.5 
Figure 130 - Secondary screen with ADH G and NADPH as cofactor. 
 
With the notable exception of 4-nitrobenzaldehyde, which interfered with the assay, all 
aldehydes tested throughout had activity, including methanal, glyoxal and large aldehydes.  
Thus, although activity noted was relatively low, rarely above 10 U mg-1, due to the very large 





Three of the more promising aldehyde substrates were taken forward to analyse their kinetics.  


























Figure 131 - Graph of rate of reaction vs [S] using ADH G and butanal.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 


































Figure 132 - Hanes-Woolf plot ([S]/v vs [S]) for ADH G and butanal.  Conditions: 50mM sodium 



























Figure 133 - Graph of rate of reaction vs [S] using ADH G and octanal in acetonitrile.  Data fitted to a 
Michaelis-Menten curve, assuming substrate inhibition, using the Levenberg-Marquardt algorithm by 


































Figure 134 - Hanes-Woolf plot ([S]/v vs [S]) for ADH G and octanal,  data fitted assuming substrate 


























Figure 135 - Graph of rate of reaction vs [S] using ADH G and 5 -norbornene-2-carboxaldehyde in 
acetonitrile.  Data fitted to a Michaelis-Menten curve using the Levenberg-Marquardt algorithm by 



































Figure 136 - Hanes-Woolf plot ([S]/v vs [S]) for ADH G and 5-norbornene-2-carboxaldehyde in 

























Figure 137 - Graph of rate of reaction vs [S] using ADH G and NADPH.  Data fitted to a Michaelis-
Menten curve using the Levenberg-Marquardt algorithm by Sigmaplot 12.  Conditions: 50mM sodium 
phosphate pH 7.0, 10mM butanal, 50 °C, 1ml assay volume. 
Hanes-Woolf
[Substrate] (mM)





























Figure 138 - Hanes-Woolf plot ([S]/v vs [S]) for ADH G and NADPH.  Conditions: 50mM sodium 






Substrate Vmax (U mg




Butanal 10.53±0.19 1.88±0.16 - 520 280 
Octanal 16.88±1.70 0.37±0.08 5.68±1.59 830 2300 
5-Norbornene-2-
carboxaldehyde 
5.46±0.28 0.21±0.04 - 270 1300 
NADPH 8.46±0.25 0.016±0.002 - 420 26000 
Table 30 - Summary of kinetic data obtained with ADH G. 
As noted with previous enzymes, it appears that ADH G has a preference for longer linear 
aldehydes despite the introduction of substrate inhibition.  When investigating octanal and 
5-norbornene-2-carboxaldehyde, both were prepared in stock solutions in acetonitrile.  This 
was necessary to obtain sufficiently concentrated stock solutions; however, even when added 
to the assay concentrations higher than those reported (5mM) resulted in occlusion of the 
assay.  Thus even when prepared in solvent, upon dissolution into buffer, there was clearly 
insufficient solvent to allow the substrates to mix fully.  
It was expected that being limited to such low concentrations of substrate would substantially 
impact upon the quality of the data obtained; however, the Michaelis constants of both 
enzymes were considerably lower than the 5mM threshold, meaning that in both cases the 
kinetics experiments were in excess of both the 3KM and 10KM points.  The only issue resulted 
in the broad error in calculating the Ki for octanal, which was estimated to be above the range 
of substrate concentrations tested. 
Strictly interpreting the specificity constants, it is not possible to determine a pattern in 
substrate acceptance based solely upon size of the substrate.  Given that octanal is preferred 
of the three substrates tested then the larger substrate 5-norbornene-2-carboxaldehyde, and 
then butanal the least, alternative substrates similar to octanal and larger should be tested.  In 
order to effect that, further solvent work is likely to be needed to solubilise the larger 
substrates in a monophasic system for study at the higher concentrations needed.  At a 
minimum it would be necessary to ensure that 5mM is maintained as a substrate 
concentration tested, which would prove difficult with larger substrates without higher levels 
of solvent. 
3.4.3. STABILITY ANALYSIS 
Given the lack of emphasis with this enzyme, only brief consideration of solvents was done, 
looking at operational solvents, or those that could be used for preparing stock solutions for 
substrates in kinetics work. 




1 86 52 99 
5 48 116 121 
10 45 133 113 
Table 31 - Solvent screen, ADH G, 10mM butanal, NADPH. 
Acetonitrile was chosen as the solvent of choice, with DMSO being totally unsuitable due to 
the immediate reduction in activity even with 1vol%.  Ethyl acetate was similarly discounted 
for its inactivating ability, although higher than expected results were obtained at 5 and 
10vol% tests.  As acetonitrile had little effect at low concentration, and perhaps an enhancing 
rate at higher concentrations, it was chosen as the best of the three. 
163 
When used to prepare stock solutions, both octanal and 5-norbornene-2-carboxaldehyde were 
prepared at 100mM concentration, meaning that the highest concentration tested, 5mM, 
corresponded to a 5vol% addition of solvent. 
 
 
Figure 139 - Thermostability test with ADH G, 60ºC, NADPH. 
Thermostability of the enzyme was tested twice during the investigation, both over three 
hours at 60 oC, to determine stability at an operational temperature rather than at elevated 
temperatures.  Given the apparent variance between the two substrates, both rates can be 













= 87 − 116 𝑚𝑖𝑛𝑠 
It should be noted that the difference in substrate should not affect the inactivation of the 
enzyme.  Therefore the variation noted is likely solely due to the relatively high scatter in the 
data and experimental variation.  The data give a range of 1.5-2.0 hours for the half-life of ADH 
G.  Further analysis of the enzyme, with regards to its optimal temperature, indicated that 60 
oC was its optimal temperature, with very rapid decrease in activity above this point, which 
implies that this enzyme is only stable at the lower end of G. thermoglucosidasius’ operating 
temperature.  
y = e-0.006x 
R² = 0.8245 
y = e-0.008x 
R² = 0.8846 
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Expon. (Butanal) Expon. (5-Norbornene-2-carboxaldehyde)
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Figure 140 - Optimal temperature study with ADH G, butanal as substrate and NADPH as cofactor. 
The thermal shift assay provided two inflection points, at 68.2 °C and 76.9 °C, although the 
second is very weak compared to the first.  This could be indicating a two-step denaturation 
process or it may be caused by having two different proteins produced, which would require 
purification to separate the proteins or recloning with the shorter gene.  Reanalysis of that 
protein would provide confirmation of the correct interpretation.  It may also be instructive to 
obtain the larger protein for additional validation, which may be possible through careful 
purification and isolation.  Alternatively removing the internal ribosome binding site from the 
expanded gene may be preferred. 
3.4.4. CHEMICAL ANALYSIS 
 Conversion 
Substrate 1 Hour 16 Hours 
5-Norbornene-2-carboxaldehyde 47% 11% 
Butanal* 9% 11% 
Furfural 28% Activity 
Methylbenzoyl formate - - 
Decanal 3% Activity 
Benzaldehyde 0% Activity 
4-Chlorobenzaldehyde 10% 12% 
2,3-Pentanedione 0% 0% 
2,3-Butanedione 0% 0% 
Table 32 - Summary of end point assays analysed by GC/MS carried out with ADH G.  *Suspected 
evaporation of substrate 
In accordance with the other enzymes, furfural, decanal and benzaldehyde results were merely 
quantitative in the 16h experiments, which limits the usefulness of the data obtained.  It is 
noticeable though that there is little effect of increasing the time from 1h to 16h in terms of 
4-chlorobenaldehyde conversion.  This substrate is likely the best example of the substrates 
tested here, and a fairly rapid denaturation of the enzyme is likely the root cause of this, even 




























3.4.5. SEQUENCE ALIGNMENT 
The first striking thing about the MSA is that it appears that ADH G has 34 additional amino 
acids appended to the N-terminus.  This has likely occurred because an early draft of the 
G. thermoglucosidasius genome was misannotated, indicating the gene started from the 
wrong methionine residue.  This mistake was unfortunately incorporated into the gene cloned 
into E. coli, probably along with a ribosome binding site.  Thus the two different proteins which 





Figure 141 - Multiple Sequence Alignment of ADH G with closest matches from the PDB and in the 
NCBI reference sequence database (obtained through NCBI Seqr Sequence Search).  All proteins 
annotated as butanol dehydrogenases (BuDH) from the genera Geobacillus and Bacillus.  Crystal 
structures are annotated as follows: 1VLJ is a BuDH from Thermotoga maritima , 4QGS is an aldehyde 
reductase (YqhD) from E. coli, 3BFJ is a 1,3-propanediol oxidoreductase from Klebsiella pneumoniae,  
3OWO is an iron dependent ADH from Zymomonas mobilis, 4FR2 is an ADH from Oenococcus oeni, 
1VHD is an iron containing ADH From Thermotoga maritima,  2BI4 is a lactaldehyde:1,2-propanediol 
oxidoreductase from E. coli, 3ZDR is the ADH domain of a bifunctional ADHE dehydrogenase from 
G. thermoglucosidasius, 1RRM is a lactaldehyde reductase from E. coli. MSA was conducted using 
default MUSCLE settings by MEGA 6.0 (Tamura et al., 2013).  Results were visualised using GeneDoc 
2.7 (Nicholas et al., 1997) with residues conserved across 100% of entries coloured green, residues 
conserved across 80% of entries coloured yellow and residues conserved across 50% of entries 
coloured red.  Blue triangles indicate dimer interface residues, purple triangles indicate active site 
residues and grey triangles indicate residues at the metal binding site.  All these sites provided via  the 
NCBI Conserved Domain Database and obtained through the Conserved Domain Search. 
 
1VLJ is a NADH dependent butanol dehydrogenase from Thermotoga maritima, but has not 
been published and thus shall not be discussed further. 
4QGS is an apo form of the NADPH dependent ADH, also known as YqhD, from E. coli.  This 
enzyme has been extensively studied and is a dimeric ADH of the iron-containing ADH family, 
although it contains zinc rather than iron in its active site.  This zinc ion is co-ordinated by 
D194, H267 and H281, corresponding to D244, H318 and H332, and matching the notation in 
Figure 141.  The remaining residue H198 (H248) is only co-ordinating in the apo structure; once 
the cofactor binds the conformational change means the residue forms a hydrogen bond with 
the cofactor instead.  The cofactor binds to two specific GGGS motifs, the first one at positions 
135-8, which is absolutely conserved among all sequences.  The second motif is at positions 
74-78, and this is not conserved amongst all sequences (Sulzenbacher et al., 2004).  For 
example 3OWO does not have this second motif, and has been previously described as a NADH 
dependent ADH.  Thus this motif is key to determining the cofactor specificity of these 
enzymes.  Other key residues for cofactor binding are D140 (conserved), N197 and G199 (not 
conserved), implying that these residues are also associated with cofactor specificity 
(Sulzenbacher et al., 2004).  Experimental evidence has also been obtained, with double 
mutant D140Q N197H both decreasing KM values and increasing kcat values with some 
substrates (Jarboe, 2011).  
Despite extensive testing with a variety of alcohols, aldehydes, amino acids and sugars, activity 
was only originally noted with a small range of alcohols.  Whilst these range from 1-propanol 
to benzyl alcohol, in no case was a Vmax>5 min
-1 reported, and KM values ranged from 5-35 mM 
(Sulzenbacher et al., 2004).  Subsequent investigation has provided additional information, 
with small aldehydes proving to be better substrates.  With KM values as low as 0.4 mM, and 
kcat values as high as 60 s
-1 butanal appears to the best substrate tested.  Activity was also 
noted with glyceraldehyde, isobutyraldehyde and furfural among other substrates (Jarboe, 
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2011).  This range of substrates has led to YqhD being utilised in a variety of metabolic 
engineering projects, but most notably isobutanol and other biofuel production (Ran et al., 
2008; Atsumi et al., 2010; Jarboe, 2011; Pick et al., 2013).  It is also notable that suppression or 
deletion of this enzyme confers furfural resistance to E. coli as the conversion of furfural to 
furfuryl alcohol consumes enough NADPH that the cell is overwhelmed; in particular cysteine 
biosynthesis is stalled.  One last key point is that YqhD has been suggested to have interfered 
with previous investigations into heterologously produced ADHs in E. coli due to its relatively 
low KM with butanal (0.5 mM).  High background rates have been noted and several ADHs 
studied over the last decades may have been affected (Jarboe, 2011). 
All other crystal structures have been mentioned previously.  3BFJ is a NADH dependent 1,3-
propanediol oxidoreductase from Klebsiella pneumoniae, a member of the iron-containing 
ADH family.  The residues annotated as co-ordinating the iron ion are the same ones that are 
annotated and are those conserved throughout the MSA.  The most obvious difference is that 
3BFJ is NADH dependent rather than NADPH dependent.  As mentioned, this appears to be 
associated with the loss of the GGGS motif at positions 74-78, and it is not present in 3BFJ.  
3OWO is an iron-containing ADH from Zymomonas mobilis.  It is NAD+ dependent, oxygen 
sensitive, dimeric and its native role is to convert ethanal to ethanol to provide NADH as part 
of the cytosolic respiratory system.  In place of the NADPH associated residues mentioned 
above, there is D39 (D71), a key residue to ensure NADH dependence.  Unlike ADH E, ADH G 
does not have the same residues noted with 3OWO to regulate substrate specificity, F149 and 
F254 (F199 and F307). 
Lastly, 4FR2 is an ADH from Oenococcus oeni. A dimeric enzyme that is NADH dependent, it 
shares many of the same features as 3OWO.  Although a member of the iron-containing ADH 
family, the active site contains nickel and is entirely inhibited by zinc.  The enzyme can catalyse 
a wide range of small aldehydes and alcohols including 1,2-propanediol, 1,3-propanediol, 
glycerol, butanal and 2-propanol (Elleuche et al., 2013). 
To conclude, this MSA appears to have both NADH and NADPH dependent enzymes as the 
most similar to ADH G.  Fortunately it appears to be easy to determine which cofactor a given 
enzyme would be able to accept, due to easily identifiable and conserved residues.  That said, 
there are a very large number of residues annotated as being relevant to the active site, dimer 
interface and co-ordinating the metal, and it is only the latter residues that are all conserved.  
The majority of residues annotated as being important in the active site are only conserved 
amongst the most similar proteins and not the crystal structures.  The presumption is that 
these residues are related to the substrate specificity of the enzymes.  The residues involved 
with cofactor binding have been identified and are conserved entirely, yet both dimer residues 
and activity residues, despite annotation, there is no definitive evidence to prove their cases.  
 
3.4.6. SUMMARY 
ADH G is a relatively insignificant enzyme in terms of its industrial relevance.  A broad 
spectrum aldehyde reductase with relatively low activity, its general weakness at higher 
temperatures and variable reaction to solvents would seem to remove any particular 
advantage of this enzyme over any other.  That said, it does have potential in converting 
particularly complex aldehydes, and therefore should be considered for such purposes if a 
recalcitrant substrate should appear.  It is a certainty that the full substrate scope for this 
enzyme has yet to be elucidated.  
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4. DISCUSSION AND FURTHER WORK 
The results obtained in this work will be discussed in further detail in this section, with 
reference to their biological relevance and potential industrial significance.  Where additional 
work is likely to be required to facilitate a better understanding this will be clearly indicated. 
4.1. RESULTS SUMMARY 
All specific activities obtained with alcohol dehydrogenases in this study are compiled in Table 
33 to better enable comparisons to be made.  In broad terms a typical specific activity 
obtained is in the region of 1-100 U mg-1, with only ADH E exceeding this with specific activities 
recorded of nearly 400 U mg-1.  Notably, however, ADH E had a much more restricted substrate 












Methanal  0.9  0.1 0 0.4 
Ethanal 56  362    
Propanal 79  376 0.7 0 2 
Butanal 95 10 227 1 5 8 
Pentanal 30      
Hexanal 0.8  99 5 0.6 9 
Octanal   280 7 2 12 
Decanal  4 9 0.3 2 7 
Isobutanal  9 7 1 5 0.5 
Glyoxal  12 0 12 14 3 
3-Methyl butanal  0 0    
2-Butanone 76 0 0 0 0 0 
2-Pentanone 25      
2-Hexanone 2      
Acetoin 33 0     
2,3-Butanone  13 0 16 24  
3-Methyl-2-butanone   0 0 0.1 0 
2,3-Pentanone  6 6 14 11 0 
3-Pentanone  0 0 0 0 0 
2,4-Dimethyl-3-pentanone  0     
2,3-Hexanedione  11 4 20 22  
2,5-Hexanedione  0 0 0 0  
3,4-Hexanedione  3 3 8 2  
2,3-Heptanedione  11 3 21 33  
3-Hexanone 0.4      
2-Decanone  0 0 0 0 0 
Cyclohexanone  0 0 0 0.9 0 
Furfural  7 122 3 9 5 
Acetophenone  0 0 0 0.3 0 
Methyl acetoacetate  0.4  0.6 0  
Ethyl acetoacetate  0.6 0 0.1 1 0 
Benzaldehyde  7 3 5 8 2 
4-Chlorobenzaldehyde  19 0 5 4 5 
Pyruvate  0 0 0 0.1 0 
Ethyl pyruvate  3 0 6 3 0 
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Ethyl levulinate  0 0 0 0.1 0 
Levulinate  0 0 0 0 0 
α-Tetralone  0 0 0 0  
Benzophenone  0  0 0  
Benzoin  +  0 0  
Benzil  0  0.3 0  
5-Norbornene-2-carboxaldehyde  13 0 10 7 7 
1-phenyl-1,2-propanedione  11 0 21 11 0 
Ethyl 2-chloroacetoacetate  9  12 11  
Methyl 4-chloroacetoacetate  3     
Ethyl 4-chloroacetoacetate 91 5 0 5 2 0 
Ethyl 4,4,4-trifluoroacetoacetate 0.1 0 0 0.7 3 0 
6-Methyl-5-hepten-2-one 0      
4-Phenyl-2-butanone 0 0 0 0 0.3 0 
2,2,2-Trifluoroacetophenone 0 0 0 3 9  
Ethyl-2-oxo-4-phenylbutyrate 0.9 7 0 2 4 0 
2',3',4',5',6'-
Pentafluoroacetophenone 
 0 0 0.3 3 0 
2,2’,4’-Trichloroacetophenone    2 0  
4’-Chloroacetophenone    0.2 0  
4’-Bromoacetophenone    0.4 0  
2-Chloroacetophenone    0.2 0  
Propiophenone    0 0  
Table 33 - Consolidated results of specific activities noted with all ADHs studied. No specific activities 
available for ADH A or ADH C; gaps indicate substrate not tested. + Unquantified Activity.  All figures 
given in U mg
-1
 
Due to the method of screening, involving a common primary screen and an ad hoc secondary 
screen based upon each enzyme’s activities, it has been possible to make comparisons 
between each enzyme.  For example, where an ADH has shown activity with methanal, it is 
always relatively low, as this substrate is known to be particularly harsh on enzymes.  In the 
case of the industrially related substrates, with the exception of ethyl 4-chloroacetoacetate, all 
the highest specific activities are noted with ADH D and ADH F, which is why these two 
enzymes were particularly heavily studied. 
4.2. NATIVE ROLE FOR ALCOHOL DEHYDROGENASES 
The first two ADHs that will be considered are ADH D and ADH F as they were the most heavily 
studied in this investigation. Both are annotated on the National Center for Biotechnology 
Information (NCBI) database as Aldo-Keto Reductases, with the former being described as an 
aryl-alcohol dehydrogenase, and the latter as a methylglyoxal reductase.  With estimated sizes 
of 35.5kDa and 31.5kDa (315 and 275 residues) respectively and with both enzymes being 
heavily conserved throughout the genera Geobacillus, Bacillus, Anoxybacillus, and many other 
related genera, it is likely that the annotation is at least approximately accurate. 
That said, there is certainly similarity to other AKR families, with ADH D and similar proteins 
being annotated as a “Voltage Gated Potassium Channel Beta Subunit” as well, both on the 
NCBI database and elsewhere, which is another AKR family.  ADH F is not similarly affected, 
with annotation referring either to glyoxal reductase or aryl-alcohol dehydrogenase. 
Whilst the assumption could be made that ADH D and ADH F are similar enzymes, which their 
substrate profiles would suggest as much as their annotations, this would not be correct.  Their 
sequence similarity is very low (26% identity) and thus despite their apparently similar 
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substrate profiles are unlikely to perform similar functions in vivo.  Noting that ADH F is similar 
to the Bacillus subtilis AKRs YvgN and YtbE (67% identity), which have been previously studied 
(Lei et al., 2009), then the B. subtilis putative functions should be considered.  YvgN is believed 
to be involved in sporulation, whereas YtbE is known as essential to B. subtilis for the removal 
of toxic aldehydes (Commichau et al., 2013).  Both, however, catalyse the reduction of 
aldehydes to their respective alcohols. 
ADH D is expressed natively at reasonably high levels, 0.099% of total RNA under anaerobic 
conditions and 0.066% under aerobic conditions; ADH F is barely expressed at all, 0.016% of 
total RNA under aerobic conditions and 0.012% under anaerobic conditions (Leak et al, 
unpublished).  A low but constant expression of ADH F would be consistent with detoxification, 
and high expression of a putative sporulation enzyme is somewhat inconsistent.  Whilst 
G. thermoglucosidasius does form spores, it is only known to do so under stress, thus it seems 
more likely that ADH F has a function similar to B. subtilis AKR YtbE, although more work is 
likely to be needed to conclusively prove this. 
Consulting the placement of the gene encoding ADH D, it appears to be the first gene in a 9 
gene cluster or operon annotated with reference to sugar transport and particularly mannitol.  
Notably, another alcohol dehydrogenase is incorporated into this cluster as well.  As AKRs are 
also known for aldose reduction as well as alcohol reduction, this could imply that ADH D is 
natively related to sugar transport and utilisation.  This cannot be refuted or confirmed by the 
substrates investigated as alcohols and sugars were not tested.  Therefore the first steps 
towards confirming this hypothesis should be to test ADH D with a range of new substrates, 
specifically mannitol, mannose and related hexoses, to determine activity.  If confirmed, gene 
deletion may provide an insight into the native role of ADH D.  As G. thermoglucosidasius is 
able to utilise both mannitol and mannose (Fong et al., 2006), a strain deficient in ADH D 
should have a slower growth rate than normal or be unable to grow entirely when grown 
exclusively on these carbon sources. 
It is less likely to be possible to determine the detoxification effects of ADH F by simply 
removing the gene as with ADH D.  As demonstrated with the similar substrate profiles of ADH 
D and ADH F, even if ADH F were removed, there will be an alternative enzyme able to replace 
it.  
The other ADHs studied have a variety of annotations.  ADH A is well known as the 
G. thermoglucosidasius variant of the AdhE bifunctional enzyme, ADH B is annotated as a 
threonine dehydrogenase, zinc-dependent alcohol dehydrogenase and a member of the MDR 
superfamily, ADH E is indicated as a bifunctional ADH/aldehyde dehydrogenase and a member 
of the iron containing ADH superfamily, and ADH G is annotated as an NADH dependent 
butanol dehydrogenase and member of the iron containing ADH superfamily. 
Turning first to gene placement, the gene encoding ADH B is not associated with any further 
genes that would provide an indication as to the in vivo role of the enzyme.  It is of note that it 
is very highly expressed under aerobic conditions, but almost entirely suppressed under 
anaerobic conditions, with 0.338% of total RNA and 0.009% respectively.  This could be an 
indication that ADH B is directly involved with primary metabolism, specifically aerobic 
metabolism.  As ADH B utilises NADH as a cofactor and is annotated as a zinc containing 
member of the MDR family, then this implies that it has dehydrogenase activity in vivo.  From 
the substrates tested this would mean that either 2-butanol or 2-propanol are the preferred 
substrates of this enzyme. 
The position of the gene encoding ADH E would support the hypothesis that this enzyme is 
involved in propanal removal, being in a 15 gene cluster annotated as involved in converting 
171 
1,2-propanediol to 1-propanol via propanal, as well as the utilisation of ethanolamine.  During 
the course of this investigation it has been shown that ADH E has a very high activity with both 
propanal and ethanal.  Therefore whilst propanal degradation is the most likely in vivo 
purpose, this does not preclude the possibility there ADH E is also involved in ethanolamine 
degradation as well.   It appears to be very poorly expressed under aerobic or anaerobic 
conditions, with approximately 0.005% of total RNA in both conditions. 
In the case of ADH G, its gene is adjacent to a number of sugar transporters, a gene annotated 
as coding for glucose-6-phosphate isomerase and a lac repressor gene.  This implies that ADH 
G is involved with the glycolysis pathway in some manner, although the exact manner of this 
relationship is difficult to say without additional work.  One of the most similar available crystal 
structures refers to an E. coli ADH designated YqhD, which has activity with a variety of small 
aldehydes and alcohols, which is similar to the noted activities of ADH G.  It has also been 
determined that YqhD is required for 1,3-propanediol production, and has been used to 
produce 1,2-propanediol (Jarboe et al., 2010), but these are not necessarily natural reactions 
for this enzyme.  It is proposed that the native substrate is an alcohol longer than C3 
(Sulzenbacher et al., 2004), but this is only based upon kinetics.  Therefore at this time it is not 
possible to definitively identify the in vivo role for either YqhD or ADH G.  Whatever the exact 
role performed by the enzyme, it is expressed moderately well in aerobic conditions (0.023%) 
and slightly better under anaerobic conditions (0.036% of total RNA). 
 
4.3. INDUSTRIAL RELEVANCE OF ENZYMES 
Again considering ADH D and ADH F first, both have substantial industrial relevance in terms of 
their substrate profiles and other features.  Taken together, their substrate profiles include 
aldehydes and ketones of significance including: 
Substrate Industrial Use 
5-Norbornene-2-carboxaldehyde Polymers 
1-Phenyl-1,2-propanedione Pharmaceuticals 
Ethyl 4-chloroacetoacetate Statins 
Ethyl-2-oxo-4-phenylbutyrate Pharmaceuticals 
2,2,2-Trifluoroacetophenone* Liquid Crystals 
2',3',4',5',6'-Pentafluoroacetophenone* Pharmaceuticals 
Table 34 - Industrially relevant substrates that ADH D and ADH F have demonstrated activity with.  
*ADH F only. 
Both ADHs D and F demonstrated potential with the above substrates; however, issues were 
noted with the chemical analysis, attributed to cofactor degradation.  For the purposes of 
analysis, this could be avoided by increasing the enzyme volume used, to ensure that the 
reaction completed ahead of the cofactor degrading.  Whilst it is highly likely that the cofactor 
is the issue, it is worth confirming this before committing to any further large scale work by 
conducting an assay over several hours, adding further cofactor on an hourly basis.  This 
should prove that cofactor degradation is the root cause of the issue.  Irrespective of which 
component degrades, additional enzyme added at the start of the reaction should allow for a 
final conversion to be determined. 
It is notable that ADH D was able to convert 95% of the substrate 5-norbornene-2-
carboxaldehyde, and ADH F also performed well with this substrate, converting 78% after one 
hour.  ADH F is especially likely to benefit from improving cofactor stability, particularly with 
NADH, due to the high KM value noted.  The relatively high conversion rates for 5-norbornene-
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2-carboxaldehyde give confidence that this is a fruitful area for further work, and should be 
prioritised to see if other substrates can be catalysed to such a high level.  Continuing to work 
with a two-enzyme, two-substrate based system with a GDH will ensure that the reaction can 
be forced to completion, which should rule out issues with the position of equilibrium. 
A further industrial consideration is cofactor regeneration itself.  Presuming that cofactor 
degradation is minimised, perhaps by a change of buffer, reduction in temperature of reaction, 
or via stabilising additives, then the regeneration of the cofactor is also an issue.  Whilst using 
a GDH is acceptable at bench scale, continued use at pilot scale or above is likely to be 
problematic.  Although the continual decrease in pH can be mitigated by effective monitoring 
of the bioreactor and the gradual addition of sodium hydroxide or similar alkaline, this 
represents a cost.  It will also increase the ionic strength of the buffer, which may cause issues 
with the reaction – this can be tested if it is the preferred route.  An alternative approach 
would be to utilise a second ADH to regenerate the cofactor with either isopropanol or ethanol 
as a sacrificial substrate.  Recommendations may include ADH B and ADH E, should further 
testing indicate that either enzyme is suitable for this task.  ADH E would need to be tested 
with alcohols; however, in principle both could be used to regenerate NADH, and ADH E may 
be useful in regenerating NADPH. 
As both ADHs D and F converted 1-phenyl-1,2-propanedione into two products, 1-hydroxy-1-
phenylpropan-2-one and 2-hydroxy-1-phenylpropan-1-one, this may be problematic for 
industrial use.  The exact proportions of these products can only be confirmed once work has 
been done to ensure that the reactions run to completion or as far as can the reaction can be 
pulled via the GDH.  It may prove that for such substrates these enzymes are simply unsuitable 
without engineering the enzyme to manipulate the conversion ratios but this will entail a 
substantial period of work including obtaining a crystal structure of the enzyme and 
determining how the substrates are catalysed.  Site saturation mutagenesis of target residues 
in the active site and further assaying with the substrates may then result in a mutant with the 
ability to convert 1-phenyl-1,2-propanedione into the required product. 
Following on from the issue of multiple products from catalysis of a diketone, the next stage of 
chemical analysis with these ADHs will be to determine if they produce enantiopure products.  
As chiral synthesis is the major advantage of utilising enzymes over chemocatalysis, aside from 
environmental consideration, then it is of critical importance to determine the enantiomeric 
excess of the products formed. 
ADH D has demonstrated substantial solvent resistance, with no negative effects noted with 
up to 20vol% of acetonitrile, ethyl acetate and CPME.  ADH F is less tolerant of solvents, but 
still retains substantial activity in the presence of the same solvents.  Interestingly, it appears 
to be resistant, or perhaps activated, by low levels of hexane.  Therefore there is a prima facie 
case for industrial processing in the presence of solvents for both enzymes, which are likely to 
be required in order to facilitate high concentrations of substrate and product. 
Due to the aforementioned high concentration of substrate necessary for a viable industrial 
process, it is necessary to ensure that enzymes are able to tolerate higher levels of substrate 
and product.  There are alternative methods, such as immobilising enzymes or operating in fed 
batch mode, to avoid excessive substrate concentrations; however, it is generally easier to 
ensure that the enzymes to be utilised in an industrial process are able to cope with expected 
concentrations of substrate and product.  No substrate inhibition was detected when working 
with ADH D, and ADH F only demonstrated substrate inhibition in rare cases, with estimates of 
Ki typically falling either on the border of substrate concentrations tested, or outside the range 
used.  To elucidate whether the enzymes are suitable for a full scale industrial process then 
substrate concentrations of at least 100mM, and preferably >500mM should be tested.  It is 
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unlikely that testing such concentrations will be simple, due to hydrophobicity of the larger 
substrates.  Through judicious use of relevant solvents it may be possible to reduce or 
eliminate substrate inhibition entirely by keeping to a biphasic system; for example, whilst the 
substrate and product may have solubilities in excess of 1M in hexane, even with 20vol% 
solvent, there may be a very limited substrate concentration exposed to the enzyme in the 
aqueous phase.  Typically this is how such substrates are catalysed by isolated enzymes in 
industrial processes. 
If the above recommendation of using ADH E to regenerate the cofactor is explored, then it 
may be possible to utilise the sacrificial substrate as a cosolvent to create a monophasic 
environment.  In the case of ADH E, it would have to be ethanol as solvent, and would 
necessitate testing both ADH E and the primary ADH (either D or F) to determine whether such 
a system was stable.  If so, this could be a particularly beneficial use of operating at 
thermophilic temperatures, as the ethanal by-product can be driven off very easily and even 
collected for further use, allowing the reaction to be pulled to completion whilst also easing 
purification downstream. 
With reference to the other ADHs studied, ADHs B and E are likely to have usefulness as 
cofactor regeneration systems far beyond solely with other G. thermoglucosidasius enzymes.  
In particular ADH E, with very high activity when used with NADH, should be tested for activity 
in the reverse direction.  Ethanol or propanol as cosolvents and sacrificial substrates would be 
particularly beneficial due to the boiling points of ethanal and propanal of 20 oC and 50 oC 
respectively.  As the putative in vivo role for this enzyme is as a dehydrogenase, operating 
conditions may need to be adjusted to ensure a high rate of reaction in the appropriate 
direction for cofactor regeneration. 
Other potential industrial uses for ADH B would be in the production of statins, through the 
utilisation of ethyl 4-chloroacetoacetate as substrate.  Due to ADH B also accepting small 
alcohols, it may be possible to establish a two-substrate one-enzyme cofactor regeneration 
system by using ethanol, isopropanol or similar alcohol as cosolvent.  The most efficient 
method for preparing such a system would be to determine the resistance of ADH B to using 
10vol% or 20vol% alcohol as a cosolvent, and establishing whether production of ethyl 3-
hydroxybutyrate can be maintained in the presence of high quantities of sacrificial alcohol. 
Further afield, both ADH B and E have demonstrated potential in the area of bioremediation 
due to their high activity with a range of small substrates.  There are a range of unusual 
industries with issues in dealing with volatile aldehydes and ketones including the aluminium 
industry (Laird et al., 2013), human waste management (Lin et al., 2013) and explosives 
remediation (Singh et al., 2008); wherever volatile aldehydes and ketones pose a risk to health 
or the environment, alcohol dehydrogenases may be considered as a potential mitigation step.  
In many instances recovery of these volatile organic compounds would be necessary, or some 
kind of in situ system designed to allow biocatalysis to be utilised.  This is not a trivial step to 
take, and would necessitate enzyme or organism lifetime to be determined.  Utilisation of 
enzymes in such environments is likely to be a relatively long term objective. 
Whichever field the ADHs may be suitable for, once a particular industrial process or task has 
been identified as appropriate for an ADH, the next stage of the feasibility study will be to 
utilise model reactions as appropriate for that process.  This is likely to involve scaling up 
reactions substantially, to produce grams of product at a time, necessitating larger amounts of 
enzyme. 
In order to produce such large quantities of enzyme in a timely fashion, optimisation of the 
production and purification method is required.  This was not carried out as sufficient enzyme 
174 
was always produced for study.  Typical parameters to consider in expression might be: IPTG 
concentration, length of time prior to and post induction, media composition and temperature 
of production.  Alternative approaches may include considering promotor modifications or 
attempts at extracellular production and attempts to reduce inclusion body formation. 
From the purification side, it may be expedient to continue using IMAC, but it is likely that 
future work will have to consider alternative methods of purification based upon the enzyme’s 
properties, and how this may affect the stability of the enzyme. 
4.4. ADDITIONAL AREAS FOR INVESTIGATION 
Given ADH F is annotated as an AKR and has substantial activity with NADH, then this enzyme 
has substantial biological significance and should be subject to further investigation as activity 
with NADH is relatively rare (Di Luccio et al., 2006).  In particular, the full potential of ADH F 
using NADH as a cofactor should be examined, as it seems likely from work conducted thus far 
that higher activities may be possible with NADH rather than NADPH.   
In addition, from previous work undertaken with the B. subtilis AKRs, it seems likely that the 
preferred substrates of ADH F have not yet been identified (Lei et al., 2009).  Comparing with 
the range of substrates tested in this work, all that can be said is that the preferred substrates 
analysed in both cases have kinetic constants of similar magnitude.  As completely different 
substrates were chosen for ADH D and F compared to YtbE and YvgN, it may be productive to 
consider screening both ADHs for activity with the same range of aldehydes, e.g. 2-
chlorobenzaldehyde and 2,4-dichlorobenzaldehyde, and consider analysing the kinetics with 
substrates that have already been demonstrated to have activity with ADH D and F, such as 
benzaldehyde, 4-chlorobenzaldehyde and glyoxal.  Not only is determining the substrate scope 
useful in and of itself, determining whether either ADH D or ADH F have identical or differing 
substrate promiscuity to B. subtilis enzymes with known activities would be enlightening.  As 
thermophilic AKRs are relatively understudied at present, with few present in the literature, 
comparisons between mesophilic and thermophilic AKRs in similar genera should be a target 
(Drury and Penning, n.d.; Willies et al., 2010). 
With >60% amino acid identity to B. subtilis AKRs previously mentioned, this means ADH F can 
be tentatively assigned the designation AKR5G4, family 5, subfamily G (Drury and Penning, 
n.d.).  Due to low sequence identity, ADH D is harder to place within the AKR superfamily; 
however, by annotation it is likely to fall within family 6 with the other potassium channel 
proteins, tentatively assigned as AKR6D1.  Accurately placing these thermophilic AKRs within 
the wider AKR superfamily would allow for further comparisons with similar mesophilic 
enzymes and therefore should be considered. 
Stepping back from concentrating on ADHs A through G, other enzymes have been isolated 
during this investigation that due to time constraints, have not been considered.  In total, 
eighteen putative ADHs were investigated to some degree.  All those not previously mentioned 






4.5. SUMMARY OF IMPLICATIONS FROM SEQUENCE ALIGMENTS 
There are some additional points raised from the sequence alignments which may inform the 
direction of further work: 
 
 ADH B may have no enantiospecificity, and it may also be possible to raise the Tm of 
ADH B by a changing a single amino acid. 
 ADH D may be the founding member of a new subfamily of AKRs, and the enzyme may 
have an in vivo role of cofactor recycling rather than the production of aldehydes, 
ketones or alcohols.  A crystal structure is likely to be particularly helpful in 
determining the likely in vivo role, as is investigation of the G. thermoglucosidasius 
sugar uptake system. 
 ADH E has very few highly similar sequences available, and therefore it may be useful 
to obtain a crystal structure of this enzyme as well.   This is reinforced by the 
substantially different activity recorded with ADH E and its most similar enzymes.  It 
may be possible to alter the co-factor specificity of ADH E relatively easily by altering 
one or few amino acids.  If proven then this could allow the enzyme to be used as a 
thermophilic cofactor regeneration system.  The presence of a metal ion in ADH E may 
also be of substantial interest, given the range of ions in similar enzymes. 
 ADH F may have significant industrial relevance as a similar enzyme has already been 
considered in the production of pharmaceutical intermediates, yet lacks stability at the 
necessary temperatures.   
 































For clarity, the methods used have been split into chronologically arranged sections.  In 
addition, where relevant, distinction is made between methods used in Chapter 2 and those 
used in Chapter 3. 
5.1. MOLECULAR BIOLOGY 
All genes encoding the enzymes under study were identified using publicly and privately held 
genome sequences of G. thermoglucosidasius with the privately held sequence taking 
precedence.  The publicly available sequence is held by the National Center for Biotechnology 
Information and is G. thermoglucosidasius C56-YS93.  The private genome, TM242, is owned 
by TMO Renewables, and held by RAST, Rapid Annotation using Subsystem Technology (Aziz et 
al., 2008). Throughout this thesis, internal designations have been used to avoid confusion, 
and a full list of all designations is available in Section 7.1.  
Suitable primers were designed by standard methods, aiming to create as lengthy primers as 
possible to ensure their Tm was approximately 72 
oC.  Dimers and cross dimers were restricted 
and hairpins severely restricted by the use of introduced silent mutations and by altering the 
six nucleotides appended to the beginning of each primer.  Silent mutations were added 
wherever possible by referral to an estimated codon bias table for E. coli such that any altered 
codons were at least as common in the species as not to affect expression adversely. 
In brief, the primer design process was as follows: 
1. It was determined whether restriction enzymes cut through a gene of interest, using 
NEBcutter v2.0 (Vincze et al., 2003) 
2. Using Artemis (Rutherford et al., 2000) to visualise the sequence, an initial sequence 
for primers was created, using the generic schematics: 
a. Forward Primer: [NNNNNN][NheI Site][First 30 bases of gene, skipping initial 
start codon] 
b. Reverse Primer: [NNNNNN][XhoI Site][Reverse complement STOP 
(TAA)][Reverse Complement last 30 bases of gene] 
3. Dimers, cross dimers and hairpins were analysed using NetPrimer (Premier Biosoft).  If 
dimers rated above 8 kJ mol-1, cross dimers rated above 8kJ mol-1 or hairpin rated 
above 3kJ mol-1, then silent mutations were added to ameliorate the situation. 
4. Manual iterations were conducted until the above conditions were satisfied.  In 
addition, the size of primers was increased or decreased as necessary to ensure that 
the estimated Tm was approximately 70 °C. 
A list of primers used is in Section 7.2, and in all cases presented the restriction enzymes 
utilised were NheI and XhoI, with the plasmid pET28a used.  E.coli cloning strains JM109 and 
BIOblue were used, and the expression strain BL21 (DE3) pLysS was used, with the exception of 
ADHs 2 and 4, where BL21 (DE3) was used instead.  
Polymerase chain reactions were carried out using genomic DNA from the TM242 strain of 
G. thermoglucosidasius, extracted using a soil microbe DNA miniprep kit (Zymo Research), and 
per manufacturer’s protocols.  The PCR protocol was adapted based upon the Tm of the 




1. Initial Denaturation Step:  98 oC for 60 seconds 
2. Denaturation Cycle:   98 oC for 20 seconds 
3. Anneal Cycle:    70 oC for 20 seconds 
4. Elongation Cycle:   72 oC for 60 seconds 
5. Termination Step:   72 oC for 5 minutes 
The components for a typical PCR were: 
 10µl High Fidelity Buffer 
 1µl dNTPs 
 2.5µl of each primer (from 10x diluted stocks)* 
 1µl genomic template** 
 32.5µl ultrapure water (Milli-Q) 
 0.5µl Phusion enzyme 
*Primers were obtained from Eurofins desiccated, and prepared as per their instruction.  A 10x 
dilution was taken as a working primer stock.  ** In repeat PCR 0.5µl of previous PCR product 
or digested DNA has also been used. 
This was run using Phusion High Fidelity DNA Polymerase (NEB), and typically 20-30 cycles.  
The annealing temperature was initially determined by the lowest primer Tm +3 
oC, or 72 oC, 
whichever was lower.  This temperature was the only one changed, and was occasionally 
varied depending on PCR success.  With particularly intractable examples, a gradient PCR was 
applied, whereby the anneal temperature was varied whilst maintaining the same 
temperatures in other stages.  This made it possible to test multiple temperatures, perhaps 
varying as much as 20 oC, at one time.  After this, typical anneal temperatures were markedly 
dropped to approximately 60 oC, which proved to be more effective than previously 
recommended temperatures. 
PCR products were then analysed by standard DNA gel electrophoresis, using gels made from 
70ml TAE buffer (Tris-acetate-EDTA buffer with final concentrations of 40mM Tris, 20mM 
acetic acid and 1mM EDTA), 1wt% agarose.  DNA was visualised using by adding 3.5µl Sybrsafe 
(Thermofisher Scientific) to the molten gel and UV light.  Relevant portions of the gel were 
excised and the DNA was purified using the Wizard Quick Protocol for PCR clean up by 
centrifugation, utilising the relevant kit. 
The PCR products were then analysed by Nanovue to determine the exact concentration of 
DNA present, which was then digested for one hour at 37 oC.  A standard 30µl digest would 
comprise 24.5µl of the PCR product or host plasmid, 3µl of the relevant buffer, 0.5µl Bovine 
Serum Albumin if required (not needed after the manufacturer released new buffers), and 
0.5µl of each restriction enzyme, typically NheI and XhoI (both NEB).  Typically approximately 
1µg of DNA was added to each digest or 24.5µl if the concentration was insufficient. 
Post digest, the DNA was purified, following the Wizard Quick Protocol again.  Ligation was 
carried out overnight at 16 oC or for one hour at room temperature.  Typical ligations were 
carried out at a volume of 30µl, using 3µl T4 DNA ligase buffer and 1µl T4 DNA ligase.  The 
remainder is comprised of PCR product digest and plasmid digest; however, the exact volumes 
of either depend on the concentration of DNA.  The concentrations of each were determined 
by Nanovue and ratios of insert to plasmid varied considerably, with ratios of 6:1 to 1:3 
typically used. 
Ethanol precipitation was the next step, with all components kept on ice prior to and during 
this step.  To each ligation 3µl 3M sodium acetate (pH 5.2), 82.5µl 100% ethanol and 1µl 
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dextran blue dye was added.  After gentle vortexing to mix all components and left on ice for 
30 minutes, each precipitation was centrifuged at 14000 rpm in a VWR microstar 17 centrifuge 
at 4 oC for one hour.  The supernatant was then gently removed and 100µl 70% ethanol was 
then gently added and removed immediately, without disturbing the DNA pellet.  The pellet 
was then dried at room temperature for 15-30 minutes, as necessary to ensure complete 
evaporation of the ethanol. 
Transformations were prepared by suspending the plasmid in 20µl Milli-Q water, vortexing 
very gently as necessary.  Electrocuvettes and E. coli JM109/BIOBlue samples were buried 
entirely in ice for at least 30 minutes and LB media was prewarmed at 37 oC for the same 
duration.  When all components were ready 5µl of DNA was added to an aliquot of E. coli and 
added directly to the chilled electrocuvette and electroporated at 1.8kV using a Genepulser 
XCell (Biorad).  Expediently as possible, 1ml of the prewarmed LB media was then used to wash 
out the transformed E. coli into a 50ml falcon tube.  The tubes were then incubated at 37 oC, 
shaken vigorously throughout. 
After the recovery period 100µl of the transformants would be directly spread to an LB plate 
containing relevant antibiotics (typically kanamycin) and the remainder briefly centrifuged 
(8000 rpm for 5 minutes), resuspended in 100µl of the drawn off supernatant and plated onto 
a second LB plate.  Both plates were incubated statically overnight at 37 oC, perhaps left as 
long as 24-30 hours to encourage larger colonies. 
Should transformant colonies grow, then they would be individually picked using a sterile 
pipette tip, carefully transferred onto a fresh plate, with the tip then being washed into a PCR 
tube for colony PCR analysis.  Typically up to 20 colonies would be picked in this manner, if 
that many were present.  The colony PCR was comprised of 15µl Red Taq (Sigma Aldrich), 1.5µl 
of each T7 primer (diluted ten-fold), 11µl Milli Q water, and the tip would be vigorously 
washed into this.  T7 primers were chosen as they are present on the pET28a plasmid used for 
transformation, and allows for batches to be made at one point, allowing for multiple colony 
PCRs using different putative transformants to be tested simultaneously. 
Colony PCRs were carried out slightly differently from previous PCRs: 
1. Initial Denaturation Step:  98 oC for 2 minutes 
2. Denaturation Cycle:   98 oC for 20 seconds 
3. Combined Anneal:   50 oC for 30 seconds 
4. Elongation Cycle:   72 oC for 105 seconds 
5. Termination Step:   72 oC for 5 minutes 
The above method applies to ADH D and E, but a variant CPCR was used for ADH F and G: 
1. Initial Denaturation Step:  95 oC for 10 minutes 
2. Denaturation Cycle:   95 oC for 30 seconds 
3. Anneal Cycle:    50 oC for 45 seconds 
4. Elongation Cycle:   72 oC for 60 seconds 
5. Termination Step:   72 oC for 5 minutes 
In both cases 40 cycles were run. 
Post PCR the products were analysed by DNA gel electrophoresis in a similar manner to 
previous.  Due to the large number of reactions typically run at this stage, larger gels were run, 
scaled up to 100ml, with 1wt% agarose (1g) and 5µl Sybrsafe.  Visualisation is again via UV 
light. 
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Should positive results be noted in the DNA gel then the relevant colony can be picked from 
the secondary plates and transferred to liquid culture.  At least two 10ml cultures (LB + 
kanamycin media) were prepared per transformant, and incubated overnight.  The next day, 
two stocks can be prepared from one of the cultures (20vol% glycerol), and the remainder of 
the same culture can be miniprepped as per the Wizard Quick Protocol for MiniPreps DNA by 
centrifugation. 
In order to check whether the transformant was as desired, the extracted plasmid was sent for 
sequencing to Eurofins and the plasmid was diluted as they recommended.  Sequencing was 
carried out using T7 primers, which flank the multiple cloning site in pET28a. 
Finally, if the sequencing was accurate, then the plasmid could be transformed into an 
expression strain of E. coli, either BL21 (DE3) or BL21 (DE3) pLysS.  In this case transformation 
was by heatshock, rather than electroporation.  1µl of DNA was added to an aliquot 
(approximately 20µl) of cells and left on ice for 20 minutes.  The aliquot was then incubated at 
42 oC for 45 seconds before being returned to ice for two minutes.  1ml of LB media was then 
added and then incubated for one hour at 37 oC.  After the recovery period 50µl-100µl was 
then plated out, this always ensured a very healthy number of colonies from which glycerol 
stocks could be obtained. 
5.2. MICROBIOLOGY 
All E. coli strains were grown using Lysogeny Broth (LB) with appropriate antibiotics 
(kanamycin 50µg ml-1 and chloramphenicol 34µg ml-1) in the first instance.  After inoculating 
with 1vol% of an overnight culture, 2L flasks containing 500ml LB would be grown until an 
optical density (OD) of approximately 0.8-1.2, after which IPTG was added to a final 
concentration of 1mM.   
Flasks were then incubated for an additional 4.5 hours, continuing at 37 oC and 225rpm 
shaking.  After this, the cells were centrifuged in 250ml portions using a Beckman-Coulter 
Allegra 25R centrifuge at 6000rpm for 10 minutes.  The cells were then resuspended in 50ml of 
the original medium; typically resuspensions from two 250ml portions were combined into 
one 50ml Falcon tube.  These were recentrifuged for 10 minutes at 4000 rpm using an 
Eppendorf 5810R centrifuge.  The supernatant was discarded and the new pellets frozen at -20 
oC until required.  All centrifugation was carried out at 4 oC, and the preparation resulted in 
one cell pellet per 500ml original culture. 
5.3. ENZYMOLOGY 
The methods and provided data comply wherever possible with the recommendations of the 
STRENDA Consortium [Standards for Reporting Enzyme Data] (Kettner, 2007; Tipton et al., 
2014), which aim to harmonise reported data amongst different research groups and journals 
to allow for easier reproducibility of data and for greater international integration of data. 
 
5.3.1. EXTRACTION AND PURIFICATION 
To prepare a sample of enzyme for study, a cell pellet was defrosted in 5ml of a buffer of 
20mM imidazole, 300mM sodium chloride and 50mM Tris.  A Complete Tablet Mini EDTA free 
Mini protease inhibitor (Roche) was also added, one tablet per 5ml pellet volume.  After the 
pellet was entirely thawed, one of two methods would be used, sonication or freeze-thaw.  In 
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the sonication variant the pellet was sonicated for 5 cycles of 15 seconds on, 30 seconds off at 
a wavelength of 21 microns on ice.  This was sufficient to lyse the cells without excessive 
degradation to the enzyme.  The freeze thaw method consisted of five cycles of being frozen at 
-80 oC, then being thawed at 42 oC in a water bath.  Typically each phase lasted five minutes.   
In addition, DNAse I (50U) was added after using the freeze thaw method, to reduce the 
viscosity of the lysate prior to further processing.  Where the production strain did not already 
natively produce lysozyme, approximately 100,000 units were added at the same time as the 
DNase I. 
To allow for the DNAse to work sufficiently, the pellet was shaken at 200rpm and 37 oC for 
circa 30 minutes to allow for sufficient mixing.  The supplied buffer was also necessary for 
efficient DNA degradation, but instead of using the recommended volumes, an equal volume 
of the supplied buffer was added to the cell pellet as the DNAse itself, i.e. 50µl of both were 
added. 
Irrespective of the overall method, freeze thaw or sonication, the pellet was then transferred 
into Eppendorfs and centrifuged at 13000rpm (~16000g) for 10 minutes to separate the 
soluble and insoluble fractions.  The insoluble fraction was reserved, whilst the soluble fraction 
was filtered through 0.45µm and 0.22µm syringe filters in preparation for purification. 
Purification was carried out by Immobilised Metal Affinity Chromatography (IMAC).  All ADHs 
were expressed in pET28a, and have a hexa-histidine tag appended to the N terminal end of 
the target protein.  Therefore, they were purified using a gradient of imidazole (20mM-
1000mM) over a nickel-based column.  The gravity column was prepared directly from His-bind 
resin (Novagen), of which 1ml were added.  After washing with 5 column volumes (CV) of 
distilled water, 5CV of 400mM nickel sulphate (NiSO4·6H2O) was added.  Excess nickel sulphate 
was removed with 5CV water and 5CV of “His-Bind Buffer”. 
The column was stored in 20% ethanol after use, and equilibrated with His-Bind Buffer prior to 
reuse.  This buffer comprised 20mM imidazole, 300mM sodium chloride and 50mM Tris.  
Various elution fractions were comprised using this buffer and the “His-Elute buffer”, 
containing 1M imidazole rather than 20mM.  To prepare the aforementioned fractions, these 
two buffers were blended as necessary, and each blend was named referring to the proportion 
of His-Elute Buffer, e.g. 20% His-Elute. 
The initial filtered soluble fraction was loaded with a small quantity (typically ~1CV) of 0% His 
Elute to dilute it to roughly 5ml in volume and to ensure that the column never dried out post 
equilibration.  After the flow through was collected, it was reloaded to the column, and the 2nd 
Flow through was then collected.  Subsequent fractions were generated by adding 5ml of the 
relevant buffer blend to the column and collecting the run off. 
Whilst purification itself was carried out at room temperature, all centrifugation and 
incubation steps were conducted at 4 oC, using ice where necessary.  
Protein concentrations were determined by Bradford Assay, utilising a commercial reagent 
(Biorad) and bovine serum albumin as standard.  Purity of proteins was determined by SDS-





Component Volume (separating) [ml] Volume (stacking) [ml] 
3.5x Buffer 2.84 1.00 
30% Acrylamide 3.34 0.46 
Milli-Q water 3.82 2.04 
10wt% APS 0.05 0.04 
TEMED 0.014 0.02 
 
Where the 3.5x buffer contained 52.32g Bis-Tris per 200ml, at a pH of 6.5-6.8. 
No further purification or isolation was conducted after fractions from the nickel column were 
collected.  The fractions were stored at 4 oC as eluted and were not processed further.  Assays 
were then conducted using raw fractions or serially diluted fractions as necessary. 
 
5.3.2. STANDARD ALCOHOL DEHYROGENASE ASSAYS 
Two methods were largely used, with the original method being used in Chapter 2, whilst an 
amended version was used in Chapter 3.  The assay method was amended by necessity and by 
the need to ensure greater control over the temperature of the assay and improved solvent 
and chemical resistance. 
 
5.3.2.1. INITIAL ASSAY METHOD 
Assays were conducted at 50 oC using disposable cuvettes, either polystyrene or poly 
(methyl methacrylate) (PMMA), which have limited solvent resistance.  Spectrophotometric 
data were acquired over approximately five minutes using a Cary 300 spectrophotometer set 
to 340nm.  Typically, assays were carried out at pH 6.0, using 50mM citric acid buffer adjusted 
with sodium hydroxide and acetic acid as needed. 
 
5.3.2.2. AMENDED ASSAY METHOD 
Assays were conducted at 50 oC, but at pH 7.0 using 50mM sodium phosphate buffer adjusted 
with sodium hydroxide and hydrochloric acid as needed.  Glass or quartz cuvettes were used, 
being washed with three volumes of 70% ethanol and dried in a static incubator at 50 oC prior 
to use.  The final change is that a Cary 50 spectrophotometer was used to acquire the data. 
 
5.3.2.3. COMMON ELEMENTS OF ASSAY METHOD 
Spectrophotometric data were acquired over a timeframe of approximately five minutes 
including equilibration time.  Rates were taken from the initial, linear, portion of all traces.  
Thus data were from direct continuous assays, most usually over a period of thirty seconds or 
more.  Where it was not possible to have such a lengthy linear trace, rates were still taken 
from the most appropriately long and linear portion of the trace at the initial phase of the 
assay, excluding any obvious discrepancy.   Generally all given data are the results of triplicate 
assays run identically, with the exception of substrate screening.  In this case, three different 
assays were run, varying the enzyme concentration with each substrate, and if enzyme 
proportionality was maintained, then the specific activity given is an average calculated from 
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all three assays.  If proportionality was not maintained using the highest concentration of 
enzyme, then the highest value was discarded and the average of the two appropriate values 
given instead. 
In a typical assay reagents were added sequentially, with the buffer as the largest volume 
being added first.  The buffer was usually the only reagent to be preincubated, and it was kept 
at 70 oC in a water bath prior to addition.  This enabled a relatively rapid acclimatisation to 
assay conditions.  After the buffer, any solvent was added, then substrate and cofactor.  The 
cuvette was then removed and shaken, if the assay temperature was 50 oC or below; above 
this, the mixing was done in situ, along with the addition of the reagents.  After this, the 
enzyme was added to start the reaction, and a further mixing step was done as previously.  
Care was also taken to ensure a minimum of bubbles was created, by lightly tapping the base 
of the cuvette immediately prior to inserting it for reading.  All assays comprised a total 
volume of 1ml, with varying volumes of enzyme, substrate and cofactor as necessary. 
Controls were done by varying the order of introducing components to the assay, for example 
to rule out the possibility of aldehydes reacting with the enzymes being tested, they were 
preincubated with the substrate and the assay started with the cofactor.  Another notable 
control was a no-substrate control, to rule out incidental effects upon the NAD(P)H readings. 
5.3.3. STABILITY ANALYSIS 
All forms of stability analysis used the same assays as given above.  When testing 
thermostability, enzyme was preincubated at various temperatures then put on ice.  Standard 
assay techniques were then used. 
Optimal temperature work used standard assays with the exception of the assay temperature.  
To accommodate higher temperatures, mixing was achieved in situ to avoid excessive heat loss 
and to prevent injury.  The cuvette was also capped to prevent evaporation of substrate, 
products or other assay components. 
Work with solvents used standard assay techniques, with solvents being directly added to the 
cuvette immediately prior to the assay. 
 
5.3.4. THERMAL SHIFT ASSAYS 
The dye SYPRO®-Orange (Invitrogen, Life Technologies, UK) was added at a final dilution of 
90-fold and enzymes were added at an approximate concentration of 0.1-1.0 mg ml-1 to 
optically clear Genie® II tubes to a final volume of 25µl.  Samples were heated from 25-105 °C 
at a rate of 0.05 °C s-1, with fluorescence measured at 470nm excitation and 555nm emission 
in a Genie® II real-time fluorescence detection instrument (Optigene, UK).  The instrument and 
instruction was kindly provided by Dr Nick Morant, GeneSys Biotech Ltd. 
The derivative of the fluorescence was recorded and plotted by the instrument, and the peak 





5.4. ANALYTICAL CHEMISTRY 
For chemical analysis, the biocatalytic reaction was carried out in 15ml centrifuge tubes, using 
identical assay components.  Thus the scale of reaction was 1ml.  The reaction was carried out 
either for one hour or 16 hours whilst capped, at 50 oC and vigorously shaken. 
Extraction was by one reaction volume (1ml) of ethyl acetate.  The solvent was vigorously 
shaken to ensure efficient mixing, and then briefly centrifuged at 4 oC to ensure separation of 
solvent and water.  The solvent was either directly analysed by GC/MS or diluted into fresh 
ethyl acetate as necessary for GC/MS analysis. 
A standard GC/MS method was used, ramping from 40 oC to 250 oC over ten minutes; the 
column used was a 30m DB-FFAP (Agilent Technologies), on an Agilent Technologies 7890B 
GC/MS system. 
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7. APPENDIX ONE –  REFERENCE DATA 
This section contains a record of all additional information with regards to the genes, enzymes, 
primers and designations used in this thesis. 
7.1. ALTERNATIVE DESIGNATIONS OF GENES AND ENZYMES 
Below is a list of all external designations utilised during this project.  For simplicity all enzymes 
were designated simply by a letter during this thesis; however, there are multiple differing 
designations given by external sources assigned to each gene and gene product, depending on 
the database.  Further, internal designations were used during the course of the project to 
ensure consistency, which are also below.  NCBI refers to the National Center for 
Biotechnology Information databases, referencing the public G. thermoglucosidasius genome 
designated C56-YS93, RAST refers to the Rapid Annotation Using Subsystem Technology 
database (Aziz et al., 2008), referencing the private genome TM242, and RTMO numbers refer 
to a previous version of the same genome.  Wherever relevant, TM242 was considered the 
primary source for sequencing purposes. 
 
ADH A Alternative Designations (Full Gene/Enzyme): 
 RTMO 02838 
 RAST 3856 
 NCBI Reference (Gene): Geoth_3897 
 NCBI Reference (Protein): YP_004589790.1 
ADH B Alternative Designations: 
 RTMO 04745 
 RAST 240 
 NCBI Reference (Gene): Geoth_3237 
 NCBI Reference (Protein): YP_004589190.1 
ADH C Alternative Designations: 
 RTMO 01825 
 RAST 3939 
 NCBI Reference (Gene): Geoth_3827 
 NCBI Reference (Protein): YP_004589720.1 
ADH D Alternative Designations: 
 RTMO 01643 
 RAST 1340 
 NCBI Reference (Gene): Geoth_2331 
 NCBI Reference (Protein): YP_004588337.1 





ADH E Alternative Designations 
 RTMO 03537 
 RAST 1773 
 NCBI Reference (Gene): Geoth_1941 
 NCBI Reference (Protein): YP_004587981.1 
 Internal Designation: ADH 6 
ADH F Alternative Designations 
 RTMO 04757 
 RAST 208 
 NCBI Reference (Gene): Geoth_3301 
 NCBI Reference (Protein): YP_004589250.1 
 Internal Designation: ADH 10 
ADH G Alternative Designations 
 RTMO 03137 
 RAST 3154 
 NCBI Reference (Gene): Geoth_0631 
 NCBI Reference (Protein): YP_004586722.1 


















7.2. LIST OF ALL PRIMERS 
Below is a list of all primers used to isolate genes encoding the enzymes referenced in this 
work.  
Gene Sequence 
ADH1 F GGGGGGGCTAGCAGTGTTTCCCGTATTGTATTTACATCGCTG 
ADH1 R GGGGGGCTCGAGTTATTTCGGCTCCGTTACCACACC 
ADH2 F GGGGGGGCTAGCAAATATCGCAAACTTGGAAGAACGG 
ADH2 R GGGGGGCTCGAGTTATGCAAGAATTTGTTCAATTTTCGCAAG 
ADH3 F GGGGGGGCTAGCAAAACTGCGAAAATTGTTCAGCACAAA 
ADH3 R GGGGGGCTCGAGTTAGAATTTAGTGATTACGTTAAACCCTTGGT 
ADH4 F GGGGGGGCTAGCAAAGCGGCAGTTGTAACGAGTTCAAA 
ADH4 R GGGGGGCTCGAGTTAACGATTGACACCGATGGTTAAAACG 
ADH5 F GGGGGGGCTAGCAAAGCGTTGGTCAAAAAAGAATTGGGTTTC 
ADH5 R GGGGGGCTCGAGTTAGTCGATAGGAGTTAACAATACTTTGATTGCCTCTC 
ADH6 F ACACACGCTAGCAATACATTCTTCTTGAAACCAAAAATCTACTTCGGAAA 
ADH6 R ACACACCTCGAGTTACCAATCTTATCCGTTATATGCCCATTT 
ADH7 F CTCTCTGCTAGCGATGTTATTGCTATTACTGGGGCG 
ADH7 R CTCTCTCTCGAGTTAAGATAAAATCATTTCGTTTTGACCG 
ADH8 F GAAAGAGCTAGCGTCACGAAACAGCAGGCAAC 
ADH8 R AAGAGGCTCGAGTTACCCATTCACCACTTTCCCAC 
ADH9 F GGGGGGGCTAGCAAGTTTTCACAAAAAGTGGTTGTCGTAA 
ADH9 R GGGGGGCTCGAGTTATTCGGCGTAAATCATCTTTCTTGTC 
ADH10 F GGGGGGGCTAGCAAACATCTGCAAGACTGTGTCACACTACAT 
ADH10 R GGGGGGCTCGAGTTAAAAATCAAAATTGTCTGGGTCCG 
ADH11 F GGGGTTGCTAGCCTTACTGAAAATATACATAAGTTTGTGAAA 
ADH11 R GGGGTTCTCGAGTTACAACGATGCACGCA 
ADH12 F GGGGGGGCTAGCATCCGATTTGCCACCATC  
ADH12 R GGGGGGCTCGAGTTATTGGTCAGCAGGAAATACGAT  
ADH13 F CCCCCCGCTAGCCGCAAAAAGAAGCAGATTACCCG 
ADH13 R CCCCCCCTCGAGTTATGGAACCTCATGACCGACTGTG 
ADH15 F GGGGGGGCTAGCAAAAAACGGCGCATCGGCTTGT 
ADH15 R GGGGGGCTCGAGTTAGCGGTGCATGTTGTACACTGAAG 
Table 35 – List of all successful primers used to isolate genes encoding putative ADHs.   Forward 
primers use NheI and reverse primers use XhoI as restriction enzymes.  Primers have six bases before 
the restriction enzyme site, typically poly G, but this section may be altered to remove hairpins or 
dimers.  Underlined bases indicate restriction enzyme sites.  
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7.3. FULL SEQUENCES OF GENES AND ENZYMES 
The full gene and protein sequences of all enzymes referred to in Chapters 2 and 3 are given 
below. 





































































































































































































































































7.4. ADDITIONAL SEQUENCES 
Following are all gene and protein sequences of additional putative ADHs that were isolated as 
part of this work, but not further referenced or studied.  They will be identified by their 
internal designations to avoid confusion with previously mentioned enzymes.  These 
sequences correspond with the primers mentioned in Table 35. 






























































































































































































































7.4.10. ADH 15 
atgaaaaaacggcgcatcggtttgtcagatttatatgtcagcgaaatcgggctcggctgcatgt
cgcttggcacggacgagcagaaagcgatccgcattattcatgaagcgctcgaacgcggcattaa
ctatttggacacggccgatctttacgaccgcggattaaatgaagaatttgtcggaaaggcgatc
aaagggaaacgcgatcaagtcatactggcaacaaaagtcggcaaccgctgggaagagggaaaag
acggatggttttgggacccgtccaaaaaatacattaaatcggaagtaaaagaaagcctgcgccg
tctgcaaacagactacatcgacttatatcagctccacggcggcacgattgatgacccgatcgat
gaaacgattgaagcgtttgaagagctaaaacaagaaggggtcatccgctattacggcatttctt
cgattcgtccgaacgtcattcgcgaatatgtaaaacggtcgaacatcgtcagtgtcatgatgca
atacagcttgctcgaccgccgccctgaagaatggtttccgctgctaagcgaacatcacatcagt
gtcatcgcccgcggacctgtcgcgaaaggattgctgacagagcggccgttagaggcggcaagcg
atgctgttaaagaaaacggttatcttgattatacatacgaagaattgcaaacactgattccaaa
gctaaaagcaaaaacagccggacatcgttcattcacagcaacggcgctgcagttttgcttatat
gatccggtcgtcgccgccgccattccaggggcaagcagcatcgaacagatcatcgaaaacataa
acgccgcttccgccccacgtttaaccaaggaagaatatgagtggctccgccagcatacgaaagc
ttcagtgtacaacatgcatcggtga 
 
MKKRRIGLSDLYVSEIGLGCMSLGTDEQKAIRIIHEALERGINYLDTADLYDRGLNEEFVGKAI
KGKRDQVILATKVGNRWEEGKDGWFWDPSKKYIKSEVKESLRRLQTDYIDLYQLHGGTIDDPID
ETIEAFEELKQEGVIRYYGISSIRPNVIREYVKRSNIVSVMMQYSLLDRRPEEWFPLLSEHHIS
VIARGPVAKGLLTERPLEAASDAVKENGYLDYTYEELQTLIPKLKAKTAGHRSFTATALQFCLY
DPVVAAAIPGASSIEQIIENINAASAPRLTKEEYEWLRQHTKASVYNMHR 
